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ABSTRACT 
 
FUNCTIONAL EVALUATION OF THE PERIPHERAL VASCULATURE USING MAGNETIC 
RESONANCE IMAGING 
Erin K. Englund 
Felix W. Wehrli, Ph.D. 
Akin to cardiac stress testing, functional integrity of the peripheral vasculature can be interrogated 
by measuring the response to a stimulus. Recent reports suggest that the reactive hyperemia 
response, the physiologic reaction following induced ischemia, is associated with disease 
presence, correlated with disease severity, and may be a sensitive biomarker of pre-clinical 
disease.  
In this dissertation, an innovative, interleaved magnetic resonance imaging method is developed, 
termed Perfusion, Intravascular Venous Oxygen saturation, and T2* (PIVOT), which 
simultaneously measures microvascular perfusion, venous oxygen saturation (SvO2), and the 
blood-oxygen-level dependent (BOLD) signal. PIVOT is first applied in healthy subjects to 
demonstrate its ability to measure reactive hyperemia response dynamics.  
Next, reactive hyperemia perfusion is compared between the more temporally efficient pulsed 
arterial spin labeling (PASL) used in PIVOT and the more recently developed and preferred 
method for the brain, pseudo-continuous ASL (pCASL). Assessment of the impact of blood flow 
variability throughout the ischemia-reperfusion paradigm on pCASL perfusion quantification is 
investigated. Then, both PASL and pCASL sequences are used to measure reactive hyperemia 
perfusion in healthy subjects. No significant differences were detected between perfusion 
measured with PASL or pCASL despite different labeling strategies, temporal resolutions, and 
perfusion quantification models. 
vi 
 
Subsequently, PIVOT is combined with a velocity-encoded dual-echo GRE to create an 
interleaved three-slice sequence that provides quantification of bulk blood flow in the arteries and 
veins in addition to the traditional PIVOT measures. This new sequence, termed Velocity and 
PIVOT (vPIVOT) is used to investigate the relationship of blood flow in the macro- and 
microvasculature and muscle oxygen consumption during the transition from exercise to rest.  
Finally, PIVOT is applied clinically in a cohort of patients with varying degrees of severity of 
peripheral artery disease. Increasing disease severity was correlated with a prolongation of the 
hyperemic response time, measured as a lengthening of time to peak perfusion, SvO2 washout 
time, and time to peak T2*. In addition, peak perfusion and SvO2 upslope were significantly 
different between patients with PAD and healthy controls. These results suggest the potential for 
PIVOT to evaluate disease severity and may present a tool to assess response to therapeutic 
intervention.  
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CHAPTER 1: INTRODUCTION 
1.1. Endothelial function and dysfunction 
Blood flow is necessary to sustain life through the delivery of oxygen and nutrients 
essential for cellular metabolism, and for the removal of waste products. In fact, every cell in the 
body is separated from a blood vessel by only 1-3 cell widths, corresponding to approximately 40 
micrometers (1). The regulation of blood flow to the tissue is a complex and dynamically 
controlled process mediated in large part by the innermost layer of the artery, the vascular 
endothelium (2) (Figure 1.1). Only one cell-layer thick, the endothelium is responsible for the 
maintenance of vascular homeostasis and among other roles serves to regulate vascular tone, 
the balance between vasodilation and vasoconstriction (3).  
 
Figure 1.1. The structure and composition of the arterial wall. The endothelium is 
the innermost layer of cells, and acts to maintain vascular tone and overall 
homeostasis. In healthy vessels, shear stress due to blood flow in the artery 
causes production and release of nitric oxide from the endothelial cells, 
promoting vasodilation. Image from (4). 
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To maintain appropriate vascular tone the endothelium produces and secretes several 
vasoactive molecules, chief among which is nitric oxide (NO) (5). NO is a potent vasodilator 
produced in the endothelium, which diffuses into the vascular smooth muscle, causing relaxation 
and subsequent vasodilation. NO is produced enzymatically from L-arginine by endothelial NO 
synthase (eNOS), which is activated by chemical (e.g. acetylcholine) or mechanical (e.g. shear 
stress) stimulus. Balancing the effects of NO are factors that promote vasoconstriction including 
endothelin-1 and angiotensin II, however in general the baseline state of endothelial function is 
one of relative quiescence (6).  
Endothelial dysfunction is the general term for the phenotypic presentation of a 
vasoconstricted, pro-inflammatory, thrombogenic state, and is purported to be the earliest stage 
of cardiovascular disease, preceding overt atherosclerotic plaque formation (3). A reduced 
bioavailability or activity of NO is thought to be the predominant mechanism underlying 
endothelial dysfunction, resulting in reduced vasodilation and delayed vascular reactivity (7). 
Endothelial dysfunction exists in many diseases including diabetes (8) and atherosclerosis (9), 
and is present in patients with significant risk factors for cardiovascular disease including aging 
and hypertension (10). One disease in particular, peripheral artery disease (PAD) is the focus of 
this thesis. 
1.1.1. Peripheral artery disease 
PAD, generally a manifestation of atherosclerosis in vessels supplying the lower limbs, 
affects over 20% of the population over 70 and is thought to be the most under-diagnosed and 
undertreated atherosclerotic disease (11-14). In PAD, atherosclerotic plaques develop at branch 
points in the peripheral arteries, resulting in occlusions or stenoses that increase vascular 
resistance and decrease blood flow to downstream skeletal muscle (15) (Figure 1.2). To meet 
the baseline oxygen and nutrient delivery demands of the muscle, the decrease in arterial flow is 
compensated by vasodilation of collateral arteries (15,16); but due to reduced vasoreactivity 
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caused by endothelial dysfunction, the vasculature is unable to quickly respond to increases in 
flow or metabolic demand (e.g. following a transient ischemia or during exercise). This creates an 
oxygen supply-demand mismatch resulting in ischemia and causing patients to present with the 
characteristic symptom of PAD – intermittent claudication, or pain on walking that is relieved by 
rest (17,18). 
 
Figure 1.2. The primary feature of PAD is the presence of atherosclerotic 
plaques in the macrovasculature, which narrow the vessel lumen and reduce 
blood flow to downstream skeletal muscle. Image from (19). 
Although endothelial dysfunction coexists (20), the presence of occlusions or stenoses 
due to atherosclerotic plaque formation in the peripheral circulation is the hallmark of PAD. In 
fact, diagnosis, staging, and standard clinical monitoring of PAD are based solely upon 
manifestations of macrovascular lesions even though those lesions are generally unchanged by 
therapeutic interventions that improve patient symptomatology (21,22). Thus, the investigation of 
endothelial function in patients with PAD may be critically important in yielding insight into the 
mechanism of action of various therapeutic approaches, and providing better tools for clinical 
monitoring.  
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1.2. Measurement of endothelial function 
1.2.1. Endothelium-dependent vasodilation 
To investigate endothelial function, a state of increased blood flow known as hyperemia 
is induced via a mechanical or chemical stimulus. In the coronary circulation, chemical stimulation 
through intra-arterial infusion of acetylcholine is the typical method used to assess endothelial 
function. Administration of acetylcholine triggers competing effects: vasoconstriction by activation 
of the muscarinic receptors in vascular smooth muscle and vasodilation by stimulation of NO 
production. Typically, the vasodilatory response dominates, however in the absence of the 
endothelium or in endothelial dysfunction, vasoconstriction occurs (2). Quantitative angiography 
can be used to directly measure the diameter of the artery before and after acetylcholine 
administration, providing a measure of the coronary endothelial function.  
In contrast to the coronary circulation, mechanical stimulation is feasible in the peripheral 
circulation by means of temporary external compression of the arteries, commonly known as an 
ischemia-reperfusion paradigm. In such a protocol, proximal arterial occlusion is sustained for 
several minutes using either supra-systolic pressure applied via a sphygmomanometer cuff 
secured around the subject’s arm or thigh, or invasively using an arterial clamp to occlude only 
the vessel of interest. During the period of arterial occlusion, blood flow in the arteries, capillaries, 
and veins is halted. The stagnant blood in the capillary bed is subjected to continued oxygen 
extraction, though the oxygen diffusion gradient between blood and tissue decreases with 
increasing ischemic duration. Additionally, there is local accumulation of vasodilators and a 
reduction in arteriolar pressure, causing an overall decrease in vascular resistance.  
Following cuff release, reactive hyperemia ensues with a transient surge of 
macrovascular flow owing to the decrease in vascular resistance downstream. This increases 
shear stress at the vessel wall, which activates eNOS, promoting NO production and release, and 
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triggering arteriolar vasodilation (23). The return of blood flow causes an increase in perfusion, 
delivering oxygenated blood to the ischemic tissue and driving out the accumulated vasodilators 
and deoxygenated capillary blood. As deoxygenated blood exits the capillary bed, there is a 
sharp decrease in intravascular venous oxygen saturation (SvO2) in the draining veins, which 
then quickly recovers, reflecting the hyperperfusion of oxygenated arterial blood in the capillary 
bed and the recovery of tissue oxygenation. SvO2 continues to rise and eventually surpasses the 
baseline value during the time that blood velocity exceeds the oxygen extraction rate. The 
kinetics and magnitude of the reactive hyperemic response provide insight about vascular 
reactivity and endothelial function (24). 
Alternatively, exercise can act as a stimulus to investigate the regulation of blood flow. 
During exercise there is a decrease in tissue partial pressure of oxygen due to a local increase in 
oxygen consumption. This triggers a metabolic response that demands increases of blood flow to 
the muscle, resulting in additional capillary recruitment by relaxing the terminal arterioles. The 
response to exercise is prolonged compared to the response elicited by transient ischemia due to 
the increase in metabolic demand that accompanies exercise, which is not present in the 
ischemic state. However, exercise is a subject-effort dependent paradigm and given the more 
combined and coordinated effort to change the local blood flow, it maybe a more difficult 
paradigm to investigate. In fact, Lopez et al recently investigated the response to ischemia 
compared to exercise hyperemia and found that the microvascular perfusion response was more 
repeatable following ischemia (25).  
1.2.2. Early measures of endothelial function and control of muscle blood flow 
The vital function of the endothelium in mediating vasodilation was not discovered until 
Furchgott and Zawadzki’s seminal report in 1980 (2), and the specific role of NO was 
subsequently uncovered by other investigators (5). Pivotal experiments were conducted prior to 
that breakthrough to study the regulation of blood flow in the skeletal muscle capillary bed. Krogh, 
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who later won the Nobel Prize in Physiology for his contribution to the field, suggested that under 
baseline conditions not all capillaries are perfused, that is, blood flows only through select 
channels within the capillary bed (26,27). Augmentation of flow largely served to increase the flow 
through those open capillaries rather than through previously unopened channels (26,28). Follow-
up studies found that in response to an increase in metabolic demand, recruitment of additional 
capillaries was realized through vasodilation at the level of the terminal arteriole (29-31), however 
this continues to be an active area of research (32).  
Early studies in humans estimated muscle perfusion through venous occlusion 
plethysmography (VOP), first described by Hewlett and van Zwaluwenburg in 1909 (33). In VOP, 
relatively low external pressure is applied to the limb of interest, serving to occlude only venous 
blood flow. The early rate of change of the distal limb circumference, measured via strain gauge, 
relates to perfusion. VOP continues to be a standard to which other measures of perfusion are 
compared, as it is noninvasive, inexpensive, and easy to combine with other methods (34). 
However VOP-measured perfusion may overestimate skeletal muscle perfusion since its 
measurement includes blood flow to the skin. 
 In 1964, Lassen, et al conducted the first study to specifically quantify skeletal muscle 
perfusion during reactive hyperemia in healthy subjects and patients with PAD (35). Radioactive 
133Xe was injected locally into the muscle, and its clearance rate was measured both at baseline 
and during reactive hyperemia. Perfusion at baseline was not significantly different between 
healthy subjects and patients with PAD, but the hyperemia response was significantly reduced 
and delayed in patients.   
As understanding of the underlying physiology and technology advanced, the methods 
developed to investigate vascular function expanded as well. Several imaging-based methods 
have emerged for the measurement of endothelial function and vascular reactivity. Flow-mediated 
dilation (FMD) of the brachial artery is perhaps the most common measure of macrovascular 
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reactivity.  To measure FMD, the diameter of the brachial artery is measured using Doppler 
ultrasound before and after a period of ischemia. In patients with PAD, low brachial artery FMD 
was associated with an increased risk for future cardiovascular event (36). However, the precise 
measurement of the artery’s diameter can be difficult, requiring technical expertise, and in general 
the brachial artery is spared from macrovascular atherosclerotic disease.  
Other imaging-based approaches to investigate blood flow in skeletal muscle include 
positron emission tomography (PET) or near infrared spectroscopy (NIRS). PET can quantify 
perfusion through an adaptation of the Kety-Schmidt model (37) following injection of 15O-water 
(38). However, the obligatory injection of a radiotracer and the need for an on-site cyclotron for 
15O due to its short half-life has limited its application to only a few studies (38-42). Optical 
imaging-based approaches on the other hand are noninvasive, the equipment is portable and 
relatively inexpensive, and patient is not subjected to ionizing radiation. NIRS or near-infrared 
diffusion correlation spectroscopy (DCS) have been used to measure relative changes in muscle 
oxygenation and blood flow, respectively (43,44). However, the quantification of these physiologic 
parameters requires complicated models and even so measurements are generally reported in 
relative rather than absolute physiologic units. Furthermore, optical imaging is restricted to 
relatively superficial structures therefore, while skeletal muscle is generally amenable, 
measurements may be prone to error if there is substantial subcutaneous fat.  
Magnetic resonance imaging (MRI) methods have also been utilized to investigate 
vascular function. MRI is entirely non-invasive, produces tomographic images, does not require 
injection of contrast, and does not expose the subject to ionizing radiation. MRI affords a wide 
variety of different structural and functional contrasts, depending on the particular pattern of 
magnetic field gradients and radiofrequency pulses, together known as a MRI pulse sequence.  
 Among the MRI methods is arterial spin labeling (ASL), a method for quantification of 
perfusion in absolute physiologic units of mL blood per minute per 100 g of tissue. Only a few 
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years after it was introduced by Detre, et al for the measurement of perfusion in the brain (45), 
Toussaint and colleagues applied a variation of the technique for the measurement of skeletal 
muscle perfusion during reactive hyperemia (46). Since then, several groups have continued to 
investigate the post-ischemia perfusion response (25,34,47,48), and have additionally looked into 
the response to exercise (25,49), hypoxia (50), various states of vascular filling (51), and in 
disease states such as PAD (52).   
Other MRI methods to assess vascular function include phase contrast flow 
measurements (53-57), MR susceptometry for dynamic measurement of intravascular venous 
oxygen saturation (SvO2) (58,59), and skeletal muscle blood-oxygen-level dependent (BOLD) 
imaging, which uses relative changes in the effective transverse relaxation time (T2*) as a 
surrogate for capillary bed oxygen content (60-65). Alterations in the dynamics of each of these 
parameters have been associated with the presence of PAD during reactive hyperemia studies. 
Patients exhibited a blunted and delayed hyperemic response in bulk arterial blood flow (66), 
perfusion (52), dynamic SvO2 (67) , and T2* (68,69). The technical foundations of each of these 
methods are described subsequently.  
1.4. MRI measures of vascular function 
1.4.2. Phase contrast MRI for quantification of flow 
Unlike many of the previously mentioned responses, which are only altered due to 
endothelial dysfunction in the post-stimulus state, the measurement of macrovascular blood flow 
velocity provides insight into vascular health both at rest and during hyperemia. In young healthy 
subjects, the baseline blood flow waveform of arteries in the peripheral circulation is triphasic, 
with high velocity antegrade flow during the systolic phase of the cardiac cycle, followed by flow 
reversal and then low velocity forward flow during diastole. In contrast to healthy subjects, 
patients with PAD generally present with a monophasic flow waveform, where blood flow velocity 
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drops during diastole, but remains antegrade throughout the entire cardiac cycle (70). In addition 
to this baseline measurement of the arterial flow waveform, the dynamics of the arterial blood flow 
response during reactive hyperemia or following exercise provide insight into endothelial function 
and vascular reactivity, as pointed out earlier.  
1.4.2.1. Quantification of blood flow velocity 
Blood flow velocity can be quantified using phase-contrast MRI (53-55,71). Generally, the 
temporal evolution of the phase of the MRI signal can be expressed as:  
  𝜑 𝑡 =  𝛾 𝑚!𝑥! +𝑚!𝑣! + !!𝑚!𝑎! +⋯    [1.1] 
where γ is the gyromagnetic ratio, m0, m1, and m2 represent the zeroth, first, and second order 
gradient moments, respectively  (𝑚! =  𝐺 𝜏 𝜏!𝑑𝜏!!  and G is the gradient amplitude at time, t), x0 
is the position of the spin, v0 is the velocity, and a0 represents acceleration. The relationship can 
be expanded to include higher order time derivatives of position such as jerk, however these 
terms are generally disregarded.  
By using bipolar gradients, it is possible to create a situation with m0 = 0, but a non-zero 
m1. In this case, stationary spins will have complete phase restoration, but moving spins will 
accumulate phase as a function of velocity (Figure 1.3).  
10 
 
 
Figure 1.3. Diagram showing the effect of bipolar gradients on stationary and 
moving spins. The phase evolution of stationary spins is shown in the center, and 
that of moving spins is shown in bottom. Bipolar gradients are balanced, having 
no net area and therefore imparting no residual phase onto stationary spins. 
However there is a non-zero first gradient moment, causing accumulation of 
phase in moving spins. 
 
In this special situation, moving spins will accrue phase simply as:  𝜑 𝑡 =  𝛾𝑚!𝑣. In 
phase contrast MRI, the first gradient moment is changed (typically toggled) between otherwise 
identical image acquisitions. The phase difference between these two images attenuates phase 
variation from background field gradients and accentuates the phase accrual due to motion. The 
range of velocities that can be measured without phase wrapping is given by a user-defined 
parameter related to the difference in m1 between the two acquisitions, the velocity encoding 
(VENC) as: 
 𝑉𝐸𝑁𝐶 = !!∙!!!       [1.2] 
Thus for toggled gradients, Δm1 = m1 – (-m1) = 2m1. 
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1.4.2.2. Gated and ungated methods 
Velocity maps can be acquired in several different forms. By gating the phase contrast 
acquisition to the electrocardiogram, several images can be reconstructed at different time points 
in the cardiac cycle, providing cine images of blood flow throughout the cardiac cycle (72). Image 
acquisition generally takes several seconds to minutes depending on the apparent temporal 
resolution desired, as k-space data are acquired over several heartbeats and synthesized 
together to create images of a single cardiac phase. Furthering this technique, velocity can be 
resolved in 3 dimensions along with 3-dimensional spatial encoding to create 4D flow images 
(73,74).  
 If the acquisition is not gated to the cardiac cycle, the velocity will be weighted by the 
phase of the cardiac cycle during the acquisition of the center portion of k-space. Alternatively, 
ungated projection phase contrast can generate time-resolved beat-to-beat velocity 
measurements (56,57). In Langham, et al’s approach to quantify velocity via k-space projections 
a fully phase encoded reference image is first obtained, followed by acquisition of only the 
centerline of k-space (k-space projection) (57). The reference image is used to create a static 
tissue k-space projection by masking out the vessels of interest, then taking the inverse Fourier 
transform and isolating the center k-space line (ky=0). This static tissue k-space projection is 
subtracted from every dynamically acquired velocity-encoded projection to isolate blood signal. 
The phase difference between adjacent positive and negative velocity-encoded projections is 
computed and the average velocity across the vessel of interest can be quantified temporal 
resolution equal to the pulse sequence repetition time (TR), using a temporal window of two TRs.  
Reactive hyperemia bulk flow or blood flow velocity time courses can provide insight into 
the vascular reactivity and endothelial function (75). Parameters of interest include the time to 
peak flow and the duration of forward flow, which are increased in the presence of PAD (66).  
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1.4.3. Arterial spin labeling for perfusion quantification 
 ASL is a well-established method for noninvasive perfusion imaging (45,76-79). 
Several variations of ASL exist, employing various labeling strategies, but generally perfusion is 
quantified by pairwise subtraction between two images – one acquired after magnetically-labeling 
the inflowing arterial blood (label) and an otherwise identical image without the label (control). 
The resultant signal difference cancels out the contribution from static tissue, leaving behind a 
signal that is related to the amount of perfusion, that is microvascular flow and exchange between 
blood water and tissue water, that occurred during the time between the label and image 
acquisition (Figure 1.4). This signal can be converted into perfusion in units of mL/min/100g 
through application of various models that describe the exchange between arterial blood water 
and tissue water (34,47,80,81).  
 
Figure 1.4. General experimental setup for ASL MRI-based perfusion measurement. Identical 
images are acquired with or without magnetically labeling arterial blood in the label and control 
conditions, respectively. Static tissue signal is unchanged between these two images, thus 
subtraction cancels out its contribution, leaving behind only the signal from exchange of blood 
and tissue water during the post labeling delay. 
 
 The ASL labeling method scan be divided into two general categories: those that label 
by flow-driven adiabatic inversion of blood as it passes through a labeling plane, as in continuous 
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ASL (CASL) or pseudo-continuous ASL (pCASL), or those that use spatially selective inversion of 
blood as in pulsed ASL (PASL) (Figure 1.5). Skeletal muscle perfusion during hyperemia has 
been quantified with all of these methods (25,34,47,48), and there are benefits and drawbacks to 
each. CASL and pCASL methods utilize a long pulse or series of pulses to achieve inversion, 
thereby reducing labeling efficiency to approximately 85% (82) and limiting temporal resolution to 
6-8 seconds (47,48,52). CASL or pCASL methods do offer an increase in theoretical signal-to-
noise ratio compared to PASL as the labeled blood water spins accumulate in the tissue 
throughout the longer labeling duration (83). PASL on the other hand uses a single RF pulse for 
nearly instantaneous and complete inversion, allowing perfusion measurement at a temporal 
resolution of up to 2 second (34).  
 Both PASL and pCASL or CASL methods have an unavoidable post-labeling delay 
(PLD). The PLD is dead time between the arterial labeling pulse and the image acquisition 
required to allow the transit of blood from the labeling location into the imaging slice location. The 
temporal resolution of PASL is largely limited by the duration of the PLD. For pCASL and CASL, 
the labeling duration and PLD are typically approximately the same at about 1-2 seconds each 
(81).  
 Due to the transient nature of the hyperemic response, high temporal resolution 
sampling of the time course is necessary. Furthermore, there is baseline signal variation over the 
course of the ischemia reperfusion experiment due to the changing oxygen saturation and 
vascular volume in the capillaries causing changes in the BOLD signal. To correct for the 
baseline signal variation, temporal matching of the label and control datasets is performed by 
linear interpolation of the control dataset (47). Interpolation works well when the signal change is 
negligible or linear between the time points, however when signal variation changes rapidly, as 
seen immediately following cuff release, linear temporal matching does not compensate for the 
dynamic changes. Given that the offset between label and control images is approximately 3 – 4 
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seconds in CASL or pCASL, and only 1 – 1.5 seconds in PASL, the BOLD signal changes are 
more accurately adjusted in PASL (84).  
 
Figure 1.5. Description and location of label and control locations in CASL, 
pCASL, and PASL experiments. In CASL and pCASL, flow-driven adiabatic 
inversion causes blood in the artery to be inverted as it passes through the 
proximal labeling plane. In the control condition for CASL, the labeling plane is 
located distal to the imaging slice location. For the pCASL control condition, the 
location of the labeling plane remains unchanged, but no net labeling of blood is 
achieved. In contrast, the label condition of the PASL sequence is a slice-
selective inversion, causing inversion of tissue, but inflowing blood is uninverted. 
In the control condition of PASL both the inflowing blood and tissue signal are 
inverted.  
 
1.4.3.1. Continuous and pseudo-continuous ASL 
In CASL, inflowing arterial blood is selectively inverted in the label condition through flow-
driven adiabatic inversion (85), in which a continuous low B1 field is played alongside a constant 
amplitude gradient to drive spins moving perpendicularly through the labeling plane to the 
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negative Z axis (Figure 1.6a). An adiabatic inversion is achieved in the presence of a constant 
gradient and B1 field, as long as the velocity of the spin meets the adiabatic condition:  
 !!! ≪ !"!!"" ≪ 𝛾 𝐵!""       [1.4] 
where T2 is the transverse relaxation time of blood water protons, v is the velocity of the spin, G is 
the average gradient amplitude, Beff is the effective magnetic field, and γ is the proton 
gyromagnetic ratio. Implications of this will be further discussed in Chapter 3.  
Labeling generally lasts one to two seconds. Current MRI transmit coils are incapable of 
playing out such a long continuous B1 field, thus pCASL was introduced as an adaptation of 
CASL (82). pCASL also relies on flow-driven adiabatic inversion, but rather than continuous 
radiofrequency (RF) excitation for the duration of a second or so, the excitation period is broken 
up into a train of short RF pulses along with oscillating gradients with a non-zero net amplitude 
are used (Figure 1.6b) to label blood.  
 To prevent errors due to magnetization transfer effects, the low flip angle RF pulse or 
pulses must be matched between the label and control image acquisitions (86). In CASL, the 
simplest option uses gradients of opposed polarity or RF of opposite phase; either option causes 
the labeling plane to be distal to the imaging location (Figure 1.6d).  For the control condition in 
pCASL, spins remain uninverted through application of similar RF pulses as in pCASL labeling, 
but alternating in phase by 180°, and zero net gradient amplitude (Figure 1.6e) (82), thereby 
imparting no net excitation.  
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Figure 1.6. Pulse sequence diagrams of label and control schemes for CASL, 
pCASL, and PASL. Flow-driven adiabatic inversion is used to label arterial blood 
water spins in both CASL and pCASL. In the control condition, spins in inflowing 
blood remain unperturbed either by labeling distal to the imaging slice (as in 
CASL) or by producing no net excitation (as in pCASL). Spatially selective or 
non-selective adiabatic inversion pulses are used for PASL label and control, 
respectively.  
1.4.3.2. Pulsed ASL 
 There are several variants of pulsed arterial spin labeling. The method that has been 
most widely applied for skeletal muscle perfusion is Flow-Alternating Inversion Recovery (FAIR) 
or offshoots of that method (25,34,49,51). In contrast to CASL and pCASL, PASL labeling is 
achieved via application of a single spatially-selective inversion pulse, meaning that the duration 
of the label or control module is much shorter, spins are inverted regardless of the flow velocity, 
and the transit distance between the locations of the label and the image acquisition is generally 
much smaller.  Thus, PASL methods have faster labeling and thus higher potential temporal 
resolution, and higher and more consistent labeling efficiency.  
In FAIR (77) a RF pulse inverts the magnetization either slice-selectively (SS) for the 
label condition, or non-selectively (NS) for the control condition (Figure 1.6 c, f). Thus for the 
a b c 
d e f 
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label condition, the tissue signal is recovering from inversion, but inflowing blood remains 
uninverted, and in the control condition both the inflowing blood and tissue are recovering from 
inversion. Saturation Inversion Recovery, a method developed for the measurement of skeletal 
muscle perfusion by Raynaud, et al (34) uses the same control and label conditions as in FAIR, 
and additionally includes a slice-selective saturation pulse after each imaging readout to ensure 
presence of the same initial magnetization in each dynamic acquisition.  
1.4.3.3. Quantification of perfusion 
 To determine perfusion in physiologic units, several models have been proposed that 
derive from the general solution to the Bloch equation for longitudinal magnetization of blood 
including a term for inflow and outflow of blood, originally described by Detre, et al (45):  
!!!!" = !!!!!!! + 𝑓 𝑀! −𝑀!      [1.5] 
where Mz is the longitudinal magnetization of water in tissue, Ma is that of arterial blood water, Mv 
is that of venous blood water (𝑀! = !! , where λ is the tissue partition coefficient), T1 is the 
relaxation time of tissue, and f represents perfusion.  
 Assuming a one-compartment model for blood (e.g. blood water is delivered and 
accumulates in tissue), pCASL perfusion can be quantified as described by Buxton, et al (80) as: 
𝑓 = !∙ !!"#$%"&!!!"#$! ∙! !"#!!,!"##$!∙!∙!!,!"##$∙!!"#$%"&∙ !!! !!!!,!"##$      [1.6] 
where PLD represents the post labeling delay – the time between the end of the labeling period 
and image acquisition, T1,blood is the longitudinal relaxation time of blood, α is the labeling 
efficiency, and τ is the labeling duration. An alternate form of this model can be used to quantify 
perfusion using the SATIR PASL sequence (34). Using a similar one-compartment model and 
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assuming the T1 of blood and tissue can be approximated as equal, perfusion can be quantified 
as: 
𝑓 = !!"# ∙ ln !!"#$!!!!"#$%"&!!"#$!!!!"#$%"& ∙ 1 − 𝑒 !"#!!,!"##$ + 1   [1.7]  
 In the brain the interest is generally in high accuracy measurement of spatially 
resolved perfusion, therefore several repeats are averaged to create a voxelwise map of 
perfusion. In skeletal muscle, although spatial localization of the signal is important, the interest is 
generally in the dynamic measurement of perfusion changes over time. Thus, each label and 
control image pair is used to calculate perfusion, yielding time-resolved perfusion in muscles of 
interest. In reactive hyperemia experiments, the time course is analyzed to determine the speed 
of response, measured as the time to peak perfusion, and the response magnitude, measured as 
the peak perfusion. Prior studies have uncovered an association between peak perfusion and 
PAD disease presence and severity, showing a decrease in peak perfusion with the presence of 
PAD and a further decrease with increasing disease severity. A similar trend was reported for the 
time to peak perfusion – with increasing disease severity there was an increase in the time to 
peak perfusion (52).  
1.4.4. Dynamic oximetry 
SvO2 is an important physiologic parameter, providing information about oxygen 
utilization in tissue (58,87). During the ischemia reperfusion paradigm, supra-systolic pressure 
halts arterial inflow and oxygen extraction continues in the stationary blood of the capillary bed, 
but due to the stagnation of blood flow there is no observed change in SvO2 of the draining vein. 
Upon cuff release, the hyperemic arterial inflow drives deoxygenated blood in the capillary bed 
into the collecting veins, causing the measured SvO2 to drop sharply. This response is followed 
by an overshoot as the increased flow velocity exceeds the maximum oxygen extraction rate. The 
SvO2 then normalizes back to the baseline value. Oxygen extraction only occurs in the capillary 
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bed, thus the dynamic measurement of SvO2 allows intravascular blood to act as an endogenous 
tracer, providing information about endothelial function and vascular reactivity (66,67,75,88).  
There are two main methods that have been introduced and reduced to practice for 
measurement of oxygen saturation in the large draining veins. These are MR susceptometry-
based oximetry (58,87), and T2-based oximetry (89), such as T2 relaxation under spin tagging, 
commonly called TRUST (90) or projection T2 (91). The T2-based oximetry method requires a 
sequence-specific calibration between the measured T2 and %HbO2 (92). On the other hand, MR 
susceptometry quantifies SvO2 by modeling the relationship between the venous oxygen 
saturation and the induced magnetic field shift (58,87). Thus susceptometry-based oximetry is 
more limited in the geometry of vessels to which it can be applied, but does not require any 
sequence-specific calibration. For applications in skeletal muscle, MR susceptometry is preferred 
owing to the fact that the vessels are generally long and oriented parallel to the main magnetic 
field, thus an analytical solution can equate the MRI measurement to SvO2. Furthermore, MR 
susceptometry has higher feasible temporal resolution than T2-based methods, which typically 
require a lengthy T2 prep and image acquisition. Maximum temporal resolution of T2-based 
oximetry is limited to 12 seconds (93), while a temporal sampling rate exceeding 2 seconds can 
be obtained with MR susceptometry (94).  
1.4.4.1. Susceptometry-based oximetry 
MR susceptometry-based oximetry is a recently developed method for quantifying SvO2, 
measured in units of percent-oxygenated hemoglobin (%HbO2) (58,87). Due to the different 
electron spin configurations of the Fe2+ heme iron in the oxygenated versus deoxygenated state 
(95), the magnetic properties of arterial and venous blood differ. Specifically, deoxyhemoglobin is 
paramagnetic thus creating a magnetic susceptibility difference between it and diamagnetic 
oxyhemoglobin and tissue. The susceptibility difference (Δχ) is related to the content of 
deoxygenated hemoglobin in the blood as:  
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  ∆𝜒 = ∆𝜒!" Hct 1 − SvO!      [1.8] 
where Δχdo represents the susceptibility difference between fully oxygenated and fully 
deoxygenated blood (Δχdo = 4π·0.27 ppm (SI units) (96,97)) and Hct is the hematocrit. The 
susceptibility difference induces a local magnetic field ΔB in the draining vein relative to the 
tissue, which, by modeling the vein as a long paramagnetic cylinder, can be described as: 
  ∆B = !!∆𝜒 B! 3cos!𝜃 − 1      [1.9] 
where B0 is the main magnetic field strength, and θ is the angle of the vessel with respect to B0. 
The incremental field ΔB can be determined by subtracting the phase accumulation of the MRI 
signal in surrounding tissue from that inside the vein (Δφ) as: 
  ∆ϕ = γ ∆B ∆TE       [1.10] 
where the phase is measured from successive echoes separated in echo time by ΔTE (Figure 
1.7). Combining equations 1.8-1.10, one can relate the intra/extravascular inter-echo phase 
difference to SvO2 as: 
 SvO! = 1 − ! !! !!"! !!!" !! !"#!!!! !  × 100   [1.11]   
It has been shown that for small angles, the induced field outside of the vessel is approximately 
homogeneous and independent of the susceptibility difference between the vein and tissue (98). 
Therefore SvO2 can be measured using a field-mapping sequence, such as a multi-echo 
gradient-recalled echo (GRE). With this technique, one can quickly, directly, and noninvasively 
quantify intravascular SvO2 at high-temporal resolution. Due to inhomogeneities in the main 
magnetic field, background phase accumulation can occur. In the image processing of multi-echo 
GRE oximetry data, the background phase modulation is fitted and subtracted out as described 
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by Langham, et al (99).  
 
Figure 1.7. Diagram depicting the vein as a long, relatively parallel, 
paramagnetic cylinder. The inter-echo phase accrual of intravascular blood (φ i) is 
compared to that of background tissue (extravascular phase, φ e). The difference 
between intra- and extravascular phase accrual is proportional to the incremental 
magnetic field shift inside the vessel, which can be related to susceptibility and 
hence SvO2. 
 
Washout time (time to minimum SvO2), upslope – representing the rate of resaturation 
(maximum slope during recovery), and overshoot (peak SvO2 minus baseline SvO2) can be 
extracted from the SvO2 time course data. These metrics reflect the reactivity of the microvessels 
to NO-mediated vasodilation. Langham et al revealed an association between alterations in the 
SvO2 time course-derived metrics in the femoral vein and the presence of PAD (66,67). 
Compared to age-matched healthy controls and young healthy subjects, patients with PAD had a 
longer washout time, diminished upslope, and lower overshoot, suggesting endothelial 
dysfunction.  
1.4.5. BOLD MRI 
In the microvasculature, as in the large veins, the paramagnetism of deoxyhemoglobin 
causes inhomogeneities in the local magnetic field. Because the microvessels are small 
compared to the MR imaging resolution, it is not possible to directly measure a change in signal 
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phase as was described above for MR susceptometry. However, changes in the concentration of 
deoxyhemoglobin will modify the local magnetic field to cause incoherent phase accrual, resulting 
in intravoxel phase dispersion, which causes the MRI magnitude signal to decay more rapidly 
(60,61). This can be measured as a reduction in the effective transverse relaxation time, T2*, and 
represents the contrast mechanism commonly known as the BOLD response. The BOLD signal 
originates not only from changes in blood oxygen level, it is also sensitive to changes in 
perfusion, cellular pH, vessel diameter, and vessel orientation (100-103). It has been postulated, 
however, that the skeletal muscle BOLD signal primarily results from changes in the 
concentration of deoxyhemoglobin in the capillary bed (103).  
BOLD imaging has been extensively applied for functional activation studies in the brain, 
and can additionally be used to investigate activation of other organs including skeletal muscle. 
Changes in T2* in response to an ischemia-reperfusion paradigm can serve as a relative marker 
of tissue oxygenation (104). The multifactorial contrast mechanism and the fact that the 
measured response is relative, rather than in physiologic units, however, can make the 
interpretation of the BOLD signal more complicated than perfusion or dynamic SvO2. 
Quantification of T2* can be achieved by fitting signal intensity (SI) data from a multi-echo 
gradient-recalled echo acquisition to a monoexponential function: 𝑆 TE = 𝑆!𝑒!!" !!∗ where TE is 
the echo time of the acquisition. Prior studies have shown the utility of investigating dynamic 
skeletal muscle BOLD during exercise (105-107), ischemia (69), reactive hyperemia (46), and in 
disease states (68,69). Important metrics that may provide information about vascular function in 
reactive hyperemia experiments include relative T2* maximum and the time to maximum T2*. 
Previous work by Ledermann and colleagues showed that patients with PAD had a reduction in 
the peak T2* and a prolongation in the time to peak T2* compared to healthy subjects (68).  
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1.4.6. Combined measures of flow and oxygenation 
The combination of measures of flow and oxygenation can provide additional information 
regarding the vascular function. Some MRI protocols explored the combination of imaging and 
spectroscopy to assess either metabolism directly, or tissue oxygen saturation. Specifically, a 
method proposed by Richardson, et al combined the measurement of ASL-based perfusion and 
31P spectroscopy to assess changes in blood flow and ATP and its metabolites, respectively, in 
response to exercise (108). Another approach pursued the measurement of perfusion, through 
MRI-based plethysmography, and of deoxymyoglobin concentration through non-localized 
spectroscopy, providing a quantitative measure of microvascular and skeletal muscle tissue 
oxygen saturation and hence muscle oxygen consumption (109). Several other methods have 
been introduced that measure two of the previously introduced processes simultaneously.  
1.4.6.1. Perfusion and BOLD 
Duteil, et al described a method to measure both the perfusion and BOLD response from 
the same series of images: either the subtraction of label and control images to quantify 
perfusion, or the addition of these two images to assess BOLD signal changes (51). As the BOLD 
response is a multi-factorial in mechanism, the authors postulated that the combined method 
might help to distinguish the different contribution of perfusion increases to the change in the 
BOLD contrast or of changes in oxygen saturation in the capillary bed.  
 Other methods have been proposed for the combined measurement of perfusion and 
BOLD changes. For example, a double excitation sequence for simultaneous quantification of 
ASL and BOLD was proposed by Walvick, et al (110), and later refined by Mendes, et al for the 
additional measurement of T2 (111,112). In the more recent adaptation (112), the image 
acquisition for perfusion quantification is followed by a separate dual-echo acquisition to quantify 
T2*. The subsequent NS or SS inversion also acts to refocus the magnetization for quantification 
of T2.  
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1.4.6.2. Flow and SvO2 
Combined measure of flow and SvO2 can be achieved using several different methods. 
Langham, et al introduced a method to measure time resolved flow via projections and field maps 
for SvO2 quantification using susceptometry-based oximetry, as detailed earlier (88). This method 
was applied in patients and healthy controls during an ischemia-reperfusion paradigm, and 
results of flow and SvO2 were analyzed independently (66).  
More recently, Mathewson, et al (113) utilized a similar combined flow and SvO2 method 
to investigate the off-kinetics of exercise, that is the transition between exercise and rest. Flow 
and SvO2 were measured in the femoral vein following quadriceps exercise, and from these data, 
muscle oxygen consumption (𝑉𝑂!) was calculated via the Fick principle as: 
 𝑉𝑂! = 𝐶!𝑂! ∙ 𝑓𝑙𝑜𝑤 ∙ 𝑆𝑎𝑂! − 𝑆𝑣𝑂!     [1.12]   
where CaO2 is the arterial oxygen content. It is important to note that the calculation of 
oxygen consumption cannot be so easily computed from reactive hyperemia studies since the 
measured changes in SvO2 reflects the aggregate effect of the desaturation during ischemia 
rather than reflecting the current capillary bed oxygen saturation.  
Others have investigated an approach that quantifies muscle oxygen consumption either 
by empirical calibration (49) or theoretical relationship between %HbO2 and T2’, the RF-reversible 
component of the transverse relaxation time !!!∗ = !!! + !!!!  (114). Therefore, instead of bulk flow 
and draining vein SvO2, perfusion and microvascular SvO2 were measured via a combined ASL 
and T2’-based methods (115,116). T2’-based oximetry methods have been used to quantify 
oxygen saturation on a voxel-wise basis in the brain (114), and combined with ASL-based 
perfusion can quantify the rate of oxygen consumption either in the steady state of an isometric 
contraction (115), or in response to the transition between exercise and rest (116). 
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1.4.6.3. Bulk flow and perfusion  
Another interesting combined measurement is the assessment of blood flow in the large 
arteries and blood flow in the capillaries, measured for instance as the combination of phase 
contrast flow and ASL perfusion. Zhang et al pursued a method to investigate these two 
parameters through Doppler ultrasound to quantify bulk arterial flow in the popliteal artery, and 
ASL MRI was used to determine perfusion (117). Although these investigations are still in an 
early stage, this combined measurement may provide insight into the specific reactivity of the 
microvasculature.  
1.3. Outline of Dissertation Chapters 
This dissertation describes the development and application of MRI-based methods for 
the measurement of peripheral vascular function. In Chapter 2, an interleaved pulsed arterial spin 
labeling and multi-echo GRE method, termed perfusion, intravascular venous oxygen saturation, 
and T2* (PIVOT) is described, evaluated compared to standard non-interleaved approaches, and 
applied to a small cohort of young healthy subjects and patients with peripheral artery disease. In 
Chapter 3, the PASL method for perfusion quantification is compared to pseudo-continuous ASL 
(pCASL) and implications of the changes in average arterial blood flow on the precision of pCASL 
quantified perfusion are investigated. In Chapter 4, the original PIVOT sequence is expanded to 
include an upstream velocity-encoded multi-echo GRE outside of the PASL portion of the 
sequence. This expanded three-slice interleaved sequence permits quantification of perfusion, 
SvO2, and T2* alongside arterial and venous bulk flow at four second temporal resolution, 
providing a comprehensive tool for evaluation of peripheral vascular function. Using both post-
ischemia reactive hyperemia and post-exercise functional hyperemia stimuli, the relationship 
between blood flow in the macro- and microvasculature was investigated, and oxygen 
consumption was quantified following exercise. Finally, in Chapter 5, the PIVOT method outlined 
in Chapter 2 was applied in a cohort including 96 patients with varying degrees of peripheral 
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artery disease and 10 healthy subjects. Results show that the reactive hyperemia timing 
response is highly correlated with the clinical measure of disease severity.  
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CHAPTER 2: COMBINED MEASUREMENT OF PERFUSION, 
VENOUS OXYGEN SATURATION, AND SKELETAL MUSCLE T2* 
DURING REACTIVE HYPEREMIA IN THE LEG  
2.1. Abstract 
Purpose: To develop and evaluate an MRI technique for simultaneous measurement of 
perfusion, venous oxygen saturation (SvO2), and skeletal muscle T2*.  
Methods: Perfusion, Intravascular Venous Oxygen saturation, and T2* (PIVOT) is comprised of 
interleaved pulsed arterial spin labeling (PASL) and multi-echo gradient-recalled echo (GRE) 
sequences. During the PASL post-labeling delay, images are acquired with a multi-echo GRE to 
quantify SvO2 and T2* at a downstream slice location. Thus time-courses of perfusion, SvO2, and 
T2* are quantified simultaneously within a single scan.  The new sequence was compared to 
separately measured PASL or multi-echo GRE data during reactive hyperemia in five young 
healthy subjects. To explore the impairment present in peripheral artery disease patients, five 
patients were evaluated with PIVOT. 
Results: Comparison of PIVOT-derived data to the standard techniques shows that there was no 
significant bias in any of the time-course-derived metrics. Preliminary data show that PAD 
patients exhibited alterations in perfusion, SvO2, and T2* time-courses compared to young healthy 
subjects. 
Conclusion: Simultaneous quantification of perfusion, SvO2, and T2* is possible with PIVOT. 
Kinetics of perfusion, SvO2, and T2* during reactive hyperemia may help to provide insight into 
the function of the peripheral microvasculature in patients with PAD. 
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2.2. Introduction 
As discussed in Chapter 1, peripheral artery disease (PAD) causes significant morbidity 
and mortality in the United States (11-13,118). Baseline blood flow to skeletal muscle is generally 
maintained through the recruitment of collateral arteries (15,119), however the vasculature is 
unable to quickly respond to changes in metabolic demand, such as those that occur with 
exercise or following a period of ischemia. Analogous to cardiac stress testing, the functional 
integrity of the peripheral vasculature can be interrogated by measuring the dynamic response to 
a period of induced ischemia. This period of transient ischemia causes buildup of vasodilator 
metabolites and reduces the vascular resistance in the capillary bed. Upon release of the 
proximal arterial occlusion reactive hyperemia ensues, and the kinetics of the hyperemic 
response can provide information on microvascular integrity and endothelial function. The 
vasculature of healthy subjects is able to rapidly respond to the increase in flow, recovering to 
baseline more quickly than patients with PAD (52,66,68).  
Also as introduced previously, there are several MRI methods that can yield data that are 
sensitive to the dynamic processes that occur during reactive hyperemia. Independently, 
perfusion (52), SvO2 (67), and T2* (68,69) have been used to evaluate the hyperemic response. 
Additionally, the measurements of perfusion and the BOLD signal have been combined to 
simultaneously investigate the relative changes in microvascular flow and capillary bed oxygen 
saturation (51,120). However, these methods have not been able to also investigate SvO2 
kinetics. On the other hand, measurement of SvO2 has been combined with the measurement of 
macrovascular flow (66,88), but not with the spatially localized measurement of perfusion.  
The post-ischemia recovery dynamics are altered in each of these parameters in 
situations of impaired vascular function, as in PAD (52,66-69); therefore there is potentially added 
benefit to concurrent measurement. Thus, in this work, we developed a method to measure 
perfusion, SvO2, and T2* simultaneously. Such a technique allows for a more complete functional 
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assessment of the peripheral vasculature during a single scan providing information on the 
temporal relationships between these various functional parameters. 
2.3. Theory 
The technical foundations of ASL perfusion quantification, MR susceptometry based 
oximetry, and the measurement of BOLD signal changes have already been described Chapter 1.  
To briefly summarize, perfusion can be measured through ASL by taking the difference 
between images acquired with and without magnetically labeling the inflowing blood (45,76). 
These images are known as the label and control images, respectively. Aside from the application 
of the labeling pulse the label and control images are otherwise identical, thus the difference 
between them cancels out signal contribution from the static tissue and the leftover signal can be 
converted into perfusion in absolute physiologic units (34,47,80,81). Specific to this application, a 
method proposed by Raynaud, et al for the measurement of perfusion in skeletal muscle uses 
slice-selective and non-selective inversion pulses to achieve the label and control conditions. To 
reset the magnetization, a saturation pulse follows each image acquisition. This variant of the 
PASL-FAIR method is known as Saturation Inversion Recovery (SATIR) (34). Essential to all ASL 
methods is the presence of a delay time between the application of the label and the image 
acquisition, known as the post-labeling delay (PLD). The PLD is necessary to allow the transit of 
labeled blood water into the tissue.  
In MR susceptometry, venous oxygen saturation is quantified by measuring the local 
magnetic field offset induced by the presence of an accumulation of paramagnetic 
deoxyhemoglobin (e.g. large draining vein) (58,87). By modeling the vein as a long paramagnetic 
cylinder, the field offset, measured as the difference in inter-echo phase accrual between the vein 
and background tissue, can be directly related to the concentration of deoxyhemoglobin provided 
that the vein is relatively parallel to the main magnetic field (59,121). Therefore a field mapping 
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sequence, such as a multi-echo GRE, can be used to quantify SvO2 in physiologic units (% 
HbO2).   
The BOLD signal refers to the measurement of relative changes in the effective 
transverse relaxation time (T2*), and is related to changes in blood oxygen level in the capillary 
bed, perfusion, and cellular pH, and is also associated with vessel diameter and vessel 
orientation (100-103). Quantification of T2* can be achieved by fitting signal intensity (SI) data 
from a multi-echo GRE to a monoexponential function.  
Thus, a multi-echo GRE sequence can be used to measure both SvO2 from the evolution 
of the signal phase, and T2* from the rate of decay of the signal magnitude. Here, a sequence is 
introduced, termed Perfusion, Intravascular Venous Oxygen saturation, and T2* (PIVOT). PIVOT 
makes use of the PLD dead time inherent to all ASL sequences to acquire multi-echo GRE data 
at a separate, downstream slice location (Figure 2.1). This allows dynamic quantification of 
perfusion, SvO2, and T2* within a single scan. 
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Figure 2.1. Pulse sequence diagram of PIVOT. A slice-selective (shown by SS 
only gradient) or non-selective adiabatic inversion pulse labels blood for 
perfusion imaging. During the PLD a keyhole multi-echo GRE acquires data 
downstream from the perfusion slice location for SvO2 (blue) and T2* (green) 
analysis. An EPI readout at isocenter (red) is used to acquire the images for 
perfusion quantification. 
 
  In PIVOT, as in SATIR, label and control conditions for perfusion imaging are achieved 
using SS and NS inversion pulses, respectively. During the PLD, a keyhole (122) multi-echo GRE 
sequence acquires data at a distal slice for SvO2 and T2* quantification. The distal location was 
chosen to ensure that the multi-echo GRE interleave does not impact the signal from previously 
labeled perfusing blood. Because the NS inversion affects both the PASL and multi-echo GRE 
slices, only multi-echo GRE data acquired following SS inversion are analyzed, though the 
interleave is run every PLD to control for magnetization transfer effects. The multi-echo GRE is 
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immediately followed by a GRE-EPI readout at isocenter to capture data for perfusion 
quantification. 
2.4. Methods 
2.4.1. Study Design 
The University of Pennsylvania’s Institutional Review Board approved all imaging 
procedures, and each subject provided informed consent prior to his or her participation. To 
evaluate PIVOT compared to the standard measurement methods, five young healthy male 
subjects (27±2 years old) were recruited and imaged on two separate occasions (Visit 1 and Visit 
2). Four ten-minute scans were run in both sessions, each scan consisting of one minute 
baseline, three minute arterial occlusion, and six minute recovery. PIVOT, a repeat of the PIVOT 
scan (PIVOT Repeat), an otherwise identical PASL-only sequence, or otherwise identical multi-
echo GRE-only sequence was run in a randomized order. To ensure the PASL interleave did not 
impact quantification of SvO2 and T2*, dynamic SvO2 and T2* results obtained with PIVOT were 
compared to the multi-echo GRE-derived SvO2 and T2* results. Similarly, to ensure the multi-echo 
GRE interleave did not confound perfusion, the perfusion results obtained with PIVOT were 
compared to the PASL-derived perfusion data. PIVOT was repeated to provide data on the intra-
session variability of these parameters.  
In addition, five PAD patients (67.2±6.8 years old, ankle-brachial index (ABI) = 0.61±0.14, 
3 male) were drawn from an ongoing study and PIVOT imaging was performed during a single 
ischemia-reperfusion paradigm. For experiments in PAD patients, the total scan time was 12 
minutes, with 2 minutes of baseline, 5 minutes of arterial occlusion, and 6 minutes of recovery. 
Since repeated arterial occlusions were not performed in PAD patients, a longer ischemic 
duration was used to ensure a maximal hyperemic response. 
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2.4.2. Imaging 
PIVOT, PASL-only, and multi-echo GRE-only sequences were written in SequenceTree 
(123) and exported for use on a 3T scanner (Siemens Medical Equipment; Erlangen, Germany). 
Each subject was positioned with the maximum girth of the calf centered in an 8-channel 
transmit/receive knee coil (InVivo, Inc; Gainesville, FL). For proximal arterial occlusion, a cuff was 
secured around the thigh and was rapidly inflated to 75 mmHg above the systolic pressure using 
the Hokanson E20 AG101 Rapid Cuff Inflation System (D. E. Hokanson, Inc; Bellevue, WA). 
Perfusion images were acquired with a partial Fourier GRE-EPI readout with the following 
parameters: FOV=250×250 mm2; acquired matrix=80×50, reconstructed to 80×80; slice 
thickness=1 cm; slice location=isocenter; TR/TE=1 s/8.05 ms; PLD=952 ms. The keyhole multi-
echo GRE used the following parameters: FOV=96×96 mm2; keyhole acquired matrix=96×24, (for 
SvO2 data analysis, reconstructed matrix=96×96 using a fully sampled reference image obtained 
immediately after the dynamic PIVOT or multi-echo GRE acquisition; only dynamic data were 
used for T2* analysis, with acquired matrix = reconstructed matrix=96×24); slice thickness=1 cm; 
slice location=3 cm inferior from isocenter; TR/TE1/TE2/TE3/TE4/TE5=38.12/3.78/6.99/12.32/ 
19.32/26.32 ms. Perfusion, SvO2, and T2* each were quantified with two-second temporal 
resolution.   
2.4.3. Data Analysis 
Perfusion: Perfusion was measured in the soleus muscle. High spatial-resolution scout 
images were used as a reference, and a region of interest (ROI) in the soleus was visually 
selected on the EPI images. As the GRE-EPI data are inherently T2*-weighted, SI variation 
occurred throughout the ischemia-reperfusion paradigm due to the BOLD effect. Direct 
subtraction between adjacent NS and SS images would yield data with a mixture of perfusion, 
and ΔT2*-weighting. To account for this potential confound, NS time-series data were linearly 
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interpolated to temporally match the SS time-course prior to perfusion quantification (124). 
Perfusion (f) was calculated as described by (34): 
f = - !! ∙ ln !!! ! -!!" !!!! ! !!!" ! ∙ 1-e! !! + 1      [2.1] 
where MSS and MNS are the signal intensities (SI) in the image acquired after SS and NS 
inversion, respectively, λ is the tissue partition coefficient (0.9 mL/g), T is the PLD, defined as the 
time between the inversion pulse and readout, and T1 is the longitudinal relaxation time of arterial 
blood.  At 3T, T1blood = 1664 ms (125) and T1tissue = 1420 ms (126). A numerical calculation based 
on actual values for blood and tissue T1 shows that for perfusion values up to 100 mL/min/100g, 
using T1tissue ≈ T1blood = 1420 ms, underestimates perfusion by less than 5%. In order to correct for 
baseline perfusion offset, the average perfusion during the period of arterial occlusion was 
calculated and subtracted from each time-point as described in (124). Peak hyperemic flow 
(PHF), time to peak (TTP), hyperemic flow volume (HFV), and hyperemic duration were 
measured (Figure 2.2a).  
Oximetry: Dynamic SvO2 images were reconstructed to a matrix size of 96×96 using 
outer k-space data from a fully sampled reference image acquired immediately after the dynamic 
scan (122). A phase difference image was generated for each of the dynamic time-points and the 
low spatial-frequency phase modulation was removed as described in (99). An ROI was 
prescribed in the larger of the peroneal veins, and reference tissue was selected in an ROI 
immediately surrounding the peroneal vein. The phase accumulation was calculated from echoes 
at TE1 and TE2, with DTE=3.21 ms and the difference between the intravascular and 
extravascular phase accumulation ∆𝜑 was computed. SvO2 was calculated as described in (58) 
as: 
 𝑆𝑣𝑂! = 1 − ! ∆! ∆!"! ∆!!"∙!"#∙!! !"#!!!! ! ×100      [2.2] 
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where Δχdo represents the susceptibility difference between fully oxygenated and fully 
deoxygenated blood (Δχdo = 4π•0.27 ppm (SI units) (96,97)), B0 is the main magnetic field 
strength, and θ is the angle of the vessel with respect to B0 (58,87). Hematocrit of 0.45 was 
assumed for the healthy subjects, and the PAD patients’ hematocrit was measured by blood 
draw. Washout time (time at which minimum SvO2 occurs), upslope, representing the rate of 
venous resaturation (maximum slope during recovery), and overshoot (peak SvO2 – baseline 
SvO2) were recorded (Figure 2.2b).  
T2*: T2* analysis was performed on keyhole-only data since high spatial resolution is not 
necessary (acquired matrix = reconstructed matrix = 96×24). T2* was calculated by fitting a 
monoexponential function to magnitude SI from echoes TE2-TE5. Even though TE1 should have 
highest SNR, TE1 was not included in the monoexponential fitting because large switching 
gradients just prior to TE1 induced significant eddy current effects that would potentially confound 
T2* quantification. For BOLD analysis, average SI in an ROI prescribed in the soleus muscle for 
each of the four echoes was fitted to a mono-exponential function to determine T2* at each time-
point. T2* values were normalized to the baseline average and relative T2*min, relative T2*max, and 
time to peak (TTPT2*) were determined (Figure 2.2c).   
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Figure 2.2. Schematic of time-course for perfusion (a), SvO2 (b), and T2* (c) 
illustrating the time-course-derived metrics for each parameter. Grey box 
indicates the period of proximal arterial occlusion. 
2.4.4. Statistical Analysis 
The average and standard deviation of every time-point across all subjects and both 
sessions was calculated for PIVOT, PASL, and multi-echo GRE time-course data. Pearson’s 
correlation coefficient was calculated to compare the time-courses measured with PIVOT and the 
standard methods. 
For each key time-course-derived parameter, Wilcoxon signed-rank tests were used to 
assess whether statistically significant differences exist between PIVOT and the standard 
method. Specifically, PIVOT-derived perfusion parameters were compared to results obtained 
with PASL-only, and PIVOT-derived SvO2 or T2* parameters were compared to results from the 
multi-echo GRE. Wilcoxon signed-rank tests were also used to determine whether significant 
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differences exist between key parameters measured with PIVOT and PIVOT Repeat. Wilcoxon 
signed-rank tests were used in lieu of a standard paired Student’s t-test as only five subjects were 
enrolled in the evaluation study and thus it cannot be assumed that the data are normally 
distributed.  Statistical significance was set at p<0.05.  
To assess both intra-session and inter-session repeatability, the average within-subject 
coefficient of variation (CV) was calculated. Specifically, to calculate intra-session repeatability, 
for each parameter the within-subject standard deviation across PIVOT and PIVOT Repeat from 
Visit 1 was averaged across subjects, then divided by the between-subject mean parameter value 
from Visit 1. The same analysis was performed for intra-session repeatability on data acquired 
during Visit 2. Similarly, to calculate inter-session repeatability, the within-subject standard 
deviation across all PIVOT scans from Visit 1 and Visit 2 (4 measurements per subject) was 
averaged across all subjects and divided by the between-subject mean parameter value from 
both visits. 
In the PAD patients, all time-course parameters described above were calculated, but no 
statistical analyses were performed since patients included in this preliminary study have varying 
disease severity and the ischemia-reperfusion paradigm was slightly different. The purpose of 
including PAD patient data was for proof of principle and to explore differences that exist between 
patients and healthy subjects. 
2.5. Results 
2.5.1. PIVOT evaluation in young healthy subjects 
Example images are shown for a representative subject in Figure 2.3. High-resolution 
images corresponding to the PASL (isocenter) and multi-echo GRE slices (30 mm inferior) along 
with highlighted regions indicating the muscle or vein of interest are included in panels (a) and 
(b). Sample baseline and peak hyperemia perfusion maps are shown in (c) and (d), respectively. 
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These images highlight the dramatic increase in perfusion that occurs in response to induced 
ischemia. The green box in (b) shows the full FOV of the multi-echo GRE. Because the FOV of 
the multi-echo GRE was only 96×96 mm, aliasing along the phase-encoding direction occurred in 
several subjects. In this subject, the tibialis anterior muscle has wrapped posteriorly, and part of 
the gastrocnemius muscle has wrapped anteriorly. This aliasing did not affect the quantification of 
SvO2, and wrapped regions were avoided when selecting the soleus ROI for T2* measurement. 
Sample phase images used for SvO2 quantification at baseline and hyperemia (corresponding to 
the minimum SvO2, which occurs at the washout time) are shown in (e) and (f). Keyhole 
reconstruction was used for the phase images to achieve higher apparent in-plane spatial 
resolution (1×1 mm), which is necessary in order to resolve the veins. However, since spatial 
resolution is less critical for T2* only data acquired every TR was used for analysis. Thus each 
image in (g) has in-plane resolution of 1×4 mm. 
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Figure 2.3. Example images from a representative young healthy subject. High-
resolution scout images located at isocenter (a) and 3 cm inferior (b), 
corresponding to the PASL and multi-echo GRE slice locations, respectively. The 
soleus is indicated in red (a) and green (b), and the blue arrow points to the 
peroneal vein. Perfusion images represent baseline (c) and peak hyperemic flow 
(d). Phase images are shown for baseline (e) and the washout time (f). Note the 
increased phase accrual in the three veins at washout time, corresponding to a 
decrease in SvO2. The blue arrow identifies the peroneal vein that was used for 
dynamic SvO2 analysis. Multi-echo GRE magnitude images for each of the echo 
times used to quantify T2* are shown in (g).  
 
Data for all healthy subjects were averaged to yield an average perfusion, SvO2, or T2* 
time-course in order to investigate the correlation of the results between PIVOT and PASL-only or 
multi-echo GRE-only methods. For each parameter, average and standard deviation of the time-
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courses across all subjects is shown in Figure 2.4. Following cessation of arterial occlusion, the 
typical reactive hyperemia response is seen in each of the measured parameters. The time-
course measured with PIVOT is in good agreement with PASL-only or multi-echo GRE-only-
measured responses. The correlation coefficient between PIVOT and PASL average perfusion 
time-course is 0.99, and between PIVOT and multi-echo GRE average SvO2 and T2* time-
courses are 0.98 and 0.99, respectively. 
 
Figure 2.4. Average time-course data measured with PIVOT and standard 
measurement methods. (a) Average perfusion time-course across all young 
healthy subjects measured with PIVOT (red) and PASL (black). Average SvO2 
(b) and T2* (c) time-courses measured with PIVOT (blue, green, respectively) 
and a multi-echo GRE (black). Error bars indicate standard deviation. Grey box 
indicates period of arterial occlusion. 
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Average (standard deviation) of key time-course parameters from PIVOT and the 
standard measurement methods are shown in Table 2.1. The Wilcoxon signed-rank tests did not 
detect statistically significant differences between PIVOT and PIVOT Repeat, or between PIVOT 
and the standard measurement method for any of the key time-course parameters (p > 0.05).  
Table 2.2 summarizes the intra-session and inter-session repeatability measured with PIVOT.  
Table 2.1. Means and standard deviations (in parentheses) of key time-course 
metrics measured with PIVOT and standard measurement methods. In five 
young healthy subjects, soleus perfusion, peroneal vein SvO2, and soleus T2* 
were measured with PIVOT, PIVOT Repeat, and the standard method (PASL or 
multi-echo GRE) on two separate occasions (Visits 1 and 2). No statistically 
significant differences in any measured parameter were detected. 
 
 Visit 1 Visit 2 
 PIVOT PIVOT Repeat 
Standard 
Method PIVOT 
PIVOT 
Repeat 
Standard 
Method 
Perfusion (Standard Method = PASL) 
PHF (mL/min/100g) 34.8 (7.5) 34.5 (10.2) 37.9 (9.0) 39.2 (4.1) 38.3 (6.0) 37.6 (5.6) 
TTP (s) 19.6 (3.6) 18.0 (3.5) 17.2 (2.3) 18.4 (5.7) 17.2 (4.1) 17.6 (5.2) 
HFV (mL/100g) 17.0 (5.3) 14.0 (5.0) 16.2 (5.6) 16.7 (5.4) 14.4 (1.9) 16.1 (2.3) 
Hyperemic duration (s) 53.6 (15.7) 46.8 (13.8) 53.6 (10.4) 48.8 (14.9) 44.8 (10.3) 49.6 (14.2) 
SvO
2 
(Standard Method = multi-echo GRE) 
Washout time (s) 11.6 (2.2) 10.0 (2.0) 10.4 (1.7) 12.4 (3.6) 11.2 (4.8) 10.0 (1.4) 
Upslope (%HbO
2
/s) 0.83 (0.32) 1.08 (0.47) 1.21 (0.54) 1.14 (0.42) 0.91 (0.43) 1.13 (0.48) 
Overshoot (%HbO
2
) 17.6 (7.5) 17.1 (6.1) 16.8 (7.1) 18.6 (6.5) 16.5 (7.6) 18.3 (5.0) 
T
2
* (Standard Method = multi-echo GRE) 
Baseline T
2
* (ms) 23.4 (1.4) 22.5 (1.5)
 
 23.1 (2.0) 22.0 (1.9) 21.7 (1.6)
 
 22.2 (2.0) 
Relative T
2
*
min
 0.90 (0.04) 0.93 (0.03) 0.92 (0.01) 0.92 (0.03) 0.93 (0.04) 0.94 (0.02) 
Relative T
2
*
max
 1.09 (0.03) 1.13 (0.04) 1.16 (0.05) 1.14 (0.05) 1.15 (0.05) 1.18 (0.05) 
TTP
T2* 
(s) 34.0 (11.6) 29.2 (3.6) 26.8 (5.2) 28.4 (3.6) 24.8 (5.0) 28.4 (4.8) 
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Table 2.2. Summary of intra-session and inter-session repeatability for all time-
course-derived metrics.  The within-subject coefficient of variation is shown for 
PIVOT versus PIVOT Repeat on Visit 1, Visit 2, and for all PIVOT data acquired 
on Visits 1 versus 2. 
 Intra-session Visit 1 
Intra-session 
Visit 2 
Inter-session 
Visit 1 vs. 2 
Perfusion 
PHF (mL/min/100g) 6.3% 5.0% 12.4% 
TTP (s) 6.0% 11.1% 16.4% 
HFV (mL/100g) 18.8% 23.4% 18.9% 
Hyperemic duration (s) 15.2% 25.4% 19.9% 
SvO2 
Washout time (s) 15.7% 12.0% 18.9% 
Upslope (%HbO
2
/s) 26.2% 15.8% 37.3% 
Overshoot (%HbO
2
) 15.3% 18.3% 6.5% 
T2* 
Baseline T
2
* (ms) 3.1% 1.3% 4.6% 
Relative T
2
*
min
 2.4% 0.9% 1.8% 
Relative T
2
*
max
 3.0% 1.1% 3.9% 
TTP
T2* 
(s) 17.9% 9.6% 19.9% 
 
2.5.2. PIVOT in PAD Patients 
Figure 2.5 shows the reactive hyperemia time-course for perfusion, SvO2, and T2* 
measured with PIVOT in a single PAD patient and a representative young healthy subject. A 
summary of key time-course parameters measured in individual PAD patients is presented in 
Table 2.3 along with average values for young healthy subjects. The perfusion time-course data 
show that patients experienced a lower PHF, a delay in TTP, a prolonged hyperemic duration, 
and a greater HFV. The SvO2 response was also delayed and blunted; PAD patients exhibited a 
longer washout time, and reduced upslope and overshoot. T2* data showed characteristic 
changes expected in patients with reduced endothelial function. PAD patients had higher T2*min, 
even though the ischemic duration is 5 minutes instead of 3 minutes as in the healthy subjects. 
Patients’ T2*max was lower and TTPT2* was delayed. These results are in agreement with previous 
findings measuring perfusion (52), SvO2 (66,67), or T2* (68,69) individually in PAD patients.  
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Figure 2.5. Time-courses measured with PIVOT for perfusion (a), SvO2 (b), and 
T2* (c) in one representative young healthy subject and one PAD patient (PAD #5 
in Table 2.3). Light colored lines represent healthy subject, and dark colored 
lines represent PAD patient. Grey box indicates period of arterial occlusion. PAD 
patient exhibits a blunted and delayed hyperemic response for each of the 
measured parameters compared to the young healthy subject. 
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Table 2.3. PIVOT results in individual PAD patients and for the average of all 
young healthy subjects. 
 Healthy PAD #1 PAD #2 PAD #3 PAD #4 PAD #5 
ABI N/A 0.41 0.52 0.68 0.72 0.74 
Perfusion  
PHF (mL/min/100g) 37.0 (6.1) 26.9 22.0 31.3 29.9 37.3 
TTP (s) 19.0 (4.5) 110 72 90 52 32 
HFV (mL/100g) 16.9 (5.1) 48.2 26.5 78.7 37.7 33.8 
Hyperemic duration (s) 51.2 (14.6) 182 124 240 110 108 
SvO
2
 
Washout time (s) 12.2 (2.2) 48 50 22 36 22 
Upslope (%HbO
2
/s) 1.0 (0.6) 0.24 0.18 0.45 0.69 0.45 
Overshoot (%HbO
2
) 18.1 (6.5) 16.4 17.9 13.2 16.7 12.9 
T
2
* 
Baseline T
2
* (ms) 22.6 (1.7) 22.2 22.4 21.6 20.4 20.0 
Relative T
2
*
min
 0.91 (0.03) 0.93 0.94 0.92 0.95 0.94 
Relative T
2
*
max
 1.11 (0.04) 1.04 1.04 1.11 1.04 1.12 
TTP
T2* 
(s) 32.8 (8.8) 120 160 94 56 68 
 
2.6. Discussion 
2.6.1. PIVOT Repeatability 
The repeatability assessment comparing perfusion, SvO2, and T2* metrics derived from 
the two successive PIVOT scans show some intra-session variability. This variability could be 
physiologic in nature or could be due to noise in the time-course data. Given the low average 
baseline signal standard deviation (perfusion: 1.6 mL/min/100g; SvO2: 1.5 %HbO2; T2*: 0.5%) it is 
likely that intra-session variations of key measured parameters are outweighed by physiologic 
variability during separate ischemia-reperfusion episodes. In all cases there were no significant 
differences detected between time-course parameters measured with PIVOT and PIVOT Repeat 
(p>0.05), suggesting that there was no training effect due to multiple periods of ischemia. This 
finding justifies the comparison of within-session PIVOT to PASL-only or to multi-echo GRE-only 
sequences, even though the data were acquired separately.  
45 
 
2.6.2. PIVOT Effect on Perfusion Quantification 
In comparing perfusion metrics measured with PIVOT to those measured with an 
otherwise identical PASL-only sequence, it is evident that the two measurements provide similar 
values of all perfusion time-course-derived metrics. Specifically, there were no significant 
differences between any of the key parameters measured with PIVOT or with PASL. This 
suggests that the multi-echo GRE interleave does not impact the quantification of perfusion.  
Perfusion time-course metrics had expected results for longitudinal reproducibility. A CV 
of approximately 20% has been reported in previous studies (47,127). Perfusion varies 
physiologically with time of day (128), hydration level (129), and hormonal fluctuations (130) 
among other factors (131). Care was taken to schedule Visits 1 and 2 at the same time, and all 
subjects were instructed to refrain from caffeine intake and vigorous activity for 12 hours prior. 
Yet even within a single scan there was variability in the hyperemic response from one ischemia-
reperfusion episode to another, suggesting that these physiologic factors cannot be completely 
controlled. The time-course data averaged over all experiments and all healthy subjects showed 
good correlation in the shape and magnitude of the reactive hyperemia response, reflected by the 
high correlation coefficients. Thus not only were the key time-course-derived metrics not 
significantly different, but that the overall response was highly similar.  
Peak hyperemic flow measured with either PIVOT or PASL was somewhat lower than 
previously reported values, where PHF was measured to be 50±13 mL/min/100g using the same 
SATIR perfusion preparation, but with a RARE readout (34). PHF in the soleus in our study was 
lower, reaching only 37.0±6.1 mL/min/100g. This difference in perfusion could be attributed to the 
fact that Raynaud et al quantified whole-leg perfusion (34), while individual muscle perfusion was 
calculated here. Additionally, care was taken to exclude vessels from the ROI, as their inclusion 
would increase measured perfusion. In another study by Proctor and colleagues, perfusion was 
measured in the calf of 64 men using strain gauge plethysmography (132), a technique 
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considered to be a standard for limb perfusion measurement. Peak perfusion in the calf was 
found to be 35.1±1.1 mL/min/100g following a period of 10 minutes of ischemia. Both this work 
and that by Raynaud (34) and Proctor (132) report much lower PHF than a similar study by Wu et 
al using continuous arterial spin labeling (CASL).  In Wu’s study, PHF in the soleus muscle was 
found to be 116±57 mL/min/100g (47), however the temporal resolution in CASL was limited to 16 
seconds. Using an EPI readout, the magnitude signal over the course of an ischemia reperfusion 
paradigm varies substantially due to the BOLD effect. If the time course is not sampled with high 
enough temporal resolution, the changing signal intensity due to the BOLD effect may 
contaminate the quantification of perfusion (84). The higher temporal resolution data acquired 
with SATIR can track the changes in signal intensity better and thus may be less susceptible to 
BOLD contamination, allowing more accurate quantification of perfusion.  
Time to peak perfusion agreed with Raynaud’s values (34), however it was much shorter 
than the TTP reported by Wu (47). Again, this discrepancy between our work and that of Wu et al 
could be due to the better temporal resolution of SATIR over CASL. The temporal resolution for 
PIVOT and SATIR was 2 seconds, while that of the CASL sequence employed in Wu’s work was 
16 s. The improvement in temporal resolution was in part due to the pulsed labeling scheme used 
in SATIR, in which arterial labeling takes only 8 ms instead of 2 seconds as in CASL.  
Hyperemic flow volume quantified the total blood delivery during hyperemia, and along 
with the hyperemic duration may provide more qualitative measures of hyperemia. HFV in 
particular may be less sensitive to time-course noise compared to PHF and TTP. PHF and TTP 
are determined based on a single data-point, whereas HFV is the total integrated area. The 
values we reported for HFV and hyperemic duration were lower and shorter than those reported 
by Wu, et al (47), which is not surprising since our measured PHF and TTP are lower and shorter 
as well.  
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2.6.2. PIVOT Effect on SvO2 Quantification 
High spatial resolution is necessary to measure the phase in the vein; therefore the 
keyhole multi-echo GRE data was supplemented with outer k-space data from a fully-phase-
encoded reference scan that was run at the end of the dynamic acquisition. Langham et al have 
previously shown that keyhole reconstruction provides accurate SvO2 results with high temporal 
resolution during reactive hyperemia in the femoral vein (56).  
No significant differences were detected between time-course metrics measured with 
PIVOT or with the multi-echo GRE. While inter-session variability was present, it was comparable 
to the intra-session variability measured between PIVOT and PIVOT Repeat on the same visit. 
Average washout time was slightly lower than previously reported in the femoral vein of young 
healthy subjects (17±7 s), but upslope and overshoot were in agreement with prior results (67). 
The lower washout time could be explained by the fact that the tourniquet system used in this 
study deflated much more quickly than that used in (67). The resulting decrease in the resistance 
to arterial flow could potentially shorten the washout time. Another potential reason that washout 
time differs is that we investigated SvO2 in the peroneal vein, as opposed to the more superior 
femoral vein. Thus not only does the peroneal vein collect from a smaller volume of muscle, but 
the distance between the capillary bed and peroneal vein was also smaller.  Overall, key 
parameters measured with PIVOT agree with multi-echo GRE-derived data, suggesting that 
inclusion of the PASL interleave does not impact quantification of SvO2.  
2.6.3. PIVOT Effect on T2* Quantification 
In both PIVOT and multi-echo GRE T2* data, the signal intensity in the ROI was first 
averaged then fit to a mono-exponential function. The fitting of average signal intensity was 
nearly perfect with an overall average R2 for all T2* fits of 0.999.  
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During the period of arterial occlusion, relative T2* was found to decrease as the 
deoxyhemoglobin concentration in the capillary bed increases. Following cuff release, hyperemic 
arterial inflow replenishes blood in the capillary bed, bringing oxygenated arterial blood in and 
moving desaturated blood into the large draining veins. Relative T2* increased during reactive 
hyperemia due to the increase in perfusion and the decrease in deoxyhemoglobin in the capillary 
bed. Even though perfusion and T2* were measured at separate slice locations, they both 
represent changes that occur in the soleus muscle. TTPT2* was longer than perfusion TTP, 
suggesting that the increase in oxygen concentration at the level of the capillary bed lasted longer 
than the increase in microvascular flow. This finding is in agreement with a prior study 
investigating the combined measurement of perfusion and BOLD during reactive hyperemia (51). 
Duteil et al suggest that because the brief period of arterial occlusion does not cause significant 
oxygen debt in muscle (as shown by (109)), the muscle’s demand for oxygen remains unchanged 
and thus the increase in perfusion results in a decrease of oxygen extraction, causing the BOLD 
signal to increase (51). The decrease in oxygen extraction also physiologically manifests as the 
SvO2 overshoot. 
The measured values are consistent with previous literature reported values for baseline 
T2* (65), relative T2*min (69), T2*max (68,133), and TTPT2* (68). Comparisons between PIVOT and 
multi-echo GRE key time-course parameters yielded no significant differences, and the T2* time-
course data measured with PIVOT and multi-echo GRE were highly correlated (Pearson’s 
r=0.99).  These results indicate that T2* quantification in a downstream slice with PIVOT is not 
affected by the PASL interleave.  
2.6.4. Considerations for Applying PIVOT in PAD Patient Studies 
Statistical comparisons between PAD patients and young healthy subjects were not 
made because the ischemic duration differed in the two cohorts. As repeated periods of arterial 
occlusion were used to compare PIVOT to standard measurement methods in healthy subjects, a 
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shortened ischemic duration was used, allowing enough time for the four scans to be performed 
during one hour of scanning. PAD patients included in this preliminary evaluation had varying 
disease severity, represented by the diverse ABIs. A five-minute period of arterial occlusion was 
employed in PAD patients to ensure the maximal hyperemic stimulus. The PAD patient data 
were, however, included to explore the range of values that exist between states of health and 
disease.  In agreement with the results of Wu et al, PAD patients exhibited a decrease in PHF 
and an increase in TTP (52).  SvO2 data showed a blunted and delayed response, in agreement 
with Langham et al (66,67). T2* data showed the characteristic alterations during the period of 
ischemia (69) and reactive hyperemia (68).  
Quantification of multiple parameters may improve diagnosis and enhance power for 
detection of the response to therapeutic intervention. The traditional marker of disease severity in 
PAD is the ankle-brachial index (ABI), which is the ratio of systolic blood pressures measured at 
the level of the ankle and in the brachial artery. The ABI primarily represents occlusions and 
stenoses on the macrovascular level. Previous studies have shown that physiologic 
improvements such as increased peak walking time do not correlate with clinically significant 
changes in ABI (21,22). PIVOT provides a measure of microvascular function, thus may be more 
sensitive to early treatment effects. By measuring many parameters, PIVOT will provide insight 
into the relationship between impairments in perfusion, SvO2, and T2*.  
 In this study we showed that no major measurement bias in key time-course parameters 
was introduced by using PIVOT instead of the standard individual measurement methods. 
However, it should be noted that the small sample size affects the power to detect such a bias. 
Even though no measurement bias was detected, the precision and thus statistical power of 
PIVOT-derived measures was limited by physiologic variability, which cannot be completely 
controlled. In order to use this method to assess disease presence or monitor a treatment effect, 
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the study must be well designed, controlling for factors that are known to affect perfusion and the 
hyperemic response (128,130,131). 
The preliminary PAD patient data showed that for many of the key time-course 
parameters there was a relatively wide range of values that exist between states of health and 
disease. A recent study performed at 1.5T showed relatively poor repeatability of BOLD 
measurements with the exception of TTPT2* during reactive hyperemia in both healthy subjects 
and PAD patients (127). In our study a lower inter-session CV, and hence better repeatability, 
was found for several key T2* parameters in healthy subjects. The improvement in repeatability 
may be due to the higher field strength, which confers increased signal to noise ratio and greater 
BOLD signal contrast. A longitudinal study will be necessary to determine the repeatability of 
PIVOT measures in PAD patients. Additionally vascular reactivity decreases with age (66), 
therefore it will be important to compare PIVOT results obtained for PAD patients to age-matched 
healthy controls to assess the impact of age on PIVOT-derived measures of microvascular 
function.  
2.7. Conclusions 
In summary, we have introduced a quantitative MRI method that measures perfusion, 
SvO2, and T2* simultaneously, thereby allowing a comprehensive assessment of the functional 
integrity of the peripheral microvasculature during a single ischemia-reperfusion paradigm. The 
added value of the proposed approach will require rigorous evaluation in cohorts of patients with 
impaired peripheral circulation in comparison to their healthy peers. In the future PIVOT could 
possibly serve as a means to monitor disease progression and effectiveness of intervention.  
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CHAPTER 3: MEASUREMENT OF SKELETAL MUSCLE 
PERFUSION DYNAMICS WITH ASL: ASSESSMENT OF PCASL 
LABELING EFFICIENCY IN THE PERIPHERAL VASCULATURE 
AND COMPARISON OF POST-ISCHEMIA PERFUSION 
MEASURED WITH PCASL AND PASL  
3.1. Abstract 
Purpose: To compare calf skeletal muscle perfusion measured with pulsed arterial spin labeling 
(PASL) and pseudo-continuous arterial spin labeling (pCASL) methods, and to assess the 
stability of pCASL labeling efficiency in the popliteal artery throughout an ischemia-reperfusion 
paradigm. 
Materials and Methods: At 3T field strength, pCASL labeling efficiency was experimentally 
assessed in five subjects by measuring the signal intensity of blood in the popliteal artery just 
distal to the labeling plane immediately following pCASL labeling or control preparation pulses, or 
without any preparation pulses throughout separate ischemia-reperfusion paradigms. The relative 
label and control efficiencies were determined during three distinct phases (baseline, hyperemia, 
and recovery) defined based on average arterial velocity, which was measured with a projection 
phase-contrast sequence. In a separate cohort of ten subjects, pCASL and PASL sequences 
were used to measure reactive hyperemia perfusion dynamics. 
Results: Calculated pCASL labeling and control efficiencies were unchanged throughout the 
baseline, hyperemia, and recovery periods. Perfusion dynamics measured with pCASL and PASL 
did not significantly differ. Average leg muscle peak perfusion was 47±20 mL/min/100g or 50±12 
mL/min/100g, and time to peak perfusion was 25±3 s and 25 ±7 s from pCASL and PASL data, 
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respectively. Further metrics parameterizing the perfusion time course did not significantly differ 
between pCASL and PASL measurements.  
Conclusion: No change in pCASL labeling efficiency was detected despite the almost ten-fold 
increase in average blood flow velocity in the popliteal artery. pCASL and PASL provide precise 
and consistent measurement of skeletal muscle reactive hyperemia perfusion dynamics.  
3.2. Introduction 
 As described Chapters 1 and 2, recent studies have shown that the dynamics of 
skeletal muscle perfusion can provide insight into endothelial function and vascular reactivity in 
normal physiologic and pathophysiologic states (48,52,134,135). Perfusion is a tightly regulated 
physiologic process, serving to provide oxygen and nutrients to active tissue, and to remove 
waste products. Because metabolic demand of resting skeletal muscle is quite low, skeletal 
muscle perfusion at baseline is generally maintained even in situations of disease such as 
peripheral artery disease (PAD) or diabetes mellitus. However, these diseases do manifest with 
an impairment of vascular reactivity. 
 These functional deficits of the vasculature can be evaluated by monitoring the 
kinetics of the response to a situation of increased flow demand, akin to cardiac stress testing. In 
skeletal muscle, this can be accomplished by measuring the response during or following 
exercise (functional hyperemia) (34,107,136), or following induced ischemia (reactive hyperemia) 
(34,47,51). Functional vascular impairment manifests as a blunting and delay of reperfusion in 
response to the stressor (52). Even though it is not physiologically analogous to the demands of 
daily living, reactive hyperemia provides a more reproducible and subject effort-independent 
stimulus compared to functional hyperemia, and thus has been purported as the preferred 
stressor for studying peripheral vascular function (25).  
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 Arterial spin labeling (ASL) permits the measurement of perfusion in physiologic units 
(45,76). Previous studies have used ASL to measure perfusion in the brain (77,82), kidneys 
(137), and skeletal muscle (34,47).  While several ASL labeling schemes exist, they each work by 
taking the pair-wise difference of two images – one with magnetically labeled blood (label) and 
one without (control). Tissue magnetization is measured with and without inversion of arterial 
blood water and after allowing enough time for the inverted or uninverted spins to perfuse the 
organ of interest. Subtraction between the label and control images cancels out the contribution 
from static tissue and yields a signal that is proportional to microvascular perfusion. This signal 
can be converted into perfusion in units of mL/min/100g through application of various models 
(34,47,80,81).  
 Skeletal muscle perfusion during hyperemia has been quantified with PASL (34), 
which achieves inversion using a single adiabatic inversion pulse (77), continuous ASL (CASL) 
(47) or, more recently, pCASL (48). Each of these methods has benefits and drawbacks. PASL 
uses a single RF pulse for nearly instantaneous and complete inversion, therefore perfusion can 
be measured at a temporal resolution of up to 2 second (34). However, pCASL and CASL utilize 
a series of pulses to achieve inversion, thereby reducing labeling efficiency (82) and limiting 
temporal resolution to 6-8 seconds (47,48,52). On the other hand, CASL or pCASL methods do 
offer an increase in signal-to-noise ratio compared to PASL as the labeled blood water spins 
accumulate in the tissue throughout the longer labeling duration (83).  
 Both CASL and pCASL rely on flow-driven adiabatic inversion to label arterial blood 
(45,82). To achieve efficient flow-driven adiabatic inversion, blood flow velocity (v) must satisfy 
the adiabatic condition: !!! ≪ !"!!"" ≪ 𝛾 𝐵!"" , where T2 is the transverse relaxation time of blood 
water protons, G is the average gradient amplitude, Beff is the effective magnetic field, and γ is the 
proton gyromagnetic ratio (85). Flow-driven adiabatic inversion will invert spins that satisfy this 
condition. However, if blood flow velocity is too slow, transverse relaxation effects dominate, and 
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blood will not be inverted. On the other hand, if flow is too fast, the effective frequency sweep rate 
will be too fast the magnetization will not be inverted. Blood flow velocity, therefore must remain 
in a specific range in order to achieve efficient flow-driven adiabatic inversion (138).  
 In contrast to the arteries supplying the brain, the peripheral circulation has higher 
impedance resulting in a distinctive flow waveform (57,139,140). Specifically in the popliteal 
artery, which supplies muscles in the calf, the blood flow waveform is triphasic at baseline with 
antegrade flow during systole followed by retrograde then antegrade flow during diastole 
(139,140). During reactive hyperemia, the flow waveform becomes entirely antegrade due to 
vasodilation of capillaries to accommodate increased blood flow demand downstream (57). 
Beyond the changes in the waveform characteristics, average blood flow velocity differs 
substantially between baseline, ischemia, and reactive hyperemia. This variability may result in 
blood flow velocity-dependent changes in labeling efficiency for techniques that rely upon flow-
driven adiabatic inversion.   
 Theoretical explorations of the dependence of blood flow velocity on labeling efficiency 
show that with decreasing peak flow, there is a decrease in labeling efficiency (76,82,138). These 
simulations have been corroborated by experimental investigations of labeling efficiency 
performed in the brain (141). However, those results may not apply to muscle perfusion, due to 
the different characteristics of the blood flow waveform in the peripheral vasculature.  
 Prior studies investigating muscle perfusion dynamics with PASL and pCASL or CASL 
have yielded disparate results, wherein peak perfusion measured with pCASL (48) or CASL (52) 
methods was much higher than that measured by PASL (34,142). However, the precise 
quantification of perfusion depends both on the acquisition approach, experimental stimulus, as 
well as the analysis methods, for instance how to deal with outliers, etc., thus true comparison 
between ASL methods for quantification of skeletal muscle perfusion has not yet been explored. 
Current hardware limitations make implementation of CASL on clinical imaging systems difficult, 
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thus the focus of this work was on comparison of perfusion quantified with pCASL and PASL. 
Furthermore, to our knowledge, there has not been any exploration of the effect of the labeling 
method on quantification of muscle perfusion and perfusion dynamics in a reactive hyperemia 
paradigm.  
 The purpose of this study was to experimentally investigate pCASL label efficiency 
during an ischemia reperfusion paradigm in the peripheral vasculature, and to compare muscle 
perfusion dynamics measured using pCASL and PASL.  
3.3. Methods 
3.3.1. Experimental overview 
 The Institutional Review Board of the University of Pennsylvania approved all aspects 
of the study. Fifteen healthy subjects were recruited to participate after providing written, informed 
consent. Five healthy subjects (33±7 years old, 4 male) participated in the pCASL labeling 
efficiency experiments, and ten healthy subjects (60±4 years old, 7 females) were scanned with 
both PASL and pCASL sequences. All subjects were free from overt cardiovascular disease. For 
each subject, all experiments were performed on the same day, within the same scan session.  
 Imaging was performed at 3.0 T (Siemens Magnetom Tim Trio, Siemens Medical 
Equipment; Erlangen, Germany) with an eight-channel transmit/receive knee coil (InVivo, Inc; 
Gainesville, FL). All experimental imaging sequences were written in SequenceTree (143). 
Reactive hyperemia was induced for both sets of experiments using an ischemia-reperfusion 
paradigm consisting of 3-5 minutes of proximal arterial occlusion via a pneumatic cuff secured 
around the thigh. The cuff was rapidly inflated to 75 mmHg above each subject’s systolic blood 
pressure using the Hokanson E20 AG101 Rapid Cuff Inflation System (D.E. Hokanson, Inc; 
Bellevue, WA). Data analysis was performed with in-house-written software using MATLAB 
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(MathWorks, Natick, MA), and statistical analyses were executed with JMP (SAS Institute., Cary, 
NC, 1989-2007).  
3.3.2. pCASL labeling efficiency during reactive hyperemia 
 First we aimed to assess whether pCASL labeling efficiency varies over the course of 
an ischemia reperfusion paradigm. By measuring the signal intensity in the artery following 
pCASL labeling period, the inversion efficiency can be experimentally estimated (144). For the 
purpose of this study, precise quantification of the inversion efficiency was of less interest than its 
variation over the course of the reactive hyperemia paradigm.   
 Relative inversion efficiency was estimated experimentally using a modified pCASL 
sequence in which the imaging readout, located just distal to the labeling plane, immediately 
followed the labeling or control period (Figure 3.1a). Rather than measuring signal intensity in the 
muscle tissue, magnitude signal intensity was measured in the blood contained within the 
popliteal artery to assess the impact of the labeling period. Following the imaging readout, 
additional time was allotted for signal recovery and inflow of fresh spins in the artery.  
 The reactive hyperemia response is relatively short-lived, therefore temporal sampling 
of popliteal artery blood signal was maximized by conducting three separate experiments: with 
EPI data acquired following pCASL label; following pCASL control; or without label or control 
preparations (termed M0) (Figure 3.1b). The duration of the label and control preparations were 
selected to match Wu, et al’s prior study using CASL for skeletal muscle perfusion quantification 
(47). For each scan, data were acquired during 1 min baseline, 3 min ischemia, and 2 min 
recovery. Five subjects were scanned with this repeated reactive hyperemia paradigm (33±7 
years old, 4 male). Each subject received additional time to recover back to his or her relative 
baseline state between scans.  
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Figure 3.1. (A) Diagram of measurement locations for both the pCASL labeling 
experiments (blue slice, located 2 cm distal from labeling plane) and perfusion 
quantification experiments (purple slice, located 6 cm distal from labeling plane). 
For both experiments, the location of the pCASL labeling plane was 
approximately at the level of the popliteal artery (grey slice). For PASL, slice 
selective and non-selective inversion was used for label and control conditions, 
respectively, but the perfusion measurement slice remained at the same location 
as in pCASL (purple slice). (B) pCASL efficiency data were acquired from 
repeated ischemia-reperfusion paradigms in which the imaging readout 
immediately followed the control or label period, and were normalized by an 
image in which no labeling was conducted (M0 – shown in the top line of B). A 
fourth scan was conducted to measure blood flow in the popliteal artery during 
the ischemia-reperfusion paradigm at the level of the labeling plane. (C) Timing 
diagram for PASL and pCASL perfusion quantification sequences. C and L refer 
to control (non-selective inversion) and label (slice-selective inversion) 
conditions, respectively for the PASL scan. For both PASL and pCASL 
measurements, the location of the imaging slice was approximately mid calf 
(purple slice).  
 
 The modified pCASL sequences used the following parameters: for pCASL label or 
control experiments, labeling duration = 2000 ms (in one subject, labeling duration was 1350 ms), 
PLD = 1.6 ms, Hanning window-shaped pulses with average B1 = 1.7 µT, pulse interval = 1 ms, 
Gmax/Gavg = 9/1 mT/m. The unbalanced control condition utilized average gradient = 0 mT/m and 
180° phase shift between adjacent RF pulses. The labeling and control plane was located 20 mm 
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superior from the EPI readout. The risk of unlabeled blood entering the measurement slice is 
negligible as flow velocity would have to exceed 1250 cm/s to travel more than 20 mm in the 1.6 
ms delay between labeling and image acquisition. The M0 experiment had identical temporal 
sampling as the pCASL label and control experiments, but neither pCASL label or control module 
was applied before the EPI readout. For all scans, an identical velocity-compensated GRE-EPI 
readout was used for image acquisition with flip angle = 90°, FOV = 20×20 cm2, slice thickness = 
10 mm, acquired matrix = 80×50 (reconstructed to 80×80), TR/TE = 4000/8.1 ms (TR = 3000 ms 
for one subject).  
 A fourth scan was conducted during which projection phase-contrast data were 
continuously acquired in the labeling plane in order to characterize the arterial velocity waveform 
throughout the ischemia-reperfusion paradigm. Although the beat-to-beat variation in arterial 
velocity will not match between the scans, average arterial velocity and the velocity range 
throughout the reactive hyperemia paradigms are repeatable (88). Acquisition parameters for the 
projection phase-contrast scan were: FOV = 176×176 mm, slice thickness = 5 mm, acquired 
matrix = 208×1, VENC = 80-120 cm/s, TR/TE = 24/6.5 ms. Fully phase encoded reference 
images were acquired immediately before and after the projection data with identical imaging 
parameters and acquired matrix = 208×208 to allow for quantification of velocity as described in 
(57).  
 Briefly, to quantify velocity, a static tissue k-space projection was computed by first 
masking out the artery in the reference image, then taking the inverse Fourier transform and 
isolating the center k-space line (ky=0). This static tissue k-space projection was subtracted from 
every dynamically acquired velocity-encoded projection to isolate blood signal (57). Then the 
phase difference between adjacent positive and negative velocity-encoded projections was 
computed and the average velocity across the popliteal artery was quantified with 24 ms temporal 
resolution. The time-resolved velocity and maximum velocity were recorded. Projection velocity 
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data were averaged over one cardiac cycle, and downsampled to match the temporal resolution 
of the pCASL labeling scans.  
 Knowledge of average arterial velocity data served two purposes. First, the data were 
used to estimate the transit time between the labeling location and the imaging slice, which will 
differ between the baseline and hyperemic states. Assuming inversion at the location of the 
labeling plane, the pCASL label data were then corrected for T1 recovery that occurs during the 
transit time. Second, the arterial velocity data were used to divide all reactive hyperemia scans 
into four periods: baseline, ischemia, hyperemia, and recovery. The hyperemic duration from the 
projection velocity acquisition was used to define the hyperemia period for pCASL data as the 
period of time during which the average arterial velocity was more than twice the baseline 
velocity. Control efficiency was defined as !!!!"#$%"&!!!  where M0 is the blood signal intensity in the 
M0 acquisition (without pCASL labeling), and similarly, Control is that in the pCASL control scan. 
Label efficiency is defined as !!!!"#$%!!! , where Label is the blood signal intensity in the pCASL 
label acquisition. However, because magnitude images were used for analysis, the 
experimentally measured label efficiency was defined as !!!!"#$%!!! . Wilcoxon signed rank tests 
were used to test whether the average label or control efficiencies differed between baseline, 
hyperemia, and recovery. 
3.3.3. Perfusion quantification with pCASL and PASL 
Next we aimed to compare perfusion dynamics measured during an ischemia-reperfusion 
paradigm with PASL and pCASL to assess whether significant differences existed between 
results obtained with the two methods. Perfusion was measured with pCASL and PASL 
sequences in ten healthy subjects (60±4 years old, 7 females). The reactive hyperemia perfusion 
data quantified with PASL had been published previously (134). Each subject underwent three 
ischemia-reperfusion paradigms consisting of 1 minute of baseline, 5 minutes of ischemia 
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induced via proximal arterial occlusion, and 6 minutes of post-ischemia recovery during a 1-hour 
scan session. In the first two ischemia-reperfusion scans, perfusion was quantified using a PASL 
variant and in the third scan, a pCASL sequence was used to measure perfusion (Figure 3.1c).  
 A standard pCASL sequence as described by Alsop, et al (81) was implemented with the 
following parameters: Single-slice GRE-EPI: acquisition matrix=80×50 (partial Fourier, 
reconstructed to 80×80), FOV=25×25 cm2, slice thickness=10 mm, TR/TE = 4000/8.1 ms. 
Labeling duration and post labeling delay matched values used in Wu, et al’s prior CASL muscle 
perfusion investigation (52), with labeling duration = 2 s, post-labeling delay (PLD) = 1.9 s, 
Hanning window-shaped pulses with average B1 =1.7 µT, pulse interval = 1 ms, Gmax/Gavg = 9/1 
mT/m. Unbalanced control condition utilized average gradient = 0 mT/m and 180° phase shift 
between adjacent RF pulses. The labeling plane was located 60 mm superior to the imaging 
slice. Perfusion was quantified with temporal resolution of 8 seconds. 
 PASL data were acquired with the Perfusion, Intravascular Venous Oxygen saturation, 
and T2* (PIVOT) sequence (142), an interleaved dual-slice PASL and multi-echo GRE sequence. 
PIVOT employs the saturation inversion recovery PASL variant described by Raynaud, et al (34) 
for perfusion quantification. Notably, evaluation of PIVOT compared to PASL showed that no 
error was introduced by interleaving the acquisition of multi-echo GRE data during the PLD, thus 
quantification of perfusion is unbiased by the use of PIVOT (instead of a standard PASL 
sequence). Sequence parameters were as follows: Slice-selective or non-selective adiabatic 
inversion for label and control condition, respectively; single-slice GRE-EPI with acquisition 
matrix=80×50 (partial Fourier, reconstructed to 80×80) identical to the pCASL imaging readout; 
FOV = 25×25 cm; slice thickness = 10 mm; TR/TE = 1000/8.1ms. Labeling duration = 8 ms 
(adiabatic inversion via hyperbolic secant pulse), PLD = 0.94 s.  Temporal resolution of perfusion 
quantified with PASL was 2 seconds. 
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 For both PASL and pCASL datasets, rigid-body motion correction was applied to the 
time-series of label and control images using National Institutes of Health ImageJ software 
(developed by Wayne Rasbands; National Institutes of Health, Bethesda, MD).  Regions of 
interest (ROIs) were manually drawn on the EPI images using high-resolution anatomical images 
as a reference for muscle boundaries (Figure 3.2a). After masking out the large arteries, signal 
intensity was averaged in the gastrocnemius muscle, soleus muscle, peroneus muscle, and 
anterior compartment, composed of the tibialis anterior and extensor digitorum longus muscles 
for label and control time series data. These individual muscle ROIs were also combined to 
determine the average muscle perfusion across the entire cross-section of the calf, referred to as 
“whole-leg”. The EPI readout used for both PASL and pCASL sequences is T2*-weighted 
resulting in appreciable change in the signal intensity of the images throughout the ischemia-
reperfusion paradigm, thus without any correction for the temporal offset, subtraction between 
adjacent label and control images yields a difference that is unrelated to perfusion. To account for 
the temporal offset between the control and label image series, adjacent control data were 
averaged to yield a temporally matched control series (124). Perfusion was computed from pairs 
of label and temporally-matched control data according to the appropriate models (Chapter 1, 
equations 1.6 and 1.7) for each ASL method as described Chapter 1 with PLD = 1.9 s in pCASL, 
0.94 s in PASL, T1,blood ≈ T1,tissue = 1420 ms (126). In the pCASL perfusion model, α is the labeling 
efficiency (85%) (82), τ is the labeling duration (τ = 2000 ms).  
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Figure 3.2. High-resolution anatomical images were used to define muscle 
boundaries for region of interest selection (A). Perfusion time courses were 
generated for each muscle ROI (B). Grey box indicates period of ischemia. 
Reactive hyperemia ensues following deflation of the cuff. Metrics of the dynamic 
reactive hyperemia response including the peak perfusion, time to peak perfusion 
(TTP), hyperemic flow volume (HFV), and the hyperemic duration were 
calculated. 
 
 Cuff inflation and deflation resulted in slight motion of the calf, thus the pair of label and 
control images acquired immediately after inflation or deflation were excluded from the time 
series. The baseline perfusion offset was calculated by averaging perfusion during the period of 
cuff ischemia (47), and the offset was then subtracted from each time point. PASL and pCASL 
perfusion time courses were smoothed to minimize non-physiologic noise using a three-time point 
sliding-window average. The peak perfusion, time to peak perfusion, hyperemic flow volume, and 
the hyperemic duration were identified and recorded from the perfusion time courses for each 
muscle ROI (Figure 3.2b). Wilcoxon signed rank tests were performed for repeated measures of 
perfusion. Holm adjustment for multiple comparisons was applied to all tests to maintain the 
family-wise error rate of 0.05. Thus, for all tests, Pholms<0.05 was considered to be significant.  
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3.4. Results 
3.4.1. pCASL labeling efficiency during reactive hyperemia 
 Figure 3.3a shows the temporally resolved and average velocity in a single 
representative subject throughout the ischemia reperfusion paradigm as measured in the 
popliteal artery at the location of the pCASL labeling plane. Velocity during the baseline period 
(Figure 3.3b) exhibited the expected triphasic waveform, with antegrade flow during systole, 
followed by slight retrograde and antegrade flow during diastole. During the hyperemic period 
blood flow became monophasic, as it was antegrade during both systole and diastole (Figure 
3.3c). From baseline to peak hyperemia, the average blood velocity increased by approximately 
tenfold and the peak velocity during systole roughly doubled. Across all subjects, the average 
baseline blood flow was 3.9±0.9 cm/s, and the diastolic to systolic range was -13.7±2.1 to 
46.3±5.4cm/s. The average peak hyperemic blood flow was 34.1±12.5 cm/s, with a range of 
14.0±6.4 to 87.6 ±33.6 cm/s.  
64 
 
 
Figure 3.3. (A) Temporally resolved (light red) and averaged over 1 second (dark 
red) blood flow velocity in the popliteal artery in a representative subject. The first 
20 seconds of data acquisition were used to acquire the reference image used to 
generate a tissue k-space projection. Baseline VENC was 80 cm/s and was 
raised to 120 cm/s at approximately 170 s into the experiment to account for the 
higher flow velocities during hyperemia. (B) Temporally resolved velocity from 
the baseline period in (A) shows the typical and expected triphasic waveform. (C) 
During reactive hyperemia, the blood flow is entirely antegrade, with forward flow 
throughout the cardiac cycle. 
The variability in blood flow velocity throughout the baseline and reactive hyperemia 
segments was not found to significantly impact labeling efficiency. Figure 3.4 shows the average 
label efficiency with and without correction for the T1 recovery during the transit time between the 
labeling plane and image slice location and the control efficiency, as well as the average blood 
flow velocity during the ischemia reperfusion paradigm. T1-corrected label efficiency data were 
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not calculated during the period of ischemia (grey box) since there is no flow, but through the 
uncorrected label data, we observe that the label and control conditions had similar signal 
intensity with respect to M0. During baseline, hyperemia, and recovery, a significant change in 
control or T1 recovery-corrected label efficiencies was not detected (Table 3.1).  
 
Figure 3.4. Control and label efficiency are plotted over the course of the 
ischemia reperfusion paradigm (grey box indicates period of arterial occlusion). 
Label efficiency data are plotted both with (black) and without (grey) correction 
for T1 recovery during the transit time between the labeling plane and the imaging 
slice location. The transit time was calculated as the separation distance (20 mm) 
divided by the average velocity (shown in red). Data are averaged across all 
subjects and error bars indicate standard error. Blood velocity was used to define 
the hyperemic period (indicated by the red box) as the time during which average 
blood velocity was at least more than double the average baseline velocity. No 
significant differences were detected between the baseline, hyperemia, and 
recovery periods for control or label efficiency.  
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Table 3.1. Average (standard deviation) of control and label efficiencies during 
the average baseline, hyperemia, and recovery periods. 
 Baseline Hyperemia Recovery 
Control efficiency (%) 88 (5) 89 (5) 89 (4) 
Label efficiency (%) 77 (9) 75 (7) 81 (10) 
 
3.4.2. pCASL versus PASL 
One subject was excluded from the analyses because the cuff-occlusion paradigm did 
not result in a reactive hyperemia response in pCASL data. Averaged over the remaining nine 
subjects, significant differences between the temporal dynamics of perfusion measured with 
PASL and pCASL were not detected in any muscle groups. Table 3.2 shows the results of the 
parameterized time-course data. Significant differences were not observed between PASL and 
pCASL or between the two PASL acquisitions for any of the perfusion time course metrics. 
Perfusion time courses were calculated for each scan and were averaged across all subjects 
(Figure 3.5). Similar to the results in Table 3.2, the measured whole-leg perfusion dynamics 
appear to be in agreement between pCASL and PASL despite the differences in labeling method, 
post-labeling delay, and perfusion quantification model. 
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Figure 3.5. Perfusion time course averaged across 9 subjects quantified with 
pCASL (purple), and two identical PASL scans (grey and black). Grey box 
indicates period of arterial occlusion. Error bars indicate standard error. The 
reactive hyperemia perfusion time course did not significantly differ between 
PASL and pCASL measurements. 
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Table 3.2. Average perfusion time course metrics measured with pCASL or 
PASL. Two identical PASL scans were conducted to assess repeatability of the 
measured hyperemic response. Results shown are average (standard deviation). 
 
 pCASL PASL (scan 1) PASL (scan 2) 
Gastroc Peak Perfusion 
(mL/min/100g) 41 (9) 51 (11) 52 (13) 
Soleus Peak Perfusion 
(mL/min/100g) 50 (26) 78 (33) 69 (28) 
Peroneus Peak Perfusion 
(mL/min/100g) 50 (6) 41 (12) 45 (12) 
AC Peak Perfusion 
(mL/min/100g) 47 (13) 44 (16) 45 (14) 
Whole-Leg Peak Perfusion 
(mL/min/100g) 47 (20) 51 (12) 50 (12) 
Gastroc TTP Perfusion (s) 23 (3) 33 (9) 30 (8) 
Soleus TTP Perfusion (s) 28(8) 30 (12) 22 (7) 
Peroneus TTP Perfusion (s) 26 (5) 27 (10) 24 (7) 
AC TTP Perfusion (s) 23 (3) 20 (8) 18 (7) 
Leg TTP Perfusion (s) 25 (3) 27 (7) 23 (7) 
Gastroc HFV (mL/100g) 33 (10) 42 (13) 37 (14) 
Soleus HFV (mL/100g) 39 (23) 70 (35) 52 (24) 
Peroneus HFV (mL/100g) 29 (10) 23 (8) 20 (7) 
AC HFV (mL/100g) 25 (11) 22 (10) 18 (5) 
Leg HFV (mL/100g) 33 (15) 42 (12) 38 (13) 
Gastroc HD (s) 82 (21) 88 (14) 90 (21) 
Soleus HD (s) 80 (29) 101 (35) 102 (28) 
Peroneus HD (s) 73 (22) 68 (17) 65 (26) 
AC HD (s) 65 (45) 71 (25) 63 (20) 
Whole-Leg HD (s) 77 (19) 99 (22) 105 (29) 
Gastroc signifies the gastrocnemius muscle, AC the anterior compartment, TTP the time to peak, 
HFV the hyperemic flow volume, and HD the hyperemic duration. 
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3.5. Discussion 
3.5.1. pCASL labeling efficiency 
 Previous studies have investigated the impact of temporal variation of blood velocity 
on the measured perfusion in the brain (138,141,145,146). In the brain, all blood delivered 
through the internal carotid and vertebral arteries traverses the brain via capillary microcirculation. 
A simple method to experimentally measure pCASL labeling efficiency was reported by Aslan, et 
al (141) in which total cerebral blood flow was measured in both the internal carotid and vertebral 
arteries using phase contrast MRI and was compared to whole-brain averaged blood flow 
measured by pCASL. If all other assumptions in the perfusion model are correct, the difference 
between total cerebral blood flow measured by phase contrast and pCASL can be accounted for 
by the labeling efficiency.  
 The approach utilized by Aslan, et al cannot be employed in the peripheral circulation 
for several reasons. First, blood flow in the popliteal artery is not exclusively delivered to the calf 
muscles. The popliteal artery branches to supply muscles of the foot, and also delivers blood to 
the skin, intra-muscular fibrous tissue, bone, and other structures, thus a precise and specific 
measure of muscle blood flow in a large artery is difficult. Furthermore, even if a distinct measure 
of total muscle blood flow in the feeding artery were achieved, the PASL and pCASL sequences 
employed in this study provided single-slice measurements therefore do not yield total muscle 
blood flow.  
 The methodology employed herein was not directed to measure absolute labeling 
efficiency, although a similar approach has been used to measure labeling efficiency in a 
phantom experiment (144). The more pertinent question was to determine whether the labeling or 
control efficiency was impacted by the substantial changes in average arterial velocity between 
rest and reactive hyperemia in skeletal muscle. As expected, the control condition did not 
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significantly impact signal in the feeding artery, and control efficiency remained relatively constant 
throughout the paradigm. No significant change was detected in labeling efficiency during the 
period of hyperemia compared to the baseline and recovery periods.  
 The correction of the label signal intensity for T1 recovery is a necessary step as the 
transit time between the labeling location and the imaging slice location differs substantially 
between the baseline and hyperemic states. For example, at an average blood flow velocity of 
approximately 4 cm/s at baseline it would take 0.5 seconds for the blood to traverse the 20 mm 
separation between the labeling plane and image slice location. If the blood water spins were 
100% inverted at the labeling plane, this would account for ~ 26% signal recovery. However, 
during hyperemia, arterial velocity increases by an order of magnitude, and the blood would 
traverse the distance between the labeling and imaging locations in only 0.05 seconds, resulting 
in much less time for T1 recovery (only about 3% signal recovery). Following correction for this 
effect, there is no significant difference between the calculated label efficiency during the 
baseline, hyperemia, and recovery states.  
 Experimentally derived average labeling efficiency of approximately 75% was lower 
than the estimated 85% labeling efficiency achieved in the brain (82), or the 94% labeling 
efficiency used in a previous muscle pCASL study (48). Partial-volume effects due to the low 
resolution of the EPI readout may have caused underestimation of the calculated labeling 
efficiency, however this would likely not affect the observed relative constancy of labeling 
efficiency between baseline and hyperemia.  
 The finding of relative stability of labeling efficiency is surprising, as studies in the 
brain have shown a significant decrease in labeling efficiency in response to a stimulus that 
increases arterial velocity (141). Potentially, the periods of retrograde and low velocity antegrade 
blood flow during diastole at baseline may not substantially contribute to the downstream delivery 
of blood, and therefore may not impact the overall labeling efficiency. Rather than blood water 
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spins traveling forward at a constant velocity of 5 cm/s, blood in the artery spurts forward at 
speeds approaching 40 cm/s, but only for the short systolic period. This hypothesis is supported 
by 4D flow measurements of blood flow in the peripheral vasculature (74), which show fast 
forward flow during systole, and near stagnation during diastole.  
3.5.2. Perfusion quantification with pCASL and PASL 
 A subset of the data included in this study has been published previously. Specifically, 
the repeated PASL measurements were used to investigate intra-session repeatability of 
perfusion dynamics and to compare perfusion dynamics between healthy individuals and patients 
with peripheral artery disease in (134). In the present work, we sought to examine the agreement 
between skeletal muscle perfusion dynamics measured with PASL and pCASL. One subject was 
excluded from the present analysis since no hyperemic response was detected with pCASL. 
 In the nine subjects in whom perfusion was measured with PASL and pCASL, the 
quantified perfusion time course metrics were not significantly different for any muscle group. The 
average perfusion time course was very similar in appearance between the two PASL scans, 
implying that there was little difference between the successive reactive hyperemia responses, 
and between either PASL and pCASL scans, suggesting that the different methods for measuring 
perfusion may not impact the measurement precision.  
 Despite the differences between the employed PASL and pCASL methods in labeling 
method, labeling duration, post-labeling delay, and perfusion quantification model, the quantified 
time course metrics were not found to significantly differ between the two sequences for any 
muscle group. Quantified reactive hyperemia peak perfusion was in approximate agreement with 
prior studies using the SATIR PASL variant (34,51,142). However compared to Wu, et al’s results 
from a CASL sequence (52), Grozinger et al’s results using pCASL (48), or Lopez, et al’s results 
using Q2TIPS PASL (25) peak perfusion in all muscles was lower in the present study. This bias 
could be attributed to different post-processing methods as we excluded macro-vessels in the 
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ROI, which would increase apparent perfusion if included. It is important to note that exactly the 
same muscle ROIs were used for quantification of perfusion in this study.  
 The present study is the first that we are aware of to directly compare skeletal muscle 
perfusion dynamics with PASL and pCASL sequences. It is not without limitation, though. The 
perfusion model used for PASL assumes that T1 of blood and muscle tissue are equal. This is not 
the case at 3T, however, the difference between T1 of muscle and blood would result in an 
approximate 5 mL/min/100g perfusion offset within the physiologic range of perfusion expected 
(142).  
 This study did not investigate the potential impact of the difference in arterial transit 
time that would occur between baseline and hyperemia. If blood flow velocity in the popliteal 
artery is only approximately 4-5 cm/s at baseline, and the pCASL labeling plane is 6 cm proximal 
to the imaging slice, it would take 1.2-1.5 seconds to travel in the large arteries to the imaging 
slice. Additional time would be required for the blood to perfuse through the muscle tissue, thus a 
longer post-labeling delay could have resulted in higher baseline perfusion. However, during 
hyperemia the average flow velocity peaks around 40 cm/s, corresponding to a transit time of 
0.15 s. These effects may have masked a true reduction in labeling efficiency between baseline 
and hyperemia. A follow-up study investigating the effect of arterial transit time would provide 
insight on this issue. Differences in arterial transit time may be more of an issue in patients with 
peripheral artery disease, in which a stenosis or occlusion may be present distal to the labeling 
plane, proximal to the perfusion imaging slice. This would result in an apparent perfusion 
reduction, but would be due to the increase in arterial transit time due to impaired arterial flow.  
 The impact of arterial transit time is less of an issue for PASL since a flow-alternating 
inversion recovery variant is used. Blood only needs to travel a short distance from just outside of 
the imaging slice to contribute to the measured perfusion. However, for fast flow (greater than 20 
cm/s in the microcirculation), there is potential that blood from outside of the coil sensitivity profile 
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could reduce the effective PASL labeling efficiency, which is assumed to be 100%. Although 
blood flow velocity in the artery exceeds 20 cm/s during hyperemia, the speed of blood flow in the 
arterioles and capillaries is much slower. However, this should be taken into consideration when 
selecting the transmit and receive coil setup.  
3.6. Conclusions 
 The pCASL labeling efficiency was not significantly impacted by the variation between 
baseline and reactive hyperemia arterial velocity. Time course metrics were similar for both PASL 
scans, and between either of PASL scans and the pCASL acquisition. The benefit of increased 
temporal resolution with PASL, particularly during non-linear changes in the T2*-based EPI time 
course may outweigh the theoretical benefit of the greater SNR achievable with pCASL. Overall, 
reactive hyperemia perfusion dynamics were in agreement whether measured with PASL or 
pCASL sequences. 
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CHAPTER 4: SIMULTANEOUS QUANTIFICATION OF 
MACROVASCULAR AND MICROVASCULAR BLOOD FLOW AND 
OXYGEN SATURATION USING VPIVOT 
4.1. Abstract 
Background: The regulation of blood flow and oxygen consumption in skeletal muscle is a 
dynamic, tightly controlled process. The purpose of this work is to develop and evaluate a 
magnetic resonance technique for simultaneous measurement of bulk blood flow, perfusion, 
draining vein SvO2, and skeletal muscle T2*.   
Methods: An expanded version of the PIVOT is introduced, termed Velocity and PIVOT 
(vPIVOT). vPIVOT comprises a three-slice interleaved structure for the measurement of blood 
velocity and SvO2 from the superior slice, perfusion from the central slice, and SvO2 and T2* from 
the inferior slice. In five subjects, vPIVOT was compared to PIVOT and a velocity-encoded dual-
echo GRE, termed OxFlow, during separate ischemia-reperfusion paradigms to assess the ability 
of vPIVOT to accurately measure the reactive hyperemia response. Then in ten subjects, vPIVOT 
was applied to assess muscle blood flow and oxygen consumption during the transition to rest 
following dynamic exercise of the calf.  
Results: No significant differences between vPIVOT-derived data and comparison sequences 
were observed. Blood flow in the large vessels and in the capillary bed was found to respond 
quickly to the cessation of induced ischemia, reaching its peak at 6±2 s, and 20±6 s, respectively. 
Following exercise, macrovascular flow response was similar, reaching its maximum 8±3 s after 
relaxation, however microvascular perfusion in the gastrocnemius muscle continued to rise for 
101±53 s.  Oxygen consumption was calculated based on either mass-normalized arterial blood 
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flow, or perfusion measurements, and the peak was measured as 15.2±6.7 mL O2/min/100g or 
6.0±1.9 mL O2/min/100g, respectively. 
Conclusion: Simultaneous quantification of bulk blood flow, perfusion, SvO2, and T2* is possible 
with vPIVOT. Together, the measurement of SvO2 and blood flow, either perfusion or bulk flow, 
may be used to quantify the muscle oxygen consumption following exercise.  
4.2. Introduction 
As described in Chapter 1, peripheral vascular reactivity and the dynamics of muscle 
metabolism may be better understood by measuring the temporal relationship of blood flow and 
oxygen saturation in the micro- and macrovasculature. Indeed, through reactive hyperemia 
studies, it has been shown that patients with peripheral artery disease (PAD) exhibit alterations in 
recovery dynamics of perfusion (52,134), arterial blood flow (66), venous oxygen saturation 
(SvO2) (66,134), and skeletal muscle T2* (68,69). Furthermore, together the measurement of 
blood flow and venous oxygen saturation can provide the metabolic rate of oxygen consumption 
(𝑉𝑂!) through the Fick principle:  
 𝑉𝑂! = 𝐶!𝑂! ∙ 𝑓𝑙𝑜𝑤 ∙ 𝑆𝑎𝑂! − 𝑆𝑣𝑂!     [4.1] 
where CaO2 is the oxygen carrying capacity of blood (𝐶!𝑂! = 𝐶! ∙ Hgb, Ca = 1.34 mL O2/g 
hemoglobin (Hgb)), flow is either muscle-mass normalized bulk arterial/venous flow or local tissue 
perfusion, and  SaO2 and SvO2 represent the arterial and venous oxygen saturations, 
respectively. The measurement of time resolved skeletal muscle 𝑉𝑂! in humans remains a 
difficult problem. 
Recently, MRI methods to investigate the regulation of skeletal muscle blood flow and 
oxygen consumption during exercise have been developed. Implementations have focused on 
either the response to a sustained isometric contraction, or to the dynamics of the transition 
between exercise and rest, known as the off-kinetics. Specifically, Mathewson, et al proposed a 
76 
 
method to simultaneously measure venous bulk flow and intravascular venous oxygen saturation 
through a projection phase-contrast and susceptometry-based oximetry approach (113). Resisted 
knee extension exercise was performed, and the oxygen consumption during the off-kinetics in 
the quadriceps muscles was dynamically assessed. However, the blood flow dynamics in the 
large arteries and draining veins may differ from the blood flow delivery to the muscle fibers via 
the capillary circulation.  
An alternate approach measures blood flow and oxygen saturation locally at the level of 
the capillary bed rather than in the large vessels. Blood flow is measured through ASL-MRI 
(45,76) and blood oxygenation is quantified based on either empirically derived (49) or theoretical 
(114) relationships between the RF-reversible transverse relaxation rate (R2’) and %HbO2. Initially 
investigated by Zheng and colleagues, the image acquisition suffered from low temporal 
resolution, thus limiting the acquisition to one measurement at baseline and one during a 
sustained isometric contraction (115). A more recent method proposed by Buck, et al uses a 
faster image acquisition strategy for the measurement of R2’, providing temporal resolution of 
approximately 2.5 seconds. To calculate 𝑉𝑂! this was combined with a separate measurement of 
blood flow through ASL with 4-second temporal resolution (116).  Thus, the investigators were 
able to assess the dynamic changes in oxygen consumption kinetics in the transition period 
between rest and exercise (on-kinetics), and between exercise and rest (off-kinetics).  
However, both of the R2’/ASL methods described in the previous paragraph required 
separate contractions for the blood flow or oxygenation measurements. Given the presence of 
variability in the physiologic response, the true temporal relationship may be slightly different 
between the two acquisitions. Therefore, a combined and simultaneous method would be 
desirable. While the work conducted by Mathewson, et al did allow for simultaneous 
measurement of blood flow and oxygenation the measurement was not spatially localized, and 
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flow may have increased in other muscles that were not specifically targeted by the exercise 
paradigm.  
 Described in chapter 2, an interleaved pulsed ASL (PASL) and multi-echo gradient 
recalled echo (GRE) sequence, termed Perfusion, Intravascular Venous Oxygen saturation, and 
T2* (PIVOT) was introduced that allows for the simultaneous acquisition of perfusion, draining 
vein SvO2, and the skeletal muscle BOLD response.  However, presently no single technique is 
capable of also measuring arterial blood flow. Concurrent acquisition of micro- and macrovascular 
blood flow alongside SvO2 and T2* would offer a comprehensive functional assessment of the 
peripheral vasculature and would perhaps allow investigation of the independent contributions of 
macrovascular and microvascular reactivity. Furthermore, results from such an approach could 
be used in aggregate to calculate muscle oxygen consumption.  
To address this unmet need, the development of a 3-slice interleaved PASL and velocity-
encoded multi-echo GRE sequence is presented, termed Velocity and PIVOT (vPIVOT). We 
hypothesize that vPIVOT allows faithful and unbiased measurement of each of the individual 
parameters, and that through investigation of the off-kinetics of exercise vPIVOT will be able to 
quantify 𝑉𝑂! based either on mass-normalized flow or local tissue perfusion. Furthermore, we 
hypothesize that these results may allow us to address the disparity in results from prior studies. 
Thus, the purpose of the work described in this Chapter was to develop a technique to 
dynamically and simultaneously measure flow in the micro and macrovasculature, as well as 
oxygen saturation, and to apply the technique to measurement of the off-kinetics of exercise in 
human skeletal muscle. 
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4.3. Methods 
4.3.1. Sequence overview 
Simultaneous measurement of perfusion, macrovascular blood flow, SvO2, and T2* was 
achieved with a 3-slice interleaved sequence termed vPIVOT shown in Figure 4.1. As described 
in Chapter 2, the original PIVOT sequence comprises a dual-slice acquisition scheme in which a 
multi-echo GRE sequence acquires data at a downstream slice location from the perfusion slice 
during the PASL post-labeling delay (PLD) (142). Here, the framework of PIVOT was expanded 
to include an upstream velocity-encoded dual-echo GRE acquisition following the PASL EPI 
readout. From the upstream dual-echo GRE data, bulk blood flow in the arteries and veins is 
quantified through phase contrast, and similarly to the downstream slice, SvO2 in the vein is 
quantified via susceptometry-based oximetry. Like in PIVOT, the non-selective (NS) inversion 
used for the control condition of PASL will impact all tissue within the volume of the coil 
sensitivity, therefore only GRE data acquired following slice-selective (SS) PASL inversion (i.e. 
the label condition) are used for analysis. 
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Figure 4.1. vPIVOT pulse sequence diagram. Similar to PIVOT, multi-echo GRE 
data are acquired downstream from the PASL slice location during the PLD. In 
vPIVOT, velocity-encoded GRE data are also acquired after perfusion EPI 
acquisition at a location superior to the PASL slice location. Perfusion is 
quantified through ASL (data used are shown in light red), SvO2 through 
susceptometry-based oximetry (data used are shown in blue), blood velocity 
through phase contrast (data used are shown in dark red), and T2* by fitting the 
magnitude signal to a mono-exponential function (data used are shown in green). 
Temporal resolution for all quantified parameters is 4 seconds. 
 
To maintain high temporal resolution sampling, keyhole reconstruction (122) was used for 
both the superior and inferior GRE datasets, allowing reconstruction of high-resolution velocity 
images and field maps from the dynamically acquired data. Thus only the central quarter of k-
space is acquired at each time point, and fully phase-encoded reference images with otherwise 
identical sequence parameters are acquired separately. The outer k-space data from the 
reference images are then used to fill in k-space of the dynamic data. Keyhole reconstruction 
requires that the reference images and dynamic data have exact anatomical correspondence 
(e.g. no movement between the two acquisitions).  Due to the extreme motion of dynamic 
exercise, data cannot be reconstructed during the exercise portion, and since there may be a 
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difference in the physical location of the leg before and after exercise, the reference images are 
acquired both before and after the dynamic acquisition and used for reconstruction appropriately.  
The combination of MR susceptometry and phase contrast was previously proposed for 
the measurement of oxidative metabolism in the brain (147,148) and was termed OxFlow. This 
velocity-encoded dual-echo acquisition provides flow through the phase difference between k-
space data from the first echo acquired in adjacent TRs with alternating gradient first moments. 
The velocity-encoding gradients cause a constant phase offset between the first and second 
echoes, therefore taking the inter-echo difference in phase accrual removes the velocity-encoded 
phase. As each k-space line is encoded twice for phase contrast, those data are averaged to 
reduce the noise in the field map used for SvO2 quantification.   
4.3.2. Experimental protocol 
vPIVOT-derived time course parameters were compared to independently acquired 
PIVOT or OxFlow data throughout ischemia-reperfusion paradigms in 5 subjects. These data 
allowed for the investigation of the presence of significant differences between vPIVOT and 
standard non-interleaved methods. Additionally, the functional hyperemia response following a 
bout of plantar flexion contractions was assessed with vPIVOT in ten healthy subjects. The 
dynamics of the macro- and microvascular flow responses were compared, and gastrocnemius 𝑉𝑂! was calculated.  
The Institutional Review Board of the University of Pennsylvania approved all aspects of 
the study. A total of ten healthy subjects were recruited to participate after providing written, 
informed consent. All imaging was performed at 3.0 T (Siemens Magnetom Tim Trio (VB17), 
Siemens Medical Equipment; Erlangen, Germany) with an eight channel transmit/receive knee 
coil (InVivo, Inc; Gainesville, FL). Subjects were positioned supine and the maximum cross-
section of the calf was centered in the knee coil. vPIVOT, PIVOT, and OxFlow experimental 
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imaging sequences were written in SequenceTree (143). Data analysis was performed with in-
house-written software using MATLAB, Version 7.12.0 (MathWorks, Natick, MA), and statistical 
analyses were executed with JMP, Version 11 (SAS Institute., Cary, NC, 1989-2007). In 
applicable experiments, arterial occlusion was achieved by application of supersystolic pressure 
(at least 200 mmHg) via a cuff secured around the thigh inflated by a pneumatic tourniquet 
system (D.E. Hokanson, Inc; Bellevue, WA). Exercise was performed against a custom-built, MRI 
compatible plantar flexion ergometer. 
Sequence parameters. PASL images were acquired with a partial Fourier GRE-EPI 
readout with the following parameters: FOV = 250 × 250 mm2; acquired matrix = 80×50, 
reconstructed to 80 × 80; slice thickness = 1 cm; slice location = isocenter; TR/TE = 2 s/8.05 ms; 
PLD = 952 ms. The inferior multi-echo GRE had the following parameters: FOV = 96 × 96 mm2; 
keyhole acquired matrix = 96 × 24, (for SvO2 data analysis, reconstructed matrix = 96 × 96 using 
a fully sampled reference image; only dynamic data were used for T2* analysis); slice thickness = 
1 cm; slice location = 3 cm inferior from isocenter; TR/TE1/TE2/TE3/TE4/TE5 = 38.1/3.8/7.0/12.3/ 
19.3/26.3 ms,	 α	= 15°. The superior velocity-encoded dual-echo GRE had the following 
parameters: FOV = 96 × 96 mm2; keyhole acquired matrix = 96 × 24, (for SvO2 and velocity 
analyses, reconstructed matrix = 96 × 96 using a fully sampled reference image); VENC = 120 
cm/s; slice thickness = 0.5 cm; slice location = 3-4 cm superior from isocenter; TR/TE1/TE2 = 
20.0/6.0/9.7 ms, α = 10°. Flip angle was reduced in the superior multi-echo GRE to mitigate the 
potential error in perfusion due to a reduction in the starting magnetization of the blood water 
spins prior to NS inversion. Perfusion, bulk flow, SvO2, and T2* each were quantified with four-
second temporal resolution. 
4.3.3. Reactive hyperemia protocol 
To assess whether vPIVOT is biased in its measurement of each parameter, vPIVOT-
derived perfusion, SvO2, and T2*, or SvO2 and flow were compared to those obtained with PIVOT 
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or OxFlow, respectively. In five healthy subjects (4 male, 32.4±6.4 years old), data were acquired 
with each of the three sequences throughout separate ischemia-reperfusion paradigms, each with 
2 minutes of baseline, 3 minutes of ischemia, and 4 minutes of recovery.  
Average signal intensity was determined for SS and NS EPI data at each time point in 
regions of interest (ROIs) in muscles of the calf including: the gastrocnemius muscle, the primary 
muscle activated by plantar flexion contraction; the soleus muscle, a postural muscle also 
involved in plantar flexion contraction; the peroneus muscles, a group of muscles that are 
involved in plantar flexion contraction and eversion of the foot; and the anterior compartment, 
comprising the tibialis anterior and extensor digitorum longus muscles, which are primarily 
responsible for dorsiflexion. Additionally, signal intensities in all of the ROIs were averaged 
together to calculate the average perfusion of the cross-section of the leg. Perfusion was 
quantified from the label and temporally-matched control data (see chapter 2 and 3 for details) 
using the model proposed by Raynaud, et al (34). As described previously (124), the perfusion 
offset was corrected by subtracting the average perfusion during the period of arterial occlusion 
from each time point. From the perfusion time courses, the time to peak perfusion and peak 
perfusion were determined. 
The superior slice was positioned such that it intersected the tibioperoneal trunk, a short 
arterial segment distal to the branch point of the anterior tibial artery, before the bifurcation of the 
posterior tibial and peroneal arteries. Artery and vein velocities were quantified from the 
superiorly located multi-echo GRE data of vPIVOT and were compared to OxFlow-derived 
measures from the same slice location. Velocity was averaged over the cross-section of the 
artery or vein, and was multiplied by the vessel’s cross-sectional area to derive flow.  
Using the susceptometry-based oximetry model (58), SvO2 was quantified for both the 
superiorly and inferiorly acquired GRE data in vPIVOT and were compared to OxFlow and 
PIVOT, respectively. Hematocrit was not measured in this study, but instead was assumed to be 
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0.45 or 0.40 for the male and female subjects, respectively. In the inferior slice, SvO2 was 
quantified in the peroneal vein and results were compared to those from PIVOT. In the superior 
slice, positive and negative VENC acquisitions were averaged and SvO2 was quantified in the 
tibioperoneal vein and results were compared to those from OxFlow. In all cases, the average 
baseline SvO2 and the washout time (time to minimum SvO2) was recorded from the dynamic 
time course. 
From the inferior multi-echo GRE data for both vPIVOT and PIVOT sequences, T2* was 
quantified in a ROI in the soleus muscle by fitting the magnitude signal intensities from echoes 2-
5 to a mono-exponential function. T2* was then normalized to the average baseline value, and the 
maximum relative T2* (T2*max) and time to peak T2* were determined. 
4.3.4. Exercise protocol 
The five subjects involved in the reactive hyperemia evaluation plus another five subjects 
(7 male, 31.7±5.0 years old) were scanned during a dynamic contraction protocol. vPIVOT data 
were acquired continuously throughout 2 minutes baseline, 2 minutes of resisted dynamic plantar 
flexion contractions, and 8 minutes recovery. Contractions were performed against the foot pedal 
of a custom-built, MRI-compatible ergometer. Subjects were coached to perform one full 
contraction and relaxation cycle every second against a pressure of 10 psi, corresponding to 6 
watts. 
Data analysis for each parameter was the same as for the reactive hyperemia evaluation. 
Of note for subjects only involved in the exercise study, vPIVOT data were acquired during a 
scan consisting of 2 mins baseline and 2 mins of arterial occlusion to determine the baseline 
perfusion offset as described above. In subjects who participated in both the ischemia and 
exercise protocols, the baseline offset calculated from the ischemia data were applied. In all 
subjects, muscle volume was quantified via manual segmentation from a 3D SSFP-echo 
acquisition. Muscle volume was converted to mass using the density of muscle (1.06 g/mL).   
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𝑉𝑂! was calculated via the Fick principle (equation [4.1]) using flow measured either from 
perfusion (𝑉𝑂!,!"#$) or muscle mass-normalized arterial flow (𝑉𝑂!,!"#$). In both cases, SaO2 was 
assumed to be 100% and thus arteriovenous oxygen difference was estimated as (1-SvO2). Peak 𝑉𝑂!, time to peak 𝑉𝑂!, and net 𝑉𝑂! (total integrated post-exercise area) were recorded for 𝑉𝑂!,!"#$ and 𝑉𝑂!,!"#$. 
4.3.5. Statistical analyses 
Given the limited sample size, Wilcoxon signed rank tests were used to assess whether 
significant differences existed between vPIVOT-measured responses and PIVOT or OxFlow 
measures from the reactive hyperemia evaluation. For the exercise evaluation, Wilcoxon-signed 
rank tests were also used to assess whether significant differences existed between the time to 
peak perfusion and time to peak arterial and venous blood flow, and whether differences existed 
between 𝑉𝑂!,!"#$ and 𝑉𝑂!,!"#$ peak, time to peak, or net responses. 
4.4. Results 
4.4.1. Post-ischemia reactive hyperemia evaluation. 
Figure 4.2 shows the time courses for the reactive hyperemia experiments from vPIVOT 
and comparison sequences. Table 4.1 shows the results of the metrics to parameterize the time 
courses from each sequence. Overall, the reactive hyperemia response was not observed to be 
significantly different when measured with vPIVOT and PIVOT or OxFlow.  
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Figure 4.2.	Averaged across all five subjects, vPIVOT reactive hyperemia data 
are compared to OxFlow-derived flow and SvO2, and PIVOT-derived perfusion 
and T2*. Grey box indicates period of arterial occlusion and error bars indicate 
standard error. A significant difference was not observed between vPIVOT and 
OxFlow or PIVOT for any of the quantified time course metrics. 
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Table 4.1.	vPIVOT derived time course metrics are compared to those obtained 
with OxFlow or PIVOT. Significant differences between sequences were not 
observed for any parameter. 
 OxFlow vPIVOT PIVOT 
Max venous flow (mL/min) 213 (21) 191 (47)  
TTP venous flow (s) 6 (3) 6 (4)  
Max arterial flow (mL/min) 513 (172) 527 (220)  
TTP arterial flow (s) 6 (3) 6 (2)  
Gastrocnemius muscle peak  
perfusion (mL/min/100g)  50  (13) 52 (13) 
Gastrocnemius muscle TTP perfusion (s)  20 (6) 18 (9) 
Soleus muscle peak  
perfusion (mL/min/100g)  42 (17) 44 (19) 
Soleus muscle TTP perfusion (s)  14 (6) 15 (7) 
Whole-leg average peak  
perfusion (mL/min/100g)  40 (12) 41 (12) 
Whole-leg average TTP perfusion (s)  13 (7) 16 (7) 
Tibioperoneal trunk baseline SvO2 (%HbO2) 70 (8) 70 (14)  
Tibioperoneal trunk SvO2 washout time (s) 8 (3) 8(0)  
Posterior tibial vein baseline SvO2 (%HbO2)  63 (7) 65 (7) 
Posterior tibial vein SvO2 washout time (s)  16 (7) 23 (15) 
Soleus muscle relative T2*max (%)  107 (3) 107 (3) 
Soleus muscle TTP T2* (s)  30 (7) 30 (8) 
 
 
Specifically for the arterial velocity time course results, no significant difference was 
detected between vPIVOT and OxFlow. Of note, the OxFlow sequence uses full k-space 
acquisition for each data point, whereas vPIVOT uses keyhole reconstruction for view sharing. 
The interleaved sequence and the keyhole reconstruction did not appear to impact the 
quantification of velocity or flow in the artery or the vein. Peak arterial flow was 706±442 mL/min 
for vPIVOT and 701±445 mL/min when quantified from OxFlow data. Of note, one subject had 
particularly high flow values, which were well represented by both vPIVOT and OxFlow. 
Removing the outlying subject’s data, the average was 527±220 mL/min and 513±172 mL/min for 
vPIVOT and OxFlow, respectively. Time to peak arterial flow was 6±2 s or 6±3 s for vPIVOT or 
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Ox Flow, respectively (P>0.05). Phase contrast data also allows for the quantification of venous 
blood flow, and again a difference was not observed between vPIVOT and OxFlow data.  
Perfusion metrics were not found to significantly differ when measured with vPIVOT or 
PIVOT. In the gastrocnemius muscle, the peak perfusion was 50±13 mL/min/100 g when 
measured with vPIVOT, and 52±13 when measured with PIVOT (P>0.05). Time to peak in the 
gastrocnemius muscle was 20±6 s and 18±9 s with vPIVOT and PIVOT, respectively. In the 
soleus muscle, the peak perfusion was 42±17 mL/min/100g and 44±19 mL/min/100g, and time to 
peak was 14±6 and 15±7 seconds when measured with vPIVOT and PIVOT. Again, the Wilcoxon 
signed rank test was not significant for differences between vPIVOT and PIVOT.  
SvO2 dynamics were not found to differ between vPIVOT and PIVOT in the inferior slice 
location, nor did they differ between vPIVOT and OxFlow in the superior slice location. In two 
subjects, the peroneal veins were too small, thus in the inferior slice SvO2 could not be measured 
with either PIVOT or vPIVOT. In the remaining three subjects, washout time was 16±7 s and 
23±15 s. In one subject, (different than the two mentioned previously) changes in SvO2 were not 
measured using either OxFlow or vPIVOT in the superior slice. In the remaining four subjects, the 
washout time was 8±0 s and 8±3 s for vPIVOT and OxFlow, respectively. A difference was not 
observed between the baseline SvO2 for either slice location.  
The BOLD response in the soleus muscle was the most delayed in reaching its peak 
magnitude for both vPIVOT and vPIVOT (TTPT2* = 30±7 s or 30±8 s for vPIVOT or PIVOT, 
respectively). Relative T2* changes were successfully measured in each of the five subjects, and 
a significant difference between sequences was not detected (P>0.05). Relative T2*max was 
107±3% in vPIVOT and 107±3% in PIVOT as well.  
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4.4.2. Post-exercise functional hyperemia investigation 
Each subject was coached throughout the two-minute bout of exercise, and plantar 
flexion contractions were practiced prior to the scan. However, the precise workload of the 
exercise was not quantified for each subject. Although hyperemia was induced by the exercise in 
all subjects, two datasets were removed from the final analysis: one because the subject was 
incapable of maintaining the 1-second contraction rate, and the other due to substantial motion 
during the recovery period following exercise. The remaining eight subjects are included in 
subsequent analyses.  
Gastrocnemius muscle volume was quantified for each subject from the SSFP-echo 
images, which provided contrast between muscle tissue and facial planes and blood, allowing 
conspicuity of muscle boundaries. Average gastrocnemius muscle mass was 349±75 g.  
Table 4.2 summarizes the results from the exercise protocol, and Figure 4.3 shows the 
time course of each of the measured parameters over the course of the scan. Compared to the 
response following induced ischemia in which the times to peak perfusion and peak arterial and 
venous flow were approximately equivalent, there is a substantial delay in the time to peak 
perfusion following exercise. In fact, both arterial flow and venous flow reached their peaks 8±3 s 
after cessation of exercise, while gastrocnemius muscle perfusion did not reach its maximum until 
101±53 s (p<0.005).  Figure 4.4 shows the average perfusion response in each of muscles in the 
calf.   
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Table 4.2. Synopsis of vPIVOT-measured responses during the dynamic 
exercise protocol. * indicates presence of a significant difference between flow 
and perfusion responses.			
 vPIVOT 
Max venous flow (mL/min) 463 (149) 
TTP venous flow (s) 8 (3) 
Max arterial flow (mL/min) 624 (223) 
TTP arterial flow (s) 8 (3) 
Gastrocnemius muscle peak perfusion (mL/min/100g) 88  (33) 
Gastrocnemius muscle TTP perfusion (s) 101 (53)* 
Peak 𝑉𝑂!,!"#$ (mL O2/min/100g) 15.2 (6.7) 
TTP 𝑉𝑂!,!"#$ (s) 12 (7) 
Net 𝑉𝑂!,!"#$ (mL O2/100g) 20.6 (9.7) 
Peak 𝑉𝑂!,!"#$ (mL O2/min/100g) 6.0 (1.9)* 
TTP 𝑉𝑂!,!"#$ (s) 102 (37)* 
Net 𝑉𝑂!,!"#$ (mL O2/100g) 22.3 (13.5) 
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Figure 4.3. vPIVOT-measured responses during the dynamic exercise protocol. 
The quantified time courses were averaged over the eight subjects, and error 
bars indicate standard error. Flow peaked and recovered rather quickly, while 
perfusion continued to increase for more than one minute after exercise. The 
SvO2 and T2* responses both drop upon relaxation then begin to recover at a 
similar rate.  
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Figure 4.4. Average exercise vPIVOT-derived perfusion data is shown for 
individual muscles. Hyperperfusion is primarily observed in the gastrocnemius. 
No substantial response is detected in the soleus or peroneus muscles or in the 
muscles of the anterior compartment.  
SvO2 was computed for both the superior and inferior slice locations and results were 
averaged for use for the quantification of muscle oxygen consumption. Figure 4.5 shows the 
calculated 𝑉𝑂!,!"#$ and 𝑉𝑂!,!"#$ responses. Similar to the relationship between macrovascular 
flow and perfusion, 𝑉𝑂!,!"#$ peaks and recovers quickly, while the 𝑉𝑂!,!"#$ response is more 
delayed.  Peak 𝑉𝑂! was significantly different when measured with mass-normalized flow 
compared to perfusion: 𝑉𝑂!,!"#$ was 15.2±6.7 mL O2/min/100g while 𝑉𝑂!,!"#$ was 6.0±1.9 mL 
O2/min/100g (p<0.005). The time to peak was also significantly different: time to peak 𝑉𝑂!,!"#$ 
was 12±7 s, and time to peak 𝑉𝑂!,!"#$ was 102±37 s (p<0.01). However, the net 𝑉𝑂! was not 
observed to significantly differ. Net 𝑉𝑂!,!"#$ was 20.6±9.7 mL/100g and net 𝑉𝑂!,!"#$was 
22.3±13.5 mL/100g (P>0.05).  
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Figure 4.5. 𝑉𝑂! was calculated via the Fick principle using perfusion or mass-
normalized average arterial flow. The average of eight subjects is shown, with 
error bars indicating standard error. Exercise occurred during the grey box from 2 
minutes to 4 minutes. Although the peak amplitude and time to peak of the 𝑉𝑂!,!"#$ and 𝑉𝑂!,!"#$ are significantly different, the total integrated post-exercise 
response is similar. 
 
4.5. Discussion 
Overall, vPIVOT was capable of measuring the reactive hyperemia and functional 
hyperemia responses. vPIVOT results quantifying the reactive hyperemia response were not 
observed to significantly differ from those obtained by the comparison sequences, however the 
limited sample size exposes this conclusion to the potential of a Type II error. The dynamic 
measurement of the functional hyperemia response of the off-kinetics using vPIVOT may provide 
insight into the regulation of blood flow and oxygen consumption in skeletal muscle.  
The ability to measure blood flow both in the large arteries and capillary bed provides a 
unique method for the investigation of the regulation of blood flow to skeletal muscle. Following 
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ischemia, no substantial delay in the perfusion response was detected in these healthy subjects. 
During the period of transient ischemia, the terminal arterioles are able to vasodilate both due to 
the accumulation of vasodilator metabolites and the reduction in intra-arterial pressure. Upon cuff 
release, the return of arterial blood flows to the low-resistance capillary bed resulting in an almost 
immediate perfusion. On the other hand, during exercise, there is still a buildup of metabolic 
waste products, and a demand for increased oxygen due to increased oxygen utilization. 
However, the capillary bed remains a high-resistance structure. Upon relaxation, the 
intramuscular pressure drops allowing for the increase in blood flow through the large arteries. 
The microvascular response, however, lags as it takes some finite amount of time for the terminal 
arterioles to relax due to NO-mediated vasodilation from increases in wall shear stress, as 
described in previous chapters. The relationship between the microvasuclar and macrovascular 
flow may differ in patients with primary microvascular impairment, such as diabetics.  
4.5.1. Post-ischemia reactive hyperemia evaluation 
In the present study, vPIVOT was compared to two sequences: OxFlow and PIVOT. 
PIVOT was previously evaluated compared to independent PASL and multi-echo GRE 
measurements during reactive hyperemia, and no bias was detected between any of these 
scans. OxFlow has been proposed as a method for the simultaneous quantification of blood flow 
and oxygen saturation and has been applied in both the brain (147-149) and in the peripheral 
circulation (88).  
The temporal resolution of sampling for both PIVOT and OxFlow were adapted to match 
that of vPIVOT, and overall this resulted in a reduction of the sampling rate. PIVOT in its original 
implementation had a temporal resolution of 2-seconds for each measurement, compared to the 
4-second temporal resolution of vPIVOT. OxFlow’s temporal resolution can be varied, depending 
on the specific application. For example, the temporal sampling rate can exceed 2 s through the 
application of view-sharing techniques, useful for the measurement of dynamic events (148). Or, 
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full images can be acquired when assessing the baseline state, with a temporal resolution of 8-30 
s (147,149). In the present study, keyhole reconstruction was used as a view-sharing technique 
(122), permitting high apparent spatial resolution from the dynamically acquired data. Each of the 
dynamic GRE acquisitions took approximately 1 second.  
Of note, none of the acquired GRE data following the non-selective inversion are used in 
the analysis, as the inversion impacts all signal within the coil sensitivity. However, it is important 
to maintain identical tissue contrast between the label and control conditions for perfusion 
quantification, thus the GRE data are still acquired.  
To evaluate the combined sequence to the standard measures, post-ischemic reactive 
hyperemia was selected as the functional paradigm since relatively good repeatability of the 
results has been reported within the same scan session (142). Furthermore, the protocol is 
subject-effort independent, and the response is shorter-lived than in the post-exercise active 
hyperemia protocol. A recent report from Lopez, et al suggests that post-ischemia reactive 
hyperemia is the method of choice for the measurement of vascular reactivity (25). However, 𝑉𝑂! 
was not quantified from the reactive hyperemia paradigm due to the fact that the measured 
temporal dynamics of oxygen saturation do not reflect the true underlying physiologic response at 
the level of the tissue. Rather, the response measured is the aggregate affect from the prior 
period of induced ischemia. This can be seen as the T2* continues to drop throughout the period 
of proximal arterial occlusion, but SvO2 remains relatively constant during this time.  
In the distal peripheral circulation, SvO2 is the most challenging of the PIVOT parameters 
to measure due to the size of the vessels in the calf and the potential for compression from the 
weight of the calf resting on the coil (134). The measurement of SvO2 at two different slice 
locations may improve the chances of acquiring suitable data, especially because veins widen as 
they become more proximal to the heart. However, the presence of differences between SvO2 
measured at the two different slice locations will require further investigation.  
95 
 
The most likely error in vPIVOT would be a reduction in the measured perfusion. During 
the superior multi-echo GRE sequence, application of RF excitation pulses proximal to the PASL 
measurement site will result in a reduction in the magnetization of blood water spins. Because of 
this, the superior GRE data are acquired outside of the PASL sequence so that the label remains 
undisturbed. However, the OxFlow interleave will cause a reduction in the magnetization prior to 
non-selective (control) inversion, reducing the labeling efficiency, thus resulting in an 
underestimation of the measured perfusion. Furthermore, this impact will depend upon the arterial 
blood flow velocity, since the number of excitation pulses, and hence the degree of excitation that 
each spin will experience is related to the slice thickness and velocity. In vPIVOT, the excitation 
flip angle and slice thickness were reduced for the superior GRE acquisition to reduce the 
potential error.  
It did not appear that the superiorly located excitation pulses substantially impacted the 
perfusion quantification, as significant differences between vPIVOT and PIVOT measures were 
not detected. Furthermore, reactive hyperemia results are in relative agreement with prior studies. 
In comparison to prior investigations, the peak perfusion in the soleus is approximately equal: 42 
± 17 mL/min/100g in the present study compared to the results from Chapter 2 where peak 
perfusion was found to be 37.0 ± 6.1 mL/min/100g (142). With the pseudo-continuous ASL 
technique described in Chapter 3, peak perfusion values of approximately the same magnitude 
as those presented herein were measured as well. However, all of these results are much lower 
than the peak perfusion in the soleus muscle of 80 ± 31 mL/min/100g reported by Wu, et al using 
a continuous ASL technique (47).  Comparing whole-leg perfusion to another study, there is 
approximate agreement: 40 ± 12 mL/min/100g in the present study compared to Raynaud, et al’s 
measurement with the same PASL sequence of 50 ± 13 mL/min/100g (34). In general, the results 
presented in this study are also in relative agreement with prior reports of arterial blood flow in the 
peripheral circulation (66,88), SvO2 dynamics (66,75,142),  and the relative response of T2* 
(68,142).  
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4.5.2. Post-exercise functional hyperemia evaluation 
In all subjects, a functional hyperemic response was stimulated from the bout of resisted 
plantar flexion contractions. Subjects reported that the exercise load was moderate; therefore it is 
assumed that muscle pH did not substantially change (although this was not measured). The 
average perfusion response was greatest in the gastrocnemius muscle, although some subjects 
also had an increase in perfusion in the soleus muscle, another muscle involved in plantar flexion 
contraction. The anterior compartment (involved in dorsiflexion) had almost no hyperemic 
response for all subjects. 
The SvO2 and T2* time courses were not parameterized for the exercise study as they 
were for the reactive hyperemia evaluation. The SvO2 washout time may have less physiologic 
relevance as the deoxygenated blood during the exercise period is constantly flowing out into the 
large draining veins though the rhythmic muscle contractions. There is, however, a slight dip in 
the average SvO2 time course upon relaxation. The relative T2* response may help to inform on 
the relationship between the oxygen saturation in the draining vein and that in the capillary bed. 
As mentioned previously, T2* depends on blood oxygen saturation in the capillary bed as well as 
perfusion, vessel orientation, pH, and other factors. The only two of those factors that are 
expected to change in this study are oxygen saturation and perfusion. Looking at the relationship 
between these three parameters, it is noted that SvO2 and T2* both continue to rise as perfusion 
is beginning to drop, perhaps providing evidence that the draining vein SvO2 response may be 
used as a surrogate for the capillary bed oxygen saturation for the post-exercise response. This, 
however, requires additional investigation.  
The discrepancy between the maximum 𝑉𝑂!,!"#$ and 𝑉𝑂!,!"#$ is partially explained by the 
fact that bulk flow was normalized only to the gastrocnemius muscle mass, yet the blood flow in 
the tibioperoneal trunk supplies other muscles of the calf and foot in addition to other structures. 
Based on the perfusion measurements, the hyperemia response seems to be primarily localized 
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to the gastrocnemius muscle, however there is an early increase in flow in all of the muscles 
around the same time as the macrovascular flow peak. Another reason that 𝑉𝑂!,!"#$ may be 
overestimating the true oxygen consumption is due to the presence of non-nutritive flow. Given 
that the macrovascular blood flow in the arteries and veins peak simultaneously, this suggests 
that there may be substantial non-nutritive flow shunted from the arteries to the veins upon 
relaxation. 
It is difficult to compare these results to the prior studies mentioned in the introduction for 
several reasons. Each study has employed different methods, have varied in their measurement 
locations, and have used different exercise protocols including type of exercise and workload. 
Compared to Mathewson, et al’s study investigating the off-kinetics in the quadriceps muscles, 
the measured peak 𝑉𝑂! was slightly lower, 9.6±1.8 mL/min/100g, however similar to this study, 
the response appears to have occurred immediately after cessation of exercise (113). Zheng, et 
al reported a 𝑉𝑂! of 3.8±2.5 mL/min/100g and 6.1±2.9 mL/min/100g during two separate 
sustained isometric plantar flexion contrations in the calf (115). Even though this result is similar 
to the findings of the present study, a direct comparison cannot be made between these two 
investigations due to the difference in exercise protocols. Finally, Buck et al’s study, investigating 
the off-kinetics used an isometric dorsiflexion contraction for their exercise protocol but only 
relative changes in 𝑉𝑂! were quantified (116).  
In addition to those explored in the present study, an advantage that vPIVOT provides is 
the potential to account for changes in vascular volume during the recovery period following 
exercise. As long as there is no change in vascular volume, the arterial inflow and venous outflow 
will match, however if there is a change in the vascular volume (e.g. vascular filling), this could 
result in an error when quantifying 𝑉𝑂!. With vPIVOT, the arterial inflow and venous outflow are 
directly measured, thus the aggregate flow volumes can be quantified and could be used to adapt 
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the calculation of 𝑉𝑂!. This was, however, not pursued for the present study, as the goal was to 
explore the fidelity and potential of vPIVOT.  
4.5.3. Study limitations 
There are several limitations to the present study. First, the sample size was limited, thus 
although a significant difference between vPIVOT and PIVOT or OxFlow was not detected, there 
is potential that a significant difference does exist, but that this study was underpowered to detect 
the significant difference. 
Additionally, blood flow in the tibioperoneal trunk does not exclusively supply the 
gastrocnemius muscle. Blood supply to the soleus and peroneus muscles also stems from the 
tibioperoneal trunk. Both of these muscles are also involved in plantar flexion contraction, and the 
peroneus muscle also plays a role in eversion of the foot. In addition, the tibioperoneal trunk 
provides the vascular supply to some muscles of the foot, and skin, tendons, and other 
connective tissue of the calf and foot. Therefore, 𝑉𝑂!,!"#$ will be overestimated since it was 
normalized to only the mass of the gastrocnemius muscle. So while the absolute magnitude of 
the response may be in error, the temporal response dynamics would not change.  
Oxygen saturation was quantified in the large draining veins rather than locally in the 
capillary bed. As mentioned earlier in the discussion, there is potential that the relative T2* 
response will allow for the investigation of this relationship, however this was not undertaken as a 
part of this study. The comparison between 𝑉𝑂! measured with either macrovascular flow or 
microvascular perfusion, and with either draining vein SvO2 or R2’-based capillary bed oxygen 
saturation would be of great interest.  
4.6. Conclusions 
In summary, the feasibility of quantification of arterial and venous bulk flow, perfusion, 
draining vein SvO2, and skeletal muscle T2* has been demonstrated in healthy volunteers. The 
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relationship between macro- and microvascular blood flow was explored following induced 
ischemia and dynamic exercise, demonstrating the disparity in primarily the microvascular 
response to the two paradigms. The measurement of the relationship between macro- and 
microvascular blood flows may be of important clinical significance in patient populations such as 
diabetics, or patients with peripheral artery disease. Finally, oxygen consumption was calculated 
based on the aggregate measures of perfusion or bulk arterial flow and draining vein SvO2, 
allowing for the dynamic measurement of the muscle’s metabolic response following exercise.  
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CHAPTER 5: MULTIPARAMETRIC ASSESSMENT OF VASCULAR 
FUNCTION IN PERIPHERAL ARTERY DISEASE: DYNAMIC 
MEASUREMENT OF SKELETAL MUSCLE PERFUSION, BLOOD-
OXYGEN-LEVEL DEPENDENT SIGNAL, AND VENOUS OXYGEN 
SATURATION  
5.1. Abstract 
Background – Endothelial dysfunction present in patients with peripheral artery disease (PAD) 
may be better understood by measuring the temporal dynamics of blood flow and oxygen 
saturation during reactive hyperemia than by conventional static measurements.  
Methods and Results – Perfusion, Intravascular Venous Oxygen saturation, and T2* (PIVOT), a 
recently developed MRI technique, was used to measure the response to an ischemia-
reperfusion paradigm in ninety-six patients with PAD of varying severity, and ten healthy controls. 
Perfusion, venous oxygen saturation (SvO2), and T2* were each quantified in the calf at two 
second temporal resolution, yielding a dynamic time course for each variable. Compared to 
healthy controls, patients had a blunted and delayed hyperemic response. Moreover, patients 
with lower ankle-brachial index had: 1) a more delayed reactive hyperemia response time, 
manifesting as an increase in time to peak perfusion in the gastrocnemius, soleus, and peroneus 
muscles, and in the anterior compartment; 2) an increase in the time to peak T2* measured in the 
soleus muscle; and 3) a prolongation of the posterior tibial vein SvO2 washout time. Intra- and 
inter-session repeatability was also assessed. Results indicated that time to peak perfusion and 
time to peak T2* were the most reliable extracted time course metrics.  
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Conclusions – Perfusion, dynamic SvO2, and T2* response times following induced ischemia are 
highly correlated with PAD disease severity. Combined imaging of peripheral microvascular blood 
flow and dynamics of oxygen saturation with PIVOT may be a useful tool to investigate the 
pathophysiology of PAD. 
5.2. Introduction 
Peripheral artery disease (PAD) is most commonly a manifestation of atherosclerosis in vessels 
supplying the lower limbs, and causes significant morbidity and mortality in the United States (11-
13,150). In PAD, atherosclerotic plaque encroaches on the peripheral artery lumen, decreasing 
blood flow and vascular reactivity of the large arteries (15,151). Collateral arteries vasodilate in 
order to meet the baseline metabolic demand of skeletal muscle; however as described in the 
preceding chapters, the collateral vasculature may be inadequate to quickly and adaptively 
accommodate increases in blood flow demand, such as those that occur during exercise (16). 
This effect can result in an oxygen supply-demand mismatch, causing patients to experience 
claudication (150). 
The presence of flow-limiting stenoses can be quickly and non-invasively detected by 
measuring the ankle-brachial index (ABI), the ratio of systolic blood pressures in the ankle and 
brachial artery (150,152). An ABI of less than 0.9 confirms the diagnosis of PAD, and an ABI of 
less than 0.4 is suggestive of critical limb ischemia (150,153). Interventions such as cilostazol 
(22) or exercise rehabilitation (21) lessen claudication symptomatology, however are not 
necessarily associated with a clinically significant improvement in the ABI. Additionally, the ABI is 
not sensitive to primary microvascular impairment, endothelial dysfunction, or alterations in 
vascular reactivity that may coexist with the macrovascular lesions (15,154). Thus, there is a 
compelling need for the development of diagnostic tools that would allow for the interrogation of 
the contribution of vascular dysfunction to PAD. 
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As detailed in prior chapters, peripheral vascular function can be interrogated by 
monitoring the dynamics of blood flow and oxygenation in response to a stressor, analogous to 
cardiac stress testing. Several magnetic resonance imaging (MRI) techniques can non-invasively 
evaluate the dynamic changes that occur in blood flow and oxygenation during the hyperemic 
response. Specifically, prior studies have investigated perfusion using arterial spin labeling (ASL) 
(34,47,155), dynamics of SvO2 using MR susceptometry-based oximetry (58,67), and changes in 
the T2* signal (commonly known as blood-oxygen-level dependent (BOLD) response) 
(68,69,156), which provides a relative measure of muscle capillary bed oxygenation (62,63). In 
response to induced ischemia, an alteration in the response dynamics of each of these variables 
is associated with the presence of PAD. Compared to healthy controls, patients exhibit a blunted 
and delayed reperfusion (52), and a reduced rate of recovery of tissue oxygenation, as evidenced 
by both direct measurement of SvO2 (66,67), and of relative changes in T2* (68). 
In Chapter 2, we developed a technique termed Perfusion, Intravascular Venous Oxygen 
saturation, and T2* (PIVOT) which allows for dynamic and simultaneous quantification of 
perfusion, SvO2, and skeletal muscle T2* (142). The purpose of this work was to evaluate the 
hyperemic response in patients with PAD and healthy controls using PIVOT. We hypothesize that 
PIVOT will be able to detect PAD severity-dependent changes in macro- and microvascular 
function, and that the relationship between these impairments will help us to better understand 
the pathophysiologic processes that underlie the disease.  
5.3. Methods 
5.3.1. Subjects 
Ninety-six patients with intermittent claudication and a diagnosis of PAD and ten healthy 
controls were recruited to participate in the study. Upon enrollment, each subject was classified 
into a disease severity group based on ABI, where healthy subjects had an ABI > 0.90 (10 
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subjects; 3 males), mild disease corresponded to an ABI range of 0.7 – 0.89 (28 patients; 18 
males); moderate disease to an ABI range of 0.50 – 0.69 (45 patients; 28 males); and severe 
disease to an ABI of less than 0.50 (17 patients; 13 males). Additional characteristics of the study 
participants are shown in Table 5.1.  
Table 5.1. Characteristics of study participants. 
 Healthy ABI>0.9 
Mild  
ABI 0.7 to 
0.89 
Moderate  
ABI 0.5 to 
0.69 
Severe 
ABI<0.5 
All patients 
ABI<0.9 
Total 10 28 49 19 96 
Repeat visit 9 11 23 8 42 
Gender (M/F) 3/7 * 18/10 29/20 15/4 62/34 
Age 59.5 (3.9) * 66.8 (6.3) 69.4 (8.1) 71.3 (8.6) 69.0 (7.8) 
BMI 26.2 (4.9) 27/6 (3.9) 27.4 (4.0) 27.5 (4.0) 27.5 (3.9) 
Systolic BP 123 (21) * 142 (18) 141 (19) 137 (17) 141 (18) 
Diabetes 0 * 10 15 6 31 
Smoking status 
(Never/Past/ 
Current) 
5/5/0 * 2/19/7 4/32/13 2/7/10 8/58/30 
Mean (standard deviation) or counts are shown. * Indicates a significant difference between 
healthy subjects and all PAD patients.  
 
5.3.2. Experimental Protocol 
Prior to participation in the study, each subject provided written informed consent. The 
Institutional Review Board of the University of Pennsylvania approved all aspects of this study.   
PAD patient protocol: Each patient reported to the testing center for two separate visits no more 
than one month apart. Some subjects were selected to return for a third visit, approximately three 
months after the second. On the first visit, screening and medical history questionnaires were 
completed, and the ABI was measured bilaterally using Doppler sonography according to the 
current standards (157). Patients were instructed to refrain from strenuous exercise for 3 days 
prior to the second visit, and to avoid alcohol and caffeine for 24 hours prior. Upon reporting for 
the second visit, patients underwent a vascular function MRI scanning session. The MRI protocol 
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consisted of dynamic imaging of blood flow and oxygenation of the mid-calf using PIVOT 
throughout an ischemia-reperfusion paradigm. If selected to return, the third visit was identical to 
the second.  
Healthy subject protocol: Healthy subjects reported to the testing center for two identical visits, 
separated by 1 day to 1 week. Each MRI session included two identical PIVOT scans throughout 
periods of ischemia-reperfusion.  
5.3.3. MRI Scan Protocol 
All imaging was performed on a 3T MR imaging system (Siemens, Erlangen, Germany). 
For every patient, the leg with the lower ABI was scanned, and for each healthy control, the right 
leg was scanned. The maximum girth of the calf was centered in an 8-channel transmit-receive 
knee coil (In vivo, Inc. Gainesville, FL). PIVOT data were continuously collected throughout one 
minute of baseline, five minutes of proximal arterial occlusion, and six minutes following cuff 
deflation. Proximal arterial occlusion was achieved using a pneumatic tourniquet system 
(Hokanson, Inc., Bellevue, WA) with a cuff placed on the mid-thigh. After one minute of baseline 
scanning, the cuff was rapidly inflated to 75 mmHg above the measured systolic blood pressure, 
or 250 mmHg, whichever was lower. For all healthy subjects, the ischemia-reperfusion paradigm 
was repeated within the same scan session to assess intra-session repeatability. 
As described previously (142), PIVOT allows for continuous, simultaneous measurement 
of perfusion, intravascular SvO2, and skeletal muscle T2* using an interleaved dual-slice pulsed 
ASL (PASL) and multi-echo GRE sequence. Briefly, perfusion quantification is accomplished 
using SATuration Inversion-Recovery (SATIR) (34), a Flow-Alternating Inversion Recovery (FAIR) 
ASL variant, in which slice-selective and non-selective adiabatic inversion pulses are used to 
achieve label and control conditions, respectively. Image acquisition follows the post-labeling 
delay (PLD), which is immediately followed by a slice-selective saturation pulse to reset the 
magnetization. In PIVOT, a keyhole (122) RF-spoiled multi-echo GRE sequence acquires data at 
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a slice located downstream from the PASL slice during the PLD.  Only multi-echo GRE data 
acquired during the PLD following the slice-selective inversion are used for SvO2 and T2* 
analysis, however the multi-echo GRE interleave was run during every PLD to control for 
potential magnetization transfer effects. From these data, SvO2 is derived using susceptometry-
based oximetry (58,67), and T2* is calculated by fitting the signal magnitude to a 
monoexponential function.  
For the PASL interleave, images were acquired with the following parameters: partial-
Fourier GRE-EPI readout; field of view (FOV) = 250 × 250 mm2; acquired matrix = 80 × 50, 
reconstructed to 80 × 80; slice thickness = 1 cm; slice location = isocenter; TR/TE = 1 s/8.05 ms; 
PLD = 952 ms. For the multi-echo GRE interleave, images were acquired with: FOV = 96 × 96 
mm2; keyhole acquired matrix = 96 × 24, slice thickness = 1 cm; slice location = 3 cm distal from 
isocenter; TR/TE1/TE2/TE3/TE4/TE5 = 38.12/3.78/6.99/12.32/19.32/26.32 ms. For SvO2 data 
analysis, the acquired matrix was keyhole (122) reconstructed to 96 × 96 pixels using outer k-
space data from a fully sampled reference image obtained immediately after the dynamic PIVOT 
acquisition; only dynamic data were used for T2* analysis. Each variable was quantified at 2-
second temporal resolution.   
5.3.4. Image Analysis 
Image analysis was performed using MATLAB (The MathWorks, Inc., Natick, MA). Prior 
to data processing, the time series of images were motion corrected with rigid-body 
transformations using NIH ImageJ software (developed by Wayne Rasbands, National Institutes 
of Health, Bethesda, MD). Perfusion was quantified in regions of interest (ROIs) in the 
gastrocnemius, soleus, and peroneus muscles, as well as in the anterior compartment (AC) – 
which includes the tibialis anterior and extensor digitorum longus muscles (Figure 5.1a). For the 
assessment of repeatability, a whole-leg ROI was used, which comprised of all four muscle 
groups. As described previously (142), an ROI was delineated in the muscle of interest using a 
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high-resolution scout image as a reference for muscle boundaries. The average signal-intensity in 
the defined ROI following slice-selective (MSS) or non-selective (MNS) inversion was determined. 
Using the model described by Raynaud, et al, (34) perfusion (f, in mL/min/100g) was quantified 
for each label-control pair as: 
  f = − !! ⋅ ln !!!!!!"!!!!!!" ⋅ 1 − e! !! + 1     [5.1] 
where λ is the tissue-partition coefficient (λ=0.9 mL/g), T is the post-labeling delay, T1 is the 
longitudinal relaxation time of blood, which in this model is assumed to be equivalent to that of 
tissue (T1 = T1muscle = 1420 ms (126) ≈ T1blood). The perfusion offset was corrected by subtracting 
the average perfusion during the period of cuff occlusion from each time point, as perfusion is 
assumed to be zero during the period of proximal arterial occlusion (124). For each muscle, the 
peak perfusion and time to peak perfusion (TTPPerf) were recorded from the dynamic time course 
data (Figure 5.1c). 
Using the first two echoes of the multi-echo GRE, SvO2 was quantified in the larger 
posterior tibial vein (Figure 5.1b). As described previously (67), SvO2 was calculated by 
measuring the difference in phase accrual (Δφ) between echoes spaced apart by ΔTE in the 
blood versus surrounding reference tissue as:  
 %𝑆𝑣𝑂! = 1 − !⋅∆! ∆!"!!!!"⋅!"#⋅!! !"#!!!! ! ×100 [5.2] 
where γ is the proton gyromagnetic ratio, Δχdo the susceptibility difference between fully 
oxygenated and deoxygenated blood (Δχdo = 4p∙0.27 ppm (96,97)), Hct the hematocrit measured 
by venipuncture, B0 the main magnetic field strength, and q the angle of the vessel with respect to 
B0 (measured from axial scout images). The washout time, equal to the time between cuff release 
and the minimum SvO2, and the upslope, calculated as the maximum slope during recovery, were 
recorded (Figure 5.1d).  
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T2* was measured within an ROI in the soleus muscle (Figure 5.1b) by fitting multi-echo 
GRE data from echoes 2-5 to a monoexponential function. Signal intensity in the ROI was first 
averaged for each echo, then the data were fit to a monoexponential function and T2* was 
computed at each time point. The T2* time course data were normalized to the average baseline 
value, and relative T2*max, and time to peak T2* (TTPT2*) were recorded from the time course 
(Figure 5.1e).  
 
Figure 5.1. Anatomic images corresponding to PASL (a) and multi-echo GRE (b) 
slice locations. As shown in (a), perfusion is quantified in regions of interest in the 
gastrocnemius (red), soleus (purple), peroneus (orange), and anterior 
compartment (AC) (yellow). From the multi-echo GRE data, SvO2 is quantified in 
the larger posterior tibial vein (blue arrow), and T2* is calculated from a region of 
interest in the soleus (green) shown in (b). Each variable is quantified every two 
seconds, yielding a dynamic time course. Schematics of the perfusion (c), SvO2 
(d), and T2* (e) time courses are shown, with the extracted metrics indicated. The 
grey box in c-e indicates the period of proximal arterial occlusion. 
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5.3.4. Statistical Analysis 
All statistical analyses were performed with JMP software (JMP®, Version 11. SAS 
Institute Inc., Cary, NC). Data normality was evaluated using the Shapiro-Wilk test. For data from 
the normal or log-normal distribution, two-sample Student’s t-tests with equal variance were used 
to determine whether differences existed between healthy subjects (ABI ≥ 0.9) and patients with 
PAD (ABI < 0.9). Non-parametric Wilcoxon rank tests were used to assess differences of non-
normally distributed variables. In patients with PAD, correlations between the ABI and each time 
course metric and between pairs of time course metrics were calculated using Pearson’s 
correlation coefficient (if data were normally distributed) or Spearman’s rank correlation 
coefficient (if data were not normally distributed).  Holm’s adjustment for multiple comparisons 
was applied to all tests and correlations to maintain the family-wise error rate of 0.05. Thus, for all 
tests, pholms < 0.05 was considered to be significant. 
In healthy controls, intra-session and inter-session (1 day to 1 week between scans) 
repeatability was assessed.  Inter-session repeatability was also assessed in a subset of patients 
with PAD (approximately 3 months between scans). In all cases, the intraclass correlation 
coefficients (ICC) and mean within-subject coefficients of variation (CVW) were calculated to 
assess measurement repeatability.  
5.4. Results 
5.4.1. Subject Demographics 
In six subjects, a cuff pressure of 75 mmHg above systolic blood pressure did not result 
in a full occlusion, likely due to calcification of the feeding arteries. Insufficient occlusion was 
determined based on appearance of venous pooling in the EPI images and T2* time course. In 
the remaining 100 subjects, several subjects’ MRI images were unanalyzable due to motion 
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contamination, partial volume effects, low SNR, or insufficient vein size. Table 5.2 shows the 
number of patients for each variable that were of sufficient quality for analysis. Notably, for all 
subjects in whom a full occlusion was achieved, at least one variable was fit for analysis. 
Table 5.2. Synopsis of number of subjects with analyzable images for each 
measured variable.  
 Healthy ABI>0.9 
Mild  
ABI 0.7 to 0.89 
Moderate  
ABI 0.5 to 0.69 
Severe  
ABI<0.5 
All patients 
ABI<0.9 
Total 10 27 45 18 100 
Gastrocnemius Perfusion 10 26 40 15 91 
Soleus Perfusion 10 26 41 14 91 
Peroneus Perfusion 10 25 40 9 84 
AC Perfusion 10 23 36 13 82 
SvO2 10 20 34 13 77 
Relative T2* 10 27 44 18 99 
 
5.4.2. Visualization of MRI time courses 
For visualization purposes, average time courses were generated for all healthy subjects and 
patients with mild, moderate, and severe PAD disease burden for perfusion in the gastrocnemius 
muscle (Figure 5.2a), posterior tibial vein SvO2 (Figure 5.2b), and relative T2* in the soleus 
muscle (Figure 5.2c). The typical ischemia-hyperemia response is seen in each variable’s time 
course. During the period of arterial occlusion, T2* decreases as the stagnant blood in the 
capillary bed becomes increasingly desaturated. After cuff release, SvO2 initially drops as the 
deoxygenated blood from the capillary bed advances into the large draining veins in the 
measurement slice. Concurrently, perfusion increases in order to repay the oxygen debt incurred 
during the ischemic period. This hyperperfusion of oxygenated blood causes T2* and SvO2 to 
recover and surpass their baseline values. As blood flow and venous oxygen saturation 
normalize, so too does T2*. From the average time courses a striking difference is seen between 
healthy subjects and patients with PAD, and furthermore, TTPPerf, washout time, and TTPT2* are 
increasingly prolonged as disease severity worsens.  
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Figure 5.2. Group-average time courses for healthy subjects (grey), and patients 
with mild (light colored), moderate (medium colored), and severe (dark colored) 
PAD for gastrocnemius muscle perfusion (a), posterior tibial vein SvO2 (b), and 
relative T2* in the soleus muscle (c). Grey box indicates the period of proximal 
arterial occlusion. With increasing disease severity, there is a delay in the 
reactive hyperemia response evident in each variable that was measured. 
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5.4.3. Comparison between healthy subjects and patients with PAD 
The group-wise average (standard deviation) of each time course metric for the 
measured variables are summarized in Table 5.3. TTPPerf in the peroneus, T2*max, and TTPT2* 
were not from the normal distribution, all other variables were from the log-normal distribution. 
Each variable, with the exception of SvO2 upslope, was significantly different between healthy 
controls and patients with PAD. With the presence of PAD, there was a significant prolongation of 
the hyperemic response time, and a reduction in the magnitude of the hyperemic response. SvO2 
washout time increased from 11 s in healthy subjects to 39 s in PAD patients. TTPPerf was 
delayed as well – averaged over all muscle groups it increased from 24 s to 72 s in patients with 
disease. Peak perfusion decreased from 52.6 mL/min/100g to 25.6 mL/min/100g with disease. 
TTPT2* in the soleus muscle increased from 33 s to 91 s between healthy subjects and PAD 
patients, and relative T2*max decreased from 110% to 106%. Averaged (standard deviation) over 
all subjects, baseline T2* was 19 (2) ms, and averaged across all muscle groups the perfusion 
offset during ischemia was 7.6 (2.7) mL/min/100g.  
Table 5.3. Associations of the presence of PAD with PIVOT time course metrics.  
 
Healthy 
ABI > 0.9 
(n = 10) 
Patients with PAD 
ABI <0.9 
(n = 90) 
ABI 1.11 (0.10) 0.60 (0.14) * 
Gastrocnemius Peak Perfusion (mL/min/100g) 54.0 (14.5) 28.3 (12.9) * 
Gastrocnemius TTPPerf (s) 29 (10) 77 (53) * 
Soleus Peak Perfusion (mL/min/100g) 74.9 (33.0) 28.9 (13.9) * 
Soleus TTPPerf (s) 25 (13) 72 (49) * 
Peroneus Peak Perfusion (mL/min/100g) 41.2 (11.3) 20.8 (12.4) * 
Peroneus TTPPerf (s) 24 (9) 74 (47) * 
AC Peak Perfusion (mL/min/100g) 43.4 (16.0) 24.5 (14.1) † 
AC TTPPerf (s) 16 (5) 64 (50) * 
Washout time (s) 11 (4) 39 (23) * 
Upslope (%HbO2/s) 0.91 (0.40) 0.51 (0.22) 
T2*max (%) 111 (4) 106 (3) ‡ 
TTPT2* (s) 35 (12) 91 (55) * 
*pholms <0.001; †pholms <0.01; ‡pholms <0.05; 
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5.4.4. Inter-variable correlations in patients with PAD 
Inter-variable correlations were assessed in PAD patients only. The correlations between 
ABI and time course metrics reinforce some of the findings from the group-wise analysis. A 
significant correlation was found between the ABI and response time following cuff release 
(Figure 5.3 a, c, e). As the ABI decreases, an increase in the time to peak perfusion in all 
muscles (gastrocnemius r = -0.60, pholms<0.0001; soleus r = -0.66, pholms<0.0001; peroneus r = -
0.43, pholms<0.0001; TA r = -0.55, pholms<0.0001), an increase in the time to peak T2* (r = -0.55, 
pholms<0.0001), and an increase in the washout time (r = -0.59, pholms<0.0001) were observed. 
However, no statistically significant correlation was detected between ABI and peak perfusion (r = 
0.08), SvO2 upslope (r = 0.14), or T2*max (r = -0.04) (Figure 5.3 b, d, f). 
In addition to the negative correlation between the hyperemic response time and ABI, 
significant positive correlations were detected between most pairs of timing metrics. For example, 
as TTPPerf in the gastrocnemius muscle increased, so too did TTPPerf in the other muscles 
(averaged over all muscle ROIs, r = 0.71, pholms<0.0001), TTPT2* in the soleus (r = 0.57; p 
holms<0.0001), and SvO2 washout time (r = 0.53; p holms<0.0001). The single exception was the 
lack of a correlation between the peroneus TTPPerf and SvO2 washout time (r = 0.26). Positive 
correlations were also detected between peak perfusion measured in the gastrocnemius and 
soleus (r = 0.53; pholms<0.0001) or anterior compartment (r = 0.40; pholms<0.02). The other 
significant correlation detected was between relative T2*max and TTPPerf in the peroneus (r=0.43; 
pholms<0.005).   
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Figure 5.3. Correlation plots for ABI versus gastrocnemius muscle time to peak 
perfusion (a) and peak perfusion (b), SvO2 washout time (c) and upslope (d), and 
time to peak T2* (e) and relative T2*max (f) measured in the soleus. As disease 
severity worsens, the reactive hyperemia response time is progressively 
prolonged. However, no correlation was observed between the magnitude of the 
hyperemic response and the ABI. 
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5.4.5. Repeatability of reactive hyperemia response  
In healthy subjects, both intra-session and inter-session repeatability were assessed 
(Tables 5.4 and 5.5). The intra-session ICC was greater than 0.7 for all measured variables, with 
the exception of TTPT2* (r = 0.61).  One healthy subject was lost to follow-up, thus the number of 
healthy subjects in whom inter-session repeatability was assessed was 9. Though lower than 
intra-session repeatability, the inter-session repeatability in the healthy subjects was still high for 
peak perfusion (r = 0.84) and time to peak perfusion (r = 0.74). The ICC, however, was lower for 
SvO2 upslope and washout time, T2*max, and TTPT2*. In all cases, the mean within-subject CV in 
healthy subjects was less than 25%. In patients with PAD, the ICCs of the perfusion time course 
metrics and TTPT2* were approximately equal to or better than the ICC of the ABI measurement (r 
= 0.53). The ICC for the SvO2 washout time and upslope, and T2*max, however, was low (r < 0.35). 
The mean within-subject CV in patients with PAD was approximately 10% greater than in healthy 
subjects for all measured variables.  
Table 5.4. Assessment of intrasession repeatability in healthy subjects. 
 Scan A Scan B ICC  CVw 
Healthy subjects  
Leg Peak Perfusion (mL/min/100g) 51.5 (13.5) 51.6 (14.3) 0.95 4.1% 
Leg TTPPerf (s) 23 (8) 21 (7) 0.76 11.0% 
Washout time (s) 11 (4) 11 (5) 0.90 8.8% 
Upslope (%HbO2/s) 0.9 (0.4) 0.9 (0.5) 0.79 18.5% 
T2*max (%) 111 (4) 112 (4) 0.78 1.1% 
TTPT2* 35 (12) 35 (11) 0.61 15.3% 
TTP indicates time to peak. 
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Table 5.5. Assessment of intersession repeatability in healthy subjects and 
patients with PAD. 
 Session 1 Session 2 ICC  CVw 
Healthy subjects  
Leg Peak Perfusion (mL/min/100g) 52.1 (14.2) 50.3 (17.1) 0.78 11.8% 
Leg TTPPerf (s) 23 (8) 21 (7) 0.71 10.9% 
Washout time (s) 12 (4) 14 (9) 0.61 23.4% 
Upslope (%HbO2/s) 0.9 (0.5) 0.8 (0.4) 0.57 24.4% 
T2*max (%) 111 (4) 110 (3) 0.58 2.0% 
TTPT2* 37 (12) 36 (12) 0.58 16.5% 
Patients with PAD  
ABI 0.59 (0.15) 0.59 (0.17) 0.53 11.8% 
Leg Peak Perfusion (mL/min/100g) 23.3 (8.9) 35.5 (9.5) 0.52 20.3% 
Leg TTPPerf (s) 68 (42) 72 (44) 0.78 22.0% 
Washout time (s) 34 (17) 30 (16) 0.13  31.9% 
Upslope (%HbO2/s) 0.5 (0.2) 0.7 (0.4) 0.08 36.7% 
T2*max (%) 106 (3) 106 (3) 0.33 1.9% 
TTPT2* 90 (49) 84 (39) 0.57 23.4% 
ABI indicates ankle-brachial index; PAD, peripheral artery disease; and TTP, time to peak. 
 
5.5. Discussion 
5.5.1. Synopsis of Results 
In this study, peripheral vascular function was investigated in patients with PAD and 
healthy controls using PIVOT, a recently developed MRI technique, allowing for simultaneous 
measurement of the dynamics of blood flow and oxygen saturation throughout an ischemia-
reperfusion paradigm. Compared to healthy controls, PAD patients exhibited a blunted and 
delayed hyperemic response, as measured by perfusion, SvO2, and T2*. Moreover, the results 
showed a significant correlation between PAD disease severity and the temporal dynamics of 
recovery of blood flow and oxygenation following induced ischemia. With decreasing ABI, the 
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time required to accommodate the hyperperfusion of oxygen-rich blood to the ischemic muscle 
was prolonged; there was an increase in the time needed for desaturated blood to flow out of the 
capillary bed into the large draining veins; and a delay in the time to peak T2*, indicating a 
decrease in the rate of recovery of oxygen saturation in the capillary bed. These data are thus 
suggestive of disease-severity-dependent impairment of vascular function in PAD.  
5.5.2. Comparison to prior studies of muscle perfusion in PAD 
Previous studies have used an ischemia-reperfusion model to investigate peripheral 
vascular function in patients with PAD compared to healthy controls, however these studies were 
limited to the measurement of a single variable – perfusion(52) or T2* (68), or two variables – 
SvO2 and bulk arterial blood flow (66,67). Separately measuring all of the variables in a single 
study would require multiple scans. However, with PIVOT, perfusion, SvO2, and T2* are 
measured simultaneously, allowing for the direct investigation of the temporal relationships 
between perfusion, oxygen saturation, and T2* at no additional scan time or patient discomfort. 
PIVOT was previously evaluated by comparing results from PIVOT to those obtained with the 
traditional PASL or multi-echo GRE sequences in a cohort of young healthy subjects. No bias 
was detected between PIVOT and the individual measurement methods, suggesting that the 
simultaneous measurement of perfusion, SvO2, and T2* at high temporal resolution is possible 
with PIVOT (142). 
Data in the present study show that the temporal dynamics during reactive hyperemia are 
associated with the presence of PAD and are tightly correlated with disease severity, thus high 
temporal resolution sampling of the response is extremely important. PIVOT provides 2-second 
temporal resolution of each of the measured variables, higher sampling rate than prior studies 
investigating perfusion alone (16-second temporal resolution) (47,52), or SvO2 and bulk arterial 
flow (5-second temporal resolution of SvO2) (66). Temporal resolution of 1-second was used in 
previous studies investigating only T2* in skeletal muscle (68,127). 
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Unlike perfusion and SvO2, the origin of the BOLD signal is less physiologically 
straightforward. BOLD signal depends upon blood oxygenation in the capillary bed, as well as 
microvascular flow, blood volume, cellular pH, and vessel diameter and orientation (63). So, while 
relative T2* can be quickly acquired, and in this study was the easiest variable to measure 
(relative T2* was analyzable in 99/100 subjects), the multifactorial contrast mechanism and the 
fact that the measured response is relative, rather than in physiologic units, makes the 
interpretation of the BOLD signal more complicated. To reduce potential confounds due to blood 
volume on the measured T2*, care was taken to ensure that the patient’s leg was at heart height, 
and each patient was supine for approximately 15 minutes prior to the onset of ischemia (51). 
Additionally, arterial occlusion was induced using a pneumatic tourniquet system capable of fully 
inflating in approximately 0.3 second, thus occluding venous and arterial flow nearly 
simultaneously. 
Hyperemia can also be induced via exercise rather than induced ischemia. Exercise is 
more physiologically relevant to PAD, however muscles may be stressed to varying degrees, 
depending on which muscle group is activated (e.g. plantar flexion vs. dorsiflexion), and total 
work is subject-effort dependent.  Conversely, tourniquet-induced ischemia is a global stimulus, 
more uniformly affecting all muscle groups downstream from the site of inflation, and more 
consistent between subjects.  
A prior study by Wu, et al measured post-ischemic skeletal muscle perfusion with a 
continuous ASL (CASL) technique in patients with PAD and healthy controls (52). Compared to 
the results from this study, there is good agreement in the trend of timing of the hyperemic 
response and disease severity – with the presence of PAD, and with increasing disease severity, 
the time to peak perfusion is progressively prolonged (52). Wu, et al also found an association 
between the peak perfusion and disease severity (52), whereas in this study an association 
between peak perfusion and disease presence, but not severity was detected.  CASL provides 
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higher signal-to-noise ratio of the perfusion signal at the cost of lower temporal resolution (16 
seconds with CASL (52) compared to 2 seconds in this study). As such, relative to this study 
much higher peak perfusions were observed in Wu, et al’s investigation for all disease severity 
subgroups. For instance, in the gastrocnemius muscle, peak perfusion of approximately 60 
mL/min/100g was reported in patients with PAD, compared to 28.3 mL/min/100g reported in the 
present study. Using an invasive, but highly precise method, Lassen, et al investigated the 
clearance rate of radioactive xenon-133 to determine perfusion in patients and healthy controls 
(35). In that study, the reported peak perfusion and time to peak perfusion are in agreement with 
the results of the present study – 51.8 mL/min/100g versus 17.1 mL/min/100g, and 22 s versus 
138 s for healthy subjects versus patients, respectively. Prior studies investigating perfusion in 
young healthy subjects using the same PASL variant, either SATIR alone (34,51) or using the 
combined PIVOT technique (142), found peak perfusion during reactive hyperemia to be similar 
to those values reported in the present work.  
5.5.3. Comparison to prior studies of dynamic oximetry in PAD 
Results of intravascular SvO2 measured in the posterior tibial vein are in relative 
agreement with Langham, et al’s work investigating SvO2 in the femoral vein of PAD patients 
compared to young healthy subjects and age-matched healthy controls (66). As in the results of 
this study, Langham, et al reported a prolonged washout time in patients with PAD compared to 
their healthy peers. In the present study, a correlation between the ABI and washout time in the 
posterior tibial vein was additionally detected. Langham, et al also observed a reduction in 
upslope in patients compared to controls, which was not observed in this study. This deviation 
could be attributed to the different vessels investigated by the two studies – posterior tibial vein in 
this study, compared to the larger and more superior femoral vein in the work by Langham, et al 
A larger vein would result in higher signal-to-noise ratio of the measured SvO2, thereby increasing 
measurement precision. In this study, it was necessary to acquire SvO2 data downstream from 
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the perfusion measurement location so as to not disturb the magnetization of inflowing blood. 
5.5.4. Comparison to prior studies of muscle BOLD in PAD 
Finally, the present results are in general agreement with previous BOLD studies in the 
leg (68,127). The average T2*max of patients with PAD of 106% is slightly lower than the relative 
T2*max of 110.5% reported by Ledermann, et al (68). However, these authors normalized T2* to 
the average T2* value of the first 3 seconds following cuff release, whereas for the present study, 
T2* was normalized to the baseline average T2*. T2* decreases during the ischemic period, 
therefore normalizing the data to the post-ischemic period would increase the T2* range and thus 
increase the relative T2*max. In agreement with Ledermann et al’s study, the current study showed 
that with decreasing ABI there is an increase in TTPT2*. 
5.5.5. Inter-variable correlations 
The inter-variable correlations were investigated to better understand the relationship 
between blood flow and oxygenation in the capillary bed and large draining veins. Strong positive 
correlations were detected between the various timing metrics, however, no significant 
correlations were observed between the response time and response magnitude (e.g. peak 
perfusion in the gastrocnemius muscle was not significantly correlated with its time to peak 
perfusion).  
In addition to the benefit of assessing inter-variable relationships, the acquisition of 
simultaneous perfusion, SvO2, and T2* measurements with PIVOT increases the likelihood that at 
least one of the variables is of sufficient quality for analysis. For example, if a patient has a very 
small posterior tibial vein, the measure of SvO2 would not be possible. However, perfusion and 
T2* data could still be used to investigate the hyperemic response. Alternatively, in some patients 
perfusion was very noisy due to partial-volume effects from unperfused intramuscular fibrous 
inclusions. Yet the T2* and SvO2 data were still able to provide insight into vascular function. In 
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the present study, though only 71 subjects had analyzable images for all three variables, in all 
100 subjects in whom a complete cuff occlusion was achieved, at least one of the variables was 
fit for analysis.  
The dynamics of the hyperemic response are a function of upstream arterial occlusions, 
diffuse atherosclerosis, and endothelium-mediated vascular reactivity. Thus, the assessment of 
the response with several variables provides complementary, rather than independent 
information. The combination of results from perfusion and SvO2 could, for example, be used to 
investigate the relative metabolic response. Furthermore, by modeling the combined PIVOT data, 
there may be added sensitivity to detect a response to a therapeutic intervention.  
5.5.6. Short-term and long-term repeatability of the reactive hyperemia response 
The intra-session repeatability in healthy subjects shows that the measured time course 
metrics have excellent precision in the short term. The hyperemic response measured for relative 
T2* had a broad peak, unlike the sharp peak of the perfusion measurement (as shown in Figure 
5.2). The TTPT2* was, therefore, more sensitive to time course noise than TTP perfusion, resulting 
in a reduction in repeatability. This pattern was observed for both intra- and inter-session 
repeatability. Compared to intra-session repeatability, inter-session repeatability was slightly 
lower. However, it is likely that there are true differences in the reactive hyperemia response due 
to normal physiologic variation. Care was taken to minimize known factors that impact vascular 
reactivity - all subjects were instructed to refrain from caffeine intake and vigorous exercise prior 
to scanning, and scans were conducted at the same time of day. The measured differences are, 
therefore, a combination of true physiologic variation, measurement error (as is present for intra-
session repeatability), and due to the potential impact of slight changes in slice location. 
Generally, the within-subject CV was still quite small, and similar to the reported results in a 
previous investigation of inter- and intra-session repeatability of PIVOT-derived time course 
metrics in young healthy subjects (142). 
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The inter-session repeatability in patients with PAD was acceptable for some variables, 
and poor for others (SvO2 washout time and upslope, and T2*max). Overall, the variables were 
similarly repeatable in healthy subjects and patients with PAD. Given that the ABI measurement 
differed between the two scan sessions, there may be true pathophysiologic progression or 
regression of disease in some patients. The ICCs of peak perfusion, TTP perfusion and TTPT2* 
were on the order of the ICC of the ABI measurement. The relatively low within-subject coefficient 
of variation suggests that although the measured response may differ between subjects, the span 
over which they differ is small compared to the range of values expected in healthy subjects 
versus patients with PAD. Time to peak perfusion and time to peak T2* both had relatively good 
repeatability, and were sensitive to disease presence and severity, making these metrics the 
most reliable for detection of alterations in vascular function.  
5.5.5. Study limitations 
There are several limitations to this study. Some variables have inter-session ICCs of 
<0.6, suggesting that the measurement of vascular function by PIVOT during reactive hyperemia 
is not suitable for clinical monitoring of a single patient. However, the present method could be 
well suited to investigate the response to therapy in a cohort of patients with PAD.  
The moderate disease severity group was much larger than either the mild or severe 
disease severity groups, though this is less of a limitation when using correlations to investigate 
the relationship between disease severity and the MRI-measured variables. Additionally, patients 
recruited for this study were not restricted to either aortoiliac or femoropopliteal artery PAD. 
Angiographic data were not available for these patients, thus the site of obstruction is not known.  
Furthermore, all correlations of the MRI data to disease severity were based on the ABI. 
Even though the ABI is the clinical standard for diagnosis of PAD, it is not without limitation. The 
ABI may be falsely elevated in patients with severely calcified arteries (158), or in situations of 
undiagnosed brachial or subclavian artery stenosis (14). Direct measurement of a patient’s 
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functional capacity via exercise testing, including the 100 foot walking time or the claudication 
onset time and peak walking time of the Gardner protocol (159), may provide more 
physiologically relevant information than the measurement of the ABI alone. However, these 
physiologic measures are subjective, based upon an individual’s pain tolerance or effort. There 
have been mixed results in prior studies as to whether the physiologic measures of disease 
severity correlate with the ABI. McDermott, et al showed that maximum treadmill walking time did 
correlate with the ABI (160); however, Szuba, et al found no correlation (161). Assessment of the 
correlation between the MRI time course metrics and physiologic testing results would be of great 
interest.  
The variables measured indicate impaired vascular function, related to both 
macrovascular lesions as well as microvascular dysfunction. Additional measurement of bulk 
arterial blood flow during the ischemia-reperfusion paradigm would allow for assessment of 
temporal dynamics of blood flow in the macrovasculature and microvasculature. Comparison of 
the temporal dynamics in the large artery and capillary bed could help to separate the 
macrovascular and microvascular responses. This can be accomplished by velocity-encoding the 
multi-echo GRE interleave of PIVOT, though the temporal resolution of the sequence must be 
decreased to accommodate double the number of phase encoding segments of the multi-echo 
GRE (162). Additionally, the MRI data may be complemented with the measurement of 
hemoglobin oxygen saturation using continuous-wave near infrared spectroscopy (NIRS) 
(163,164).  
5.6. Conclusions 
In conclusion, earlier studies investigating peripheral vascular function in patients with 
PAD were limited to the investigation of only one or two variables. Using PIVOT, simultaneous 
measurement of perfusion, SvO2, and T2* can be achieved. Results indicate that increasing PAD 
disease severity is associated with a prolongation of response time following induced ischemia. 
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Time to peak perfusion and time to peak T2* were both highly repeatable measures and were 
sensitive to the presence and severity of PAD. In the future, PIVOT could be used as a means to 
monitor disease progression and evaluate treatment response in patients with PAD.  
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CHAPTER 6: CONCLUSIONS AND FUTURE WORK 
6.1. Conclusions 
The regulation of blood flow to skeletal muscle remains an active area of research, 
despite the fact that early work was conducted almost 100 years ago. Work progressed from the 
assessment of blood flow in individual capillaries through the quantitative measurement of flow 
and oxygenation in vivo. Applications assessing vascular reactivity and the regulation of blood 
flow in healthy individual enhanced the knowledge of normal physiology, and investigations in 
states of disease have provided insight into the consequences of endothelial dysfunction.  
To that end, the work in this thesis has focused on the development, evaluation, 
expansion, and clinical application of an MRI method to assess vascular function in humans. In 
Chapter 2, the PIVOT method was introduced for the measurement of temporally-resolved 
perfusion, SvO2, and T2*. PIVOT was initially evaluated in comparison to the individual 
components of the sequence: a PASL interleave for the quantification of perfusion; and a multi-
echo GRE sequence for the measurement of SvO2 from the evolution of the signal phase and for 
the measurement of T2* from the measured magnitude signal decay rate. In healthy subjects, 
PIVOT and comparison sequences were used to measure the reactive hyperemia response, and 
results showed that no bias existed between the combined and individual measurements. Neither 
the magnitude nor the timing of the reactive hyperemia response was found to significantly differ 
between PIVOT and the individual methods. However, the maximum post-ischemia perfusion was 
lower than previous reports, which led us to the pursuit of Chapter 3. 
In Chapter 3, internal consistency of the reactive hyperemia perfusion response was 
assessed between PASL and pCASL. pCASL is a more recently developed technique that has 
been purported as the preferred method for investigation of perfusion in the brain. Similar to 
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CASL, pCASL inverts inflowing spins using flow-driven adiabatic inversion, which has not been 
specifically evaluated in the peripheral circulation. Given the difference in the flow waveform 
characteristics between the central and peripheral circulation, and given the wide range of blood 
flow velocities experienced in the peripheral circulation during a reactive hyperemia paradigm, 
this merited specific investigation. pCASL labeling efficiency was experimentally measured in the 
popliteal artery throughout an ischemia-reperfusion paradigm. Results suggest that despite the 
variation in average flow velocity throughout the paradigm, labeling efficiency may not change. 
Reactive hyperemia perfusion was then quantified with PASL and pCASL sequences and results 
were not found to significantly differ despite the differences in labeling method, perfusion 
quantification model, and temporal resolution.  
In Chapter 4, the original PIVOT sequence was expanded to include an OxFlow 
interleave after the PASL acquisition. This third interleaved slice provides a proximal measure of 
arterial and venous bulk blood flow as well as an additional measurement of SvO2 in a larger 
draining vein. The new sequence was termed vPIVOT and was applied to the measurement of 
transient changes of blood flow and oxygen saturation both in the post-ischemia reactive 
hyperemia and post-exercise functional hyperemia states. Reactive hyperemia results were again 
compared between the adapted vPIVOT sequence and independent measures using either 
PIVOT or OxFlow. The reactive hyperemia dynamics were not found to differ depending on the 
acquisition sequence. The measurement of vPIVOT during the post-exercise period of functional 
hyperemia allowed for the investigation of muscle oxygen consumption (𝑉𝑂!). With vPIVOT, 𝑉𝑂! 
was measured as the product of draining vein SvO2 and either muscle mass-normalized bulk 
arterial blood flow or local tissue perfusion. Although the total oxygen consumption was not 
different between the two measures, the response dynamics including the timing of the maximum 
and the peak magnitude were significantly different.  
Finally, in Chapter 5, we applied the original PIVOT sequence described in Chapter 2 in a 
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cohort of patients with PAD and healthy controls. Results, in agreement with prior independent 
studies of perfusion, SvO2, and skeletal muscle T2*, showed that compared to healthy controls, 
patients had a blunted and delayed hyperemic response. Furthermore, correlations between the 
clinical measurement of disease severity, the ABI, and the timing of the reactive hyperemia 
response were detected. Specifically, patients with a lower ABI had: 1) a more delayed reactive 
hyperemia response time, manifesting as an increase in time to peak perfusion in the 
gastrocnemius, soleus, and peroneus muscles, and in the anterior compartment; 2) an increase 
in the time to peak T2* measured in the soleus muscle; and 3) a prolongation of the posterior tibial 
vein SvO2 washout time. These results suggest that PIVOT may be a useful tool to investigate 
the pathophysiology of PAD and potentially response to therapy. 
6.2. Future Directions 
If I’ve learned anything in my time as a graduate student, it’s that answering one question leaves 
you asking more. Based on the results presented in this dissertation, several issues could benefit 
from further investigation: 
6.2.1. Technical Development 
Dual acquisition for ASL and BOLD measurement: Presently in PIVOT, T2* is quantified 
at the downstream slice location, generally located at the distal extent of the gastrocnemius 
muscle. Thus, T2* was quantified in the soleus muscle, whose central location and larger cross-
sectional area provided better data. However, as described in the introduction there have been 
several recent studies using a dual echo EPI acquisition to measure the combined ASL and 
BOLD responses: the first echo with short echo time is used for perfusion quantification, and the 
second echo with longer echo time is sensitive to BOLD signal changes. PIVOT could be adapted 
to include a dual-echo readout, which would allow the measurement of the BOLD response in all 
muscles of the calf and furthermore would provide direct spatial correspondence between the 
perfusion and BOLD data.  
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Improved temporal/spatial resolution of MR susceptometry-based oximetry: Given 
the limited time of the ASL post-labeling delay, a view sharing technique was required to allow the 
limited data acquired during the dynamic acquisition to be reconstructed at high enough spatial 
resolution. However, for keyhole acquisition and reconstruction, exact anatomic correspondence 
must be maintained between the dynamically acquired data and the reference image acquisitions. 
Cuff-induced motion notwithstanding, it can be very difficult for clinical patients to remain still for a 
13 minute scan. The use of more advanced view sharing techniques would allow for more 
tolerance to patient motion. These include BRISK, in which a slightly smaller segment of the 
central portion of k-space is acquired dynamically and outer k-space is periodically acquired. 
Rodgers, et al employed BRISK sampling in OxFlow showed improved motion sensitivity 
compared to keyhole acquisition (165). Alternatively, the use of parallel imaging methods could 
increase the speed of acquisition, thus reducing the number of missing k-space lines.  
6.2.2. Technical investigations 
Comparison between T2’-based oximetry and susceptometry-based oximetry: As 
discussed in Chapter 4, draining vein venous oxygen saturation is not synchronized with the 
tissue oxygen saturation in post-ischemia evaluations, but rather the measured washout of 
deoxygenated blood is the aggregate from the previous period of ischemia. This is one of the 
reasons why 𝑉𝑂! was not calculated for any of the reactive hyperemia experiments. There is no 
physical barrier between the capillary bed and the draining vein in exercise, and in fact the 
rhythmic contractions help to drive the venous flow, thus in the post-exercise functional 
hyperemia state, we assumed that the draining vein SvO2 was equivalent to the local capillary 
bed oxygen saturation.  However, given the discrepancy between the macrovascular and 
microvascular flow responses during the post-exercise functional hyperemic period, there may 
also be differences between the macro- and microvascular oxygen saturation. The combined 
assessment with BOLD may help to elucidate this issue, however the direct comparison to a T2’-
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based method would help to directly answer the question. This could be investigated by 
comparing post-exercise SvO2 dynamics in the draining vein measured via susceptometry-based 
oximetry to the capillary bed oxygen saturation measured via the SAGE technique used by Buck, 
et al (116).  
6.2.3. Additional Clinical Translation 
Presently, measurement of ABI and physiologic testing via standardized treadmill walking 
tests are used to assess response to intervention and disease progression. ABI, however, may 
not change due to exercise intervention despite improvements in patient symptomatology. 
Therefore, the development and investigation of a non-invasive, subject effort-independent 
method to assess vascular function is highly desirable. In the future, reactive hyperemia response 
dynamics measured with PIVOT could potentially be used as a biomarker for disease progression 
and response to therapeutic intervention. In fact, progress is already being made toward 
investigating the potential of PIVOT to detect a treatment response. Building upon the study 
described in Chapter 5, 136 patients with PAD were scanned at baseline, randomized into either 
a supervised exercise rehabilitation (SER) program or standard medical care (SMC), and then 
returned for an identical follow-up visit after three months of intervention (Figure 6.1). The 
patients randomized to SMC continued their medical management as prescribed by their primary 
care physician or cardiologist, and those randomized to SER additionally met with a personal 
trainer and exercised three times per week for a period of approximately three months.   
The baseline and follow-up visits both consisted of a physiologic testing session as well 
as a reactive hyperemia MRI scan. Physiologic testing involved a treadmill-walking test using the 
Gardner protocol, which requires patients to walk on a treadmill at 2 mph initially with 0% incline 
and the incline is increased by 2% every 2 minutes. Patients indicate to study coordinators when 
they first experience pain (claudication onset time, COT), and when the pain limits their ability to 
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walk (peak walking time, PWT). For the reactive hyperemia scan, PIVOT was used to investigate 
the vascular function as described in Chapters 2 and 5.  
 
 
 
Figure 6.1. Study design for patients recruited to participate. Following screening 
and baseline testing visits, each patient was randomized into either supervised 
exercise rehabilitation or standard medical care. All patients returned for a follow-
up testing visit approximately 3-4 months after his or her baseline testing visit. 
 
112/136 patients returned for their follow-up visit 119±28 days after the baseline visit (19 
lost to follow-up, 5 presently enrolled). From the initial testing visit, significant correlations were 
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detected between ABI and reactive hyperemia response time across all patients, however no 
correlation was observed between ABI and reactive hyperemia response magnitude or between 
ABI and indices of functional disease impairment measured by treadmill-walking test (Figure 6.2). 
From baseline to follow-up, COT and PWT significantly increased in the SER group (paired t-test, 
p<0.0001 for both). COT significantly increased in the SMC group as well (paired t-test, p<0.01). 
From the MRI data, no significant differences were detected between the SER and SMC groups 
at baseline or follow-up for any metric. In the SER group, the change in peak perfusion between 
baseline and follow-up significantly increased in the peroneus (p<0.05) and when averaged 
across the whole leg (p<0.05) (Figure 6.3).   
 
131 
 
 
Figure 6.2. Correlation plots between treadmill-walking test and disease severity 
as assessed by ABI (a-b) and MRI-measured reactive hyperemia response 
metrics and ABI (c-h). Significant correlations exist between ABI and reactive 
hyperemia response time (e.g. time to peak perfusion, SvO2 washout time, and 
time to peak T2*). 
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Figure 6.3. Average measurements at baseline and follow-up for SMC (solid) 
and SER (striped). Error bars represent standard error. * indicates significant 
difference between SMC and SER groups (unpaired t-test), † significant within-
group difference between baseline and follow-up (paired t-test). All of the 
significant differences observed are displayed.   
 
This preliminary analysis showed that patients enrolled in a supervised exercise 
intervention had a significant increase in peak perfusion in the peroneus and across the entire 
cross-section of the leg. This response may be attributed to increased angiogenesis induced by 
exercise, however additional studies are needed to investigate that hypothesis. Moreover, since 
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the reactive hyperemia response time is highly correlated with ABI as seen in Figure 6.2 (which 
is primarily a marker of macrovascular disease), it may make sense that changes in response 
time are not observed since the stenoses, which are responsible for reducing the ABI, are 
relatively fixed. Future analyses will explore whether changes in the MRI-measures of vascular 
function are correlated with changes in physiologic response as measured by the treadmill-
walking tests, blood markers of angiogenesis, and patient quality of life questionnaires.  
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